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Abstract 
Insecticide resistance is an important aspect of pest control on both crop pests and vectors 
of animal diseases.  Resistance can be caused by a number of mechanisms, one of which is 
enhanced detoxification of the insecticide by metabolic enzymes.  Synergists may be used in 
insecticide formulations to inhibit metabolic defences in the insect, allowing the insecticide 
to reach its target site and kill the insect, thus enhancing the effect of the insecticide.    
 
This PhD project investigated the use of the synergist piperonyl butoxide (PBO) in 
combination with natural pyrethrins (tank mix) and as a pre-treatment prior to application of 
pyrethrins, as methods of enhancing the efficacy of the insecticide.  The insects studied were 
Myzus persicae, Bemisia tabaci and Musca domestica.  Results showed that the combination 
treatment (tank mix) was at least as good as, and sometimes better than, the pre-treatment. 
This is unlike the situation for synthetic pyrethroids where pre-treatments have been shown 
to be more effective than tank mixes.  It is proposed that for natural pyrethrins, PBO aids 
the penetration of the pyrethrins into the insect, and this enhancement effect is greater than 
full inhibition of the metabolic enzymes.  In some cases, the tank mix enabled less insecticide 
to be used to achieve 50 % mortality in resistant insects, compared to a susceptible 
population treated with pyrethrins alone.  
 
A novel laboratory assay was developed to enable the screening of botanical extracts for their 
ability to inhibit esterase enzymes.  This was used to test a range of compounds and those 
showing esterase inhibition were also screened for their ability to inhibit cytochrome P450 
activity.  The competency of some of these compounds as synergists was also tested in vivo 
with some showing potential activity both in vitro and in vivo.   
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1 CHAPTER ONE:  INTRODUCTION AND LITERATURE REVIEW  
Insects become pests in agriculture when they destroy crops and reduce yields thus becoming 
a nuisance to humans.  Some act as disease vectors, often with devastating consequences for 
crop performance.  In animal- and public-health, an insect is considered a pest when it 
carries disease, is an irritation, or makes living environments unsanitary.  Insecticides are used 
in agricultural farming and animal/public-health to keep the damage and disease caused by 
insect pests to a minimum.  The pyrethrins, the subject of this project, are a naturally 
occurring insecticide that is obtained from processing the Chrysanthemum flower.  Due to 
its high cost per unit dose and low environmental stability, cheaper and more stable 
synthetically derived pyrethroid insecticides have been developed using the natural pyrethrins 
as a template.  However, intensive use has meant that resistance to the synthetic pyrethroids 
is increasing and causing problems for pest-control.  This PhD project looks at refocusing on 
the natural pyrethrins for insect control and examines different methods and approaches to 
improve their efficacy.  
 
Resistance can be caused by a number of mechanisms which are discussed later in this 
chapter.  One of these mechanisms is enhanced detoxification of the insecticide by metabolic 
enzymes.  In this situation, synergists may be used in insecticide formulations to inhibit the 
metabolic defences in the insect, allowing the insecticide to reach its target site and kill the 
insect, thus enhancing the effect of the insecticide.   It is upon this principle that this PhD 
project is based.  The study first looks at the use of a well known synergist, Piperonyl 
Butoxide (PBO), and then moves on to testing other compounds for their ability to synergise 
natural pyrethrins and increase their efficacy. 
 
Since pyrethrins work by acting on the sodium channel in the nervous system of insects, this 
chapter begins with a brief overview of insecticide mode of action (section 1.1 and Table 1.1) 
and a description of the nervous system and how a normal nerve protein functions (section 
1.1.1).  Resistance is a growing problem in pest control (section 1.2) so the chapter then 
moves on to describe the different mechanisms that can cause resistance (section 1.2.1 and 
1.2.2), focussing on the enzymes capable of detoxifying insecticides (esterases, section 
1.2.1.1; cytochrome P450 monooxygenases, section 1.2.1.2; and glutathione S-transferases, 
section 0), and then a description of different target-site based resistance 
(acetylcholinesterase, section 1.2.2.1; and knock-down resistance (kdr)/super kdr, section 
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1.2.2.2).  There is then a brief description of cross and multiple resistance which, as explained 
in section 1.2.3, can increase resistance even further than resistance caused by a single factor.   
 
Over the years there has been much research performed to investigate the use of synergists 
to increase the efficacy of insecticides.  A synergist is a compound that if applied alone, 
would not exert a noticeable effect on the insect, but when applied with the insecticide, it 
enhances the effect of the insecticide.  Hence the introduction then moves on to describe the 
use of synergists for enhancing the efficacy of insecticides (section 1.3) and a relatively novel 
concept which uses a time delay between the application of the synergist and the insecticide 
(temporal synergism) (section 1.3.1).  With this section there is also a description of how the 
effect of a synergist on an insecticide can be measured (section 1.3.2).  The next section 
focuses on giving an overview of the pyrethrins, the main topic of this study, (section 1.4), 
looking at their chemistry (section 1.4.1), mode of action (section 1.4.2), residues, persistence 
and toxicity (section 1.4.3) and then a few examples of when synergists have been used with 
pyrethrins (section 1.4.4).  Since pyrethrins were used as the template for the synthetic 
pyrethroids, it is important to have an understanding of how the natural pyrethrins were 
improved upon to create synthetic pyrethroids (section 1.5).  The chapter finishes with the 
aims and objectives of this PhD project (section 1.6). 
 
1.1 Insecticide mode of action 
Insecticides are frequently classified by their mode of action.  Most affect one of five 
biological systems in insects: the nervous system; energy production; cuticle production; the 
endocrine system (insect growth regulators) and water balance.  There are several groups of 
insecticides that act on, and adversely affect, the nervous system and a brief description of 
each is given in Table 1.1.  This project focused on one of those groups of insecticides, the 
pyrethrins, which affect the sodium channel.   
1.1.1 Nervous systems and nerve proteins  
The nervous system consists of neurons (single nerve cells) connected to other neurons or 
muscle fibres through synapses (gaps) at the end of each neuron.  Incoming electrical signals 
are transformed by neurons into an electrical charge that travels the length of the neuron via 
the movement of ions in/out of the neuron through channels in the membrane of the 
neurons creating an action potential.  There are four main channels that enable different ions 
to move in and out of the neuron: sodium; potassium; calcium and chloride channels.  The 
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sodium channel has gates which allow the channel to open (to cause stimulation of the 
nerve) or close (to terminate a nerve signal) in response to a stimulus.   
 
When an electrical charge reaches the end of a neuron, a neurotransmitter (chemical 
transmitter) is released.  It crosses the synapse and binds to a receptor on the post-synaptic 
membrane of the next neuron.  The signal is then converted back into an electrical charge in 
the second neuron and is transmitted along the length of that neuron.  After transmitting its 
message across the synapse, the neurotransmitter is broken down and reabsorbed back into 
its originating neuron which is then left in this resting stage until the next signal is received, 
e.g. the neurotransmitter acetylcholine, is broken down and the choline is reabsorbed. 
 
Table 1.1  Summary of insecticides acting on the nervous system: their modes of 
action and effects 
Primary target site 
of action 
Chemical subgroup/ 
exemplifying active ingredient 
E.g. Active ingredients Mode of action Effect 
Acetylcholine 
esterase 
Carbamates 
Aldicarb, 
Methiocarb Synaptic poisons: bind to 
and inhibit the 
acetylcholinesterase enzyme 
that is normally responsible 
for breaking down the ACh 
ACh is not broken down and 
the neurotransmitter 
continues to cause the 
neuron to send the electric 
charge hence preventing 
termination of the nerve 
impulse. Continuous 
stimulation of the nerve leads 
to tremors, uncoordinated 
movement and death. 
Organophosphates 
Chlorpyrifos, 
Dimethoate, 
Malathion 
GABA-gated 
chloride channel 
receptor  
Cyclodiene 
organochlorines 
Endosulfan, 
Lindane 
Inhibit GABA-receptor 
Neurotransmitter is not able 
to close the chloride channel, 
thus electrical charge 
continues down the neuron 
leading to overstimulation of 
the nervous system and 
death. 
Phenylpyrazoles Fipronil 
Sodium channel 
Pyrethroids 
Allethrin, 
Cypermethrin, 
Deltamethrin, 
Fenvalerate, 
Permethrin  
 
Axonic poisons: bind to 
voltage-gated sodium 
channel,  
Prevent normal closure of 
the channel, thus continuous 
nerve firing leading to 
tremors and uncoordinated 
movement and death. 
Pyrethrins 
Pyrethrins 
(pyrethrum) 
Nicotinic 
acetylcholine 
receptor 
Neonicotinoids 
Acetamiprid, 
Imidacloprid, 
Thiamethoxam 
Antagonists of acetylcholine 
receptor (mimic action of 
ACh) 
Cholinesterase itself is not affected 
but nerve is continuously stimulated 
by the neonicotinoid itself which 
cannot terminate it.  Nervous system 
is overexcited leading to tremors and 
uncoordinated movement and death. 
Chloride channel 
Avermectins,  
Milbemycins 
Abamectin 
Stimulate GABA receptor 
thus activating the chloride 
channel to close 
Causes an inhibitory effect, nerve 
impulses are unable to travel down 
the chloride channel.  Leads to 
paralysis, insect stops feeding and 
consequently dies. 
 
1.1.2 Voltage-gated Sodium Channels 
The voltage-gated sodium channel, the point of the nervous system where the pyrethrins act, 
is a large transmembrane protein that regulates the flow of sodium ions across axonal 
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membranes mediating the rising phase of action potentials.  The name of the „para‟ voltage-
gated sodium channel (Nav) was derived from the location of the channel within the paralysis 
(para) locus on the Drosophila X chromosome, from which the channel was first cloned by 
Loughney et al. (1989).  The para channel has been found to be structurally and functionally 
homologous with the α-subunit of mammalian Nav channels (reviewed by Catterall, 2000).  
The structure of the channel can be seen in Figure 1.1. 
 
 
 
extracellular 
intracellular 
The voltage dependence of channel activation 
is considered to result from the movement of 
the 4 positively charged S4 segments 
Intracellular linkers 
connect domains 
S1-S4 helices assemble 
to form 4 independent 
voltage sensing domains 
(VSD) (only 2 are shown 
in this figure) 
Central aqueous pore is 
lined by the S5, S6 helices 
and S5, S6 linkers (P-
loops) 
P-loop: re-entrant 
hairpin loops form 
the narrow ion-
selective filter (at 
extracellular end of 
pore) 
 
Figure 1.1  The transmembrane structure of the voltage-gated sodium channel 
Adapted from Davies et al. (2007) 
 
The pore-forming α-subunit consists of a single polypeptide chain with 4 internally homologous domains (I-IV).  Each domain has 6 
membrane-spanning segments (transmembrane helices) (S1-S6).  The 4 domains assemble to form a central aqueous pore (PD).  In 
response to depolarisation the channel undergoes a conformational change which allows a selective influx of sodium ions (Na+) through the 
pore.  The S1-S4 helices are responsible for the voltage sensitivity of the channel – they assemble to form 4 independent voltage sensing 
domains (VSD).  
 
1.2 Insecticide resistance 
The World Health Organisation (WHO) defines insecticide-resistance as “the inherited 
ability of a strain or an organism to survive doses of toxicant that would kill the majority of 
individuals in a normal population of the same species” (WHO, 1957).  The extent to which 
insecticide resistance develops, and the rate at which it occurs, is dependent on a 
combination of chemical, genetic and biological factors.  These include the rate and 
frequency of application of insecticides used; the mode of action of the applied insecticide; 
whether resistance is monogenic or polygenic; the frequency of resistant genotypes and the 
strength (intensity) of resistance associated with each genotype; levels of inherent genetic 
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variation and the life-cycle and ecology of the insect species in question (Brown, 1990, Roush 
& Tabashnik, 1990, Hemingway & Ranson, 2000).  Short life cycles and production of 
abundant progeny enable insecticide resistance to evolve and the strong selection pressure of 
insecticide use results in rapid spread of resistance alleles through pest populations 
(Hemingway & Ranson, 2000). 
 
There are three main mechanisms by which insects can develop resistance to insecticides.  
There can be a change in the insects‟ cuticle which no longer allows the insecticide to 
penetrate (not discussed), detoxification of the insecticide by metabolic enzymes (section 
1.2.1) or target site resistance (section 1.2.2).  The most important mechanisms of resistance 
in insects are metabolic detoxification and target site resistance which can both occur in the 
same insect.  For example, Anopheles gambiae (Giles) (Diptera: Culicidae), Anopheles culicifacies 
(Diptera: Culicidae) and Anopheles subpictus (Grassi) (Diptera: Culicidae) have all been found 
with both elevated P450s (section 1.2.1.2) and kdr (section 1.2.2) (Karunaratne et al., 2007, 
Chen et al., 2008). 
 
1.2.1 Metabolic detoxification 
All xenobiotics, including naturally occurring plant allelochemicals as well as insecticides and 
their synergists, are at risk of detoxification (Bernard & Philogene, 1993) involving the 
transformation of the compound which ultimately reduces its capacity to interact with its 
target molecule (Figure 1.2).  At a biochemical level, detoxification involves three major 
groups of enzymes: esterases (section 1.2.1.1), cytochrome P-450 monooxygenases (section 
1.2.1.2), and glutathione S-transferases (GSTs) (section 0), which can metabolise many 
pesticides for example organochlorines, organophosphates (OPs), carbamates and 
pyrethroids.    In most, but not all cases, metabolic resistance can be detected in individual 
insects through increased quantities of enzyme compared to their susceptible counterpart 
(Brown & Brogdon, 1987, Hemingway, 1989, Hemingway et al., 1995) . 
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Figure 1.2  The general transformation pathway for most insecticides 
(after Hodgson, 1985) 
The rate of these metabolic reactions converting a toxic compound into a non-toxic compound involves two 
steps and is a critical factor in the development of resistance in pest populations. 
 
1.2.1.1 Esterase-based resistance 
Esterases are a group of phase I metabolic enzymes that are capable of hydrolysing 
compounds that contain ester bonds.  The increased esterase activity involved in insecticide 
resistance may be due to an altered enzyme with a higher catalytic rate, or from the esterases 
being present in elevated levels, through the process of gene amplification (Field et al., 1988, 
Devonshire et al., 1998, Hemingway et al., 1998, Hemingway, 2000), a spontaneous event 
which results in an increase in the copy number of one (or more) gene(s) in a genome.  This 
increase in activity was correlated by Field et al. (1988) to the level of resistance in Myzus 
persicae (Sulzer) (Hemiptera: Aphididae) and OP resistance in Culex species has been 
associated with increased esterase activity resulting from the amplification of the 
corresponding structural gene (Mouches et al., 1990, DeSilva et al., 1997). 
 
The esterases involved in insecticide metabolism include carboxylesterases, 
phosphorotriester hydrolases, carboxylamidases and epoxide hydrolases (Oppenoorth, 1985).  
Insect carboxylesterases are a large family of enzymes that work by hydrolysis and/or 
sequestration and have a significant role in insect resistance to many insecticides including 
OPs, carbamates and pyrethroids (Gupta & Dettbarn, 1993, Devonshire et al., 1998, Casida 
Insecticide 
(lipophilic) 
Metabolite 
(more 
hydrophilic) 
Phase I 
Final 
metabolite 
Phase II 
Involves a polar group being 
added onto the substrate 
Involves the addition of sugars, amino 
acids, sulfates or phosphate groups 
which increase the polarity 
Excreted 
Excreted 
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& Quistad, 2004, Stok et al., 2004).  Esterases hydrolyse ester bonds (on the insecticide) 
forming a carboxylic acid and an alcohol (Figure 1.3) with the rate of hydrolysis being 
dependent on the chemical structure of the insecticide (Devonshire & Moores, 1989). 
 
 
Figure 1.3  Esterase enzymes cleave esters by hydrolysis, forming a carboxylic acid 
and an alcohol 
 
In the peach-potato aphid, M. persicae, detoxification was first characterised biochemically by 
Devonshire (1977), who carried out enzyme purification studies and demonstrated that a 
single esterase isozyme (called E4) was highly over expressed in OP resistant clones.  E4 can 
account for as much as 1% of the total proteins in the aphid and confer broad spectrum 
resistance to OPs, carbamates, and pyrethroid insecticides by ester hydrolysis and 
sequestration (Devonshire & Moores, 1982).  When analysing insecticide-resistant M. persicae 
populations from Italian peach orchards, Mazzoni and Cravedi (2002) found that the over 
production of E4 and a variant, FE4, was common.  
 
Although many of the esterase studies have focussed on M. persicae, high levels of resistance-
associated esterases have been reported in other species, including Culex pipiens (Linnaeus) 
(Diptera: Culicidae) (Ben Cheikh et al., 2008, Yan et al., 2008) and Musca domestica (Linnaeus) 
(Diptera: Muscidae) (Zhang et al., 2007).  
 
Changes in the activity of esterases are caused by mutations in the esterase genes. For 
example OP resistance can occur in M. domestica when a single point mutation in an esterase 
gene confers a single amino acid substitution which results in a reduction in carboxylesterase 
hydrolysis, but increase in OP hydrolysis, so forming the mutant ali-esterase theory 
(Oppenoorth & Vanasperen, 1960).  Mutations in esterase genes and corresponding changes 
in the enzymes  have also been reported for other insect species, including OP resistant Culex 
tarsalis (Diptera: Culicidae) (Whyard et al., 1995), M. domestica (Claudianos et al., 1999) and the 
sheep blow fly, Lucilia cuprina (Wiedemann) (Diptera: Calliphoridae) (Campbell et al., 1998).   
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1.2.1.2 Cytochrome P450-based resistance 
Detoxification of insecticides has been frequently correlated to the action of mixed-function 
oxidases (MFOs) that catalyse a reaction that ends with the reduction of molecular oxygen 
(Casida, 1970).  Insects have a complex family of MFOs that are involved in the metabolism 
of xenobiotics and in endogenous metabolism of insect hormones, pheromones and fatty 
acids, where they are usually the rate limiting step in the chain (Terriere, 1984, Hodgson et al., 
1993).  
 
One group of MFOs are the cytochrome P450s (from here on termed P450s) which are 
haem-(iron) containing enzymes found in the endoplasmic reticulum of cells and with the 
ability to carry protons/electrons, thus having oxidative/reductive abilities (Feyereisen, 
1999).  P450s are phase I metabolic enzymes and are capable of oxidising both endogenous 
and exogenous compounds (Figure 1.2) and produce a pigment at 450nm which is formed 
by the absorbance of light at wavelengths near 450nm when the haem-iron is reduced and 
complexed to form carbon monoxide (Omura & Sato, 1964). 
 
P450s and P450-associated reductases are very diverse and have broad substrate specificity 
and catalytic versatility enabling them to give some level of resistance to all classes of 
insecticide (Feyereisen, 2005); metabolising pyrethroids, activating/detoxifying OPs and to a 
lesser extent, carbamates.  There are 25 P450 genes from 4 different gene families which 
have been found to be overproduced by the up-regulation of genes (reviewed by Li et al., 
2007).  Up-regulation is a genomic change that increases the production of an enzyme or 
protein without increasing the number of copies of the gene responsible for producing it. 
 
There are many reports of resistance due to P450s, for example: P450-mediated permethrin 
resistance that confers limited and larval-specific resistance in Culex pipiens quinquefasciatus 
(Say) (Diptera: Culicidae) (Hardstone et al., 2007) and increased levels of P450s in An. gambiae 
populations in an area of Kenya where permethrin-impregnated bed nets were used (Vulule 
et al., 1999).  In the latter the authors speculated that the use of the impregnated nets selected 
for higher oxidase and esterase levels.  Anopheles funestus (Giles) (Diptera: Culicidae), a major 
vector of malaria in Africa also has P450-based resistance to pyrethroid insecticides.  Amenya 
et al. (2008) identified a gene from the P450 CYP6 family, that is highly over-expressed in a 
pyrethroid-resistant strain of An. funestus and is genetically linked to a major locus associated 
with pyrethroid resistance in the population studied.  Later, Wondji et al.(2009) identified two 
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duplicated P450 genes (CYP6P9 and CYP6P4) which are associated with pyrethroid 
resistance in An. funestus. 
1.2.1.3 Glutathione-S-transferase based resistance 
Glutathione-S-transferases (GSTs) comprise a family of phase II metabolic dimeric 
multifunctional enzymes that play a role in the detoxification of a wide range of xenobiotics 
(reviewed by Li et al., 2007).  Generally, GSTs catalyse the conjugation of pesticides or their 
primary metabolites.  This conjugation neutralises the electrophilic sites of the lipophilic 
substrate (e.g. the insecticide) and protects the components of the cell, in particular, the 
nucleophilic oxygen and nitrogen of DNA from the electrophilic attack of nucleophiles.  The 
conjugation also causes GSTs to increase the water solubility of the conjugation product 
which then becomes more easily excreted from the cell (Clark, 1989, Enayati et al., 2005). 
 
Although elevated GST activity has been associated with resistance, in many cases the 
individual GST enzyme(s) involved have not been identified and the role of GSTs has only 
been established using model substrates (Enayati et al., 2005).  Where resistance can be linked 
to increases in the levels of specific GSTs, it was previously thought to be mainly due to gene 
amplification or increases in transcription, rather than changes in the enzymes (Grant & 
Hammock, 1992, Ranson et al., 2001).  Amplification or over-expression, have been reported 
in various insect species including OP-resistant M. domestica (Wang et al., 1991, Syvanen et al., 
1994); OP-resistant Plutella xylostella (Linnaeus) (Lepidoptera: Plutellidae) (Huang et al., 1998) 
and DDT-resistant An. gambiae (Prapanthadara et al., 1995, Ranson et al., 1997, Ranson et al., 
2001).  However, more recent studies have suggested the existence of at least one specific 
GST in conferring resistance.  Ding et al.(2003) performed expression profiling of the 
Epsilon class of GSTs which showed that this class is important in conferring insecticide 
resistance to DDT in An. gambiae. 
 
As a phase II metabolic enzyme, elevated GST activity has not been linked to the direct 
metabolism of pyrethroids but Vontas et al. (2001) suggest that they may play a role in 
conferring resistance to pyrethroids by detoxifying the lipid peroxidation products induced 
by pyrethoids and Kostaropoulous et al. (2001) suggest that GSTs may protect insects against 
the toxicity of pyrethoids by sequestering the insecticide. 
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1.2.2 Target-site resistance 
A change in an insecticidal target-site protein can lead to a reduction in sensitivity to the 
inhibiting action of the insecticide.  Target-site resistance gives specific resistance profiles, 
only conferring resistance to insecticides which attack that specific protein. Examples of 
altered target sites are modified acetylcholinesterase (MACE) and insensitive sodium 
channels (knock down resistance – kdr) (Oppenoorth, 1985, Devonshire et al., 1998).  The 
efficacy of pyrethrins and pyrethroids is decreased by the presence of kdr (section 1.2.2.2).  
 
1.2.2.1 Acetylcholinesterase (AChE) 
AChE is the target site for OP and carbamate insecticides (Aldridge, 1971).  At cholinergic 
nerve synapses and neuromuscular junctions, the neurotransmitter acetylcholine (ACh) is 
hydrolysed by AChE following transmission of the impulse so preventing the repeated firing 
of the postsynaptic nerve. When AChE is inhibited, repeated firing occurs resulting in 
uncoordinated movements and the eventual death of the insect (Toutant, 1989).  
 
Mutations that result in alterations in the primary structure of AChE reduce the level of 
inhibition by OPs and carbamates and confer resistance in insects and other arthropod 
species (Oppenoorth, 1985).  It was first found in the M. persicae - M. nicotianae complex in 
1990 (Moores et al., 1994) and in the UK, aphids with MACE were first identified in 1995 
from samples collected in suction traps.  In the following year aphids with insecticide-
insensitive AChE were found in eastern England, with the insensitivity being specifically to 
dimethylcarbamates, pirimicarb and triazamate (Foster et al., 1998).  Molecular studies have 
since shown that the reduced sensitivity of AChE is due to one or more point-mutations in 
the gene which lead to structural changes in the enzyme (Andrews et al., 2004). 
 
1.2.2.2 Knock-down resistance (kdr) and super-kdr 
First recognised by Busvine (1951), kdr has been found to be the most common form of 
resistance to DDT and pyrethroids.  Kdr results from modifications in the axonal sodium 
channel and is now known to be caused by a recessive allele conferring cross-resistance to 
both pyrethroids and pyrethrins, as well as DDT (and its analogues).  Kdr, which has been 
reported in many insect species, is often accompanied by a second resistance mutation (also 
recessive) termed super-kdr which confers much greater levels of resistance to pyrethroids 
(Farnham et al., 1987).   
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Various point mutations in sodium channel genes altering the amino acid sequence of the 
sodium channel protein have been shown to be responsible for causing DDT and pyrethroid 
resistance in a wide range of agricultural pests and disease vectors (Davies et al., 2007).  In a 
normal sodium channel, DDT and pyrethroid insecticides bind to sites in the channel, 
causing it to stay partially open and the nerve to fire continuously, but when kdr is present, 
there is a loss of insecticide binding, resulting in insecticide-insensitvity (Soderlund & 
Knipple, 2003).  Two amino acid substitutions, L1014F (in domain IIS6) and M918T (in 
domain IIS4-S5 channel linker) were originally identified in pyrethroid resistant housefly 
strains and were associated with high levels of resistance (Williamson et al., 1996).  This kdr 
mechanism involves a mutation in the sodium channel para-type gene which causes the 
replacement of a leucine by a phenylalanine.  The L1014F mutation was also identified 
cockroaches (Miyazaki et al., 1996) and several other insect species including M. persicae 
(Martinez-Torres et al., 1997).  For other kdr and super-kdr mutations, refer to Davies et al. 
(2007). 
 
 
Figure 1.4  Predicted binding sites for pyrethroids in the voltage-gated sodium 
channel 
The O‟Reilly model (O'Reilly et al., 2006) shows a hydrophobic cavity formed between the IIS4-S5 linker, the 
IIS5 helix and the IIIS6 helix.  There are several residues, thought to be involved in pyrethroid resistance, which 
face into this cavity.  The acid group is thought to be positioned „upwards‟ towards the inner side chains of IIS5 
and IIS6.  The central ester group is thought to be positioned close to hydrophilic residue T929, and the alcohol 
groups close to residues of the IIS5 and IIS4-S5 linker (e.g. L925 and M918).  The T929 residue on IIS5 helix 
appears to be a common binding determinant for all pyrethroids, regardless of their structure (O'Reilly et al., 
2006). 
 
 
Williamson et al., (1996) identified the mutations in the voltage-gated sodium channel 
associated with kdr to pyrethroids in houseflies and kdr has been found to be a major 
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mechanism for pyrethroid resistance in field populations of M. domestica (Huang et al., 2004). 
It is now thought that the esterase-based resistance of some M. persicae to pyrethroids is of 
secondary importance  to a kdr-type mechanism.  It is also thought that the modification of 
the sodium channel which causes kdr may not occur at the site at which the insecticide binds, 
but more likely in a region elsewhere, where the modification affects the conformation of the 
protein and where ion conductance of the sodium channel is modified (Davies et al., 2007).  
By contrast modifications of the sodium channel causing super-kdr are predicted to be at the 
actual binding site for pyrethroid insecticides (Figure 1.4) and the  change is thought to cause 
a rejection of the large cyclic side chains in the alcohol component of the pyrethroid 
molecules (Davies et al., 2007).  In normal circumstances, the alcohol component would bind 
strongly by electrostatic attraction and a number of van der Waals forces (O'Reilly et al., 
2006). 
 
1.2.3 Cross-resistance and multiple resistance 
Unlike target-site resistance, enzymatic detoxification has the potential to confer cross-
resistance to more than one toxin independent of their target site.   The occurrence of two or 
more resistance mechanisms in the same population (multiple resistance) has the potential to 
produce very high levels of resistance. 
 
The interaction of different mechanisms of resistance can be demonstrated using M. persicae 
where elevated E4 alone can give widespread resistance.  However, the combination of 
enhanced E4 and kdr gives an additional resistance to pyrethroids (Devonshire et al., 1998).  
The combination of enhanced E4 and an insensitive AChE target site gives widespread 
resistance plus additional high resistance to the insecticide pirimicarb (Moores et al., 1994, 
Devonshire et al., 1998).  The insensitive AChE target site in M. persicae is very specific: 
conferring resistance only to pirimicarb and triazamate.  It does not confer resistance to 
many OP and carbamates (Moores et al., 1994). 
 
Cross-resistance has also been found in M. domestica, for example by Sawicki et al. (1984) who 
demonstrated that very strong pyrethroid resistance could be achieved through the use of 
non-pyrethroid insecticides.  Sawicki reported that the sequential use of two different groups 
of insecticides (DDT and organophosphates) contributed to a rapid failure of pyrethroid 
insecticides by the selection for common resistance mechanisms.  This work was confirmed 
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with the production of a pyrethroid-resistant laboratory strain of housefly, by selection with 
only DDT and trichlophon (Sawicki et al., 1984). 
1.3 Synergists and synergism 
Metcalf (1967) defined insecticide synergists as non-toxic chemicals that are added to 
insecticides to increase the insecticidal lethality, or more generally, their effectiveness, against 
insect pests.  When used on its own, a synergist will not produce a notable effect on the 
insect.  However, when it is applied in combination with an insecticide, the synergist 
enhances the effect of the insecticide.  Synergists have been used commercially for over 60 
years and have contributed significantly to improve the efficacy of insecticides, especially 
those to which resistance has occurred (Metcalf, 1967, Bernard & Philogene, 1993).  The 
most efficient synergists are the ones that can interfere with the in vivo detoxification of the 
insecticide (Wilkinson & Hicks, 1969, Raffa & Priester, 1985, Scott, 1990) and the role of a 
synergist is usually related to its enzyme-inhibiting activity.   
 
 
a 
 
b 
 
Figure 1.5  Structures of a) sesamin and b) sesamolin 
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Figure 1.6  Synthesis of PBO from Safrole 
(after Casida & Quistad, 1995a) 
PBO is synthesised by the hydrogenation of safrole (which is extracted from the root-bark or fruits of sassafras 
plants, in the form of sassafras oil) chloromethylation, and the addition of the butylcarbityl side chains (Wachs 
1947). 
 
Hedenburg investigated the use of compounds containing the methylenedioxyphenyl (MDP) 
group as insecticides and although it was found that the insecticidal properties were poor, 
they gave encouraging results when used with pyrethrins.  One such compound was 
piperonyl cycloene. The synergistic activity of sesame oil was due to the sesamin and 
sesamolin components was also found to be due to the MDP ring (Casida & Quistad, 1995a) 
(Figure 1.5) and the investigations which followed led to the discovery and production of 
piperonyl butoxide (PBO).  A collaboration between Hendenburg and Wachs found PBO 
(Figure 1.6) to be the first truly effective and commercially viable synergist with advantages 
over piperonyl cycloene including complete miscibility with petroleum solvents (Wachs, 
1947).  It was originally, and still is, regarded as a potent P450 inhibitor (Hodgson & Levi, 
1998, Scott et al., 2000).  However, PBO has more recently been shown to inhibit resistance-
associated esterases in a wide range of agriculturally important pests (Moores et al., 1998a, 
Moores et al., 1998b, Young et al., 2005, 2006), therefore giving the possibility of enhancing 
insecticide efficacy in insects where either/both esterase and/or P450-based resistance 
mechanisms are present. 
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The mode of action of PBO in the inhibition of P450s is proposed to result from the 
formation of a stable metabolite (carbene) to form a P450 complex (Philpot & Hodgson, 
1972).  This is formed between the haem-iron of the P450 and the carbene that is formed 
when water is cleaved from the hydroxylated methylene carbon of the MDP compound 
(Dahl & Hodgson, 1979) (Figure 1.7). Little is known about the way in which PBO interacts 
with esterase enzymes. 
 
 
Figure 1.7  Oxidation of MDP compounds by cytochrome P450 
(after Hodgson & Levi, 1998) 
 
The ability of PBO to synergise the action of insecticides and overcome resistance has been 
demonstrated in many systems. For example Vulule et al. (1999) found significantly higher 
mortality rates in a permethrin-tolerant An. Gambiae colony in Kenya when the permethrin 
was synergised with PBO.  The colony of mosquitoes studied had increased esterase and 
oxidase levels and thus the authors speculated the synergism by PBO was due to the 
suppression of oxidases responsible for permethrin resistance. However it is likely that the 
PBO was also suppressing the esterases.   
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PBO has also been found to inhibit AChE and carboxylesterases in Bemisia tabaci 
(Gennadius) (Homoptera: Aleyrodidae) (Kang et al., 2006) and it is speculated that the high 
levels of synergism seen when PBO is used in combination with various insecticides, is due 
to PBO‟s multiple effects on esterases and AChE.  Gunning (2006) has also found PBO 
inhibited AChE in the cotton boll worm, Helicoverpa armigera (Hübner) (Lepidoptera: 
Noctuidae) and Wu et al. (2007) proposed that there is more than one target for PBO as 
indicated by its high levels of synergism being correlated to its multiple attack on the AChE 
or detoxification enzymes in various insect species. 
 
Cakir et al. (2008) studied the use of PBO as a synergist, with and without tetramethrin as a 
knock down agent, in combination with synthetic pyrethroids against different housefly 
populations.  They found that PBO promoted the ratio of knockdown to kill with the time 
taken for the knock down effect decreasing with the addition of tetramethrin, compared to 
PBO and insecticide, or insecticide only treatment. Synergism studies using PBO and 
synthetic pyrethroids along with tetramethrin as a knock down agent, have shown PBO to be 
very beneficial for the biological efficacy of the synthetic pyrethroids, with the PBO and 
tetramethrin combinations potentially giving a new option for household pest control. 
 
Synergists have also been used to identify the resistance mechanisms present in an insect 
population.  A recent study by Moores et al. (2009) investigated the use of a PBO analogue 
(16/5) to confirm resistance mechanisms.  As previously discussed, PBO is known to inhibit 
both microsomal oxidases and resistance-associated esterases thus making it an ideal 
synergist.  However, it‟s ability to diagnose resistance mechanisms is limited as it does not 
clarify which enzyme group is conferring resistance.  PBO analogue 16/5 is able to inhibit 
esterases but due to it‟s structure it is unable to inhibit microsomal oxidases.  By comparing 
the effect of PBO and the analogue, Moores et al. (2009) were able to confirm the 
identification of the metabolic mechanisms conferring pyrethroid resistance in a clone of M. 
persicae and strain of B. tabaci. 
 
When using synergists it is important to note that single inhibitors may not block the activity 
of all of the toxicologically relevant enzymes, so even if a synergist is applied, the resistance 
of the insect to a particular insecticide may not be overcome.  This is because resistance-
associated enzymes may be present but not inhibited by the synergist (Brown & Brogdon, 
1987) and a synergist that inhibits a specific metabolic enzyme in one species may not 
necessarily inhibit the enzymes in another species. For example DEF is commonly used to 
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inhibit resistance-associated esterases, but does not inhibit those present in Aphis gossypii 
(Glover) (Hemiptera: Aphididae) (Moores pers. comm.). 
 
1.3.1 Temporal synergism 
PBO is believed to work by binding to the insects‟ metabolic enzymes that would ordinarily 
detoxify the insecticide, before the insecticide can act on its target site.  With the metabolic 
enzymes bound to the synergist, the insecticide can act on its target site without being 
stopped by the enzymes. However, the inactivation of the metabolic enzymes may take time, 
for example, the topical application of PBO and biochemical analysis has shown that in B. 
tabaci and H. armigera PBO-esterase binding is relatively slow (in vivo) and a non-permanent 
process (Young et al., 2005).  Temporal synergism (Moores et al., 2005) is the application of a 
synergist prior to the application of the active insecticide several hours later and it has been 
shown to enhance the effectiveness of pyrethroids in B. tabaci, H. armigera, M. persicae, and A. 
gossypii (Young et al., 2005, 2006, Bingham et al., 2007) and carbamates and neonicotinoids in 
M. persicae, B. tabaci and A. gossyppi (Bingham et al., 2008). The work on temporal synergism 
has led to the development of microencapsulated formulations that deliver an initial burst of 
PBO followed several hours later by the active insecticide (Bingham et al., 2007).   
 
This idea forms part of the present study, whereby it is determined if the pre-application of a 
synergist to pyrethrin-resistant insect pests will enable the pyrethrin insecticide, applied 
several hours later, to act as it would in a susceptible insect and kill the insect rapidly.   
1.3.2 Calculating the effect of using a synergist 
The synergistsic factor (SF), also known as the synergistic ratio (SR) and the factor of 
synergism (FOS) can be calculated from the LC50 values, where the LC50 is the concentration 
of insecticide required to kill 50% of an insect population. 
SF  = LC50 insecticide  
LC50 synergised insecticide 
 
The SF evaluates the significance of the specific enzymes which are inhibited by the synergist 
for the detoxification of the insecticide, within a given strain of insects (Bernard & 
Philogene, 1993).  It is helpful to know the SF of a synergist to evaluate its efficacy when 
used in conjunction with a particular insecticide on a particular insect population.  It is 
important to note however that in calculating the SF certain aspects of the potential activity 
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of the synergist is overlooked, for example, the insects‟ behavioural responses (Bernard & 
Philogene, 1993).  The SF, measured in vivo, is dependent firstly on the synergist‟s ability to 
survive detoxification itself, enabling it to reach its target enzymes, and secondly, upon its 
inhibitory effect on the detoxifying enzymes which is measurable in vitro.   
 
The efficacy of the insecticide normally increases with the relative amount of synergist in the 
synergist/insecticide mixture (Bingham et al., 2007).  As sites on the detoxification protein 
are occupied by the synergist, the SF reaches a plateau (Brindley & Selim, 1984).  At such 
concentrations the synergist itself becomes toxic, which can interfere with the interpretation 
of the SFs.   
 
Resistance factors (RF), sometimes known as resistance ratios (RR) (with and without a 
synergist) can be used to identify the effects of the synergist on the levels of resistance when 
both a resistant and susceptible strain/clone are treated with the same compounds (Scott, 
1990): 
 
RF = LC50 resistant strain 
LC50 susceptible strain 
 
Another method of calculating the effect of a synergist, and the one which is used in the 
present study, is by use of the effective synergism ratio (ESR): 
 
ESR (effective synergism 
ratio) 
= LC50 for any given treatment and clone 
LC50 susceptible clone, insecticide only 
 
 
Calculating the RFs can establish the effect of certain treatments on populations of insects 
but has a major drawback in that it is only calculable if the treatment is tested against both a 
resistant and a susceptible clone/strain.  Not only is this not always practical but the effect of 
synergism may not be clear if the synergist also acts on the susceptible clone/strain.  
However, it does give an indication of how a population is responding to a certain treatment 
and hence is included in some analyses.  The RF describes how many times more insecticide 
is required on one strain/clone compared to another -normally, a resistant strain/clone 
compared to a susceptible strain/clone. 
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The ESR is a useful analysis tool alongside the RF as it gives a better representation of how a 
population responds to a treatment in relation to how a susceptible population responds to 
an insecticide only treatment.  This means that analysis can show how a treatment responds 
in relation to field control with a susceptible population.  An ESR of 1 means the treatment 
gives the resistant population of interest the same LC50 as the susceptible population after the 
resistant population has had a given treatment (e.g. synergist plus insecticide).  An ESR of 
less than 1 means the given treatment gives the population of interest a lower LC50 than the 
susceptible treated with insecticide alone and hence comparatively less insecticide is required 
to kill the resistant population (in the presence of the synergist) than the susceptible 
population.  An ESR greater than 1 means the treatment does not give an LC50 as low as the 
susceptible, ie more/different control would be needed in the field (Moores et al., 2009).  
 
Clearly, neither of the calculations overcome the difficulties where an LC50 has not been 
found in the dose ranges used in the experiments.   
 
1.4 Pyrethrum 
Pyrethrum is the generic name for the plant-based insecticide that is derived from the 
powdered, dried flower heads of the pyrethrum daisy, primarily Tanacetum cinerariaefolium, 
(formerly Chrysanthemum cinerariaefolium, of the family Asteracae) but also Chyrsanthemum 
coccineum and C. marshalli.  Pyrethrum daisies are native to South West Asia with the leading 
producers being Australia and Kenya (Casida & Quistad, 1995b).  The flower is dried and 
made into pellets and then the pyrethins are extracted using hexane.  The solvent is removed 
to leave a crude oleoresin with a pyrethrin content typically greater than 35 % (Carlson, 
1995).  The oleoresin is then refined to remove some of the impurities such as vegetable 
waxes and resins and produce a high quality product. 
 
Pyrethrum is a broad spectrum insecticide consisting of a group of insecticidal compounds 
with activity against a wide spectrum of insect species which work together to both repel and 
kill insects.  Pyrethrum is made up of six naturally occurring chemical esters, collectively 
termed pyrethrins (Crombie & Elliot, 1961) and these pyrethrins work as powerful insect 
nerve agents although they are low in toxicity to humans and other warm blooded animals 
(Tomlin, 2000), hence making them favourable over other insecticides when human and 
animal exposure is likely.   
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Of the hundreds of plants containing chemicals known to be toxic to insects, the pyrethrum 
daisy is one of the few which has been exploited commercially.  Natural pyrethrins have been 
very important because their chemical constitutions have been used as a template for the 
development of more cost effective and photostable synthetic pyrethroids (see section 1.5).  
A major problem with the use of pyrethrins is the high cost per unit dose.  Thus, over the 
years there have been attempts to extend the efficacy of natural pyrethrins and hence provide 
more economic feasibility, by use of synergists, namely PBO. 
1.4.1 Chemistry of pyrethrins 
Pyrethrum extract contains three naturally occurring closely related insecticidal esters of 
chrysanthemic acid (Pyrethrins I) which have a CH3 group on the acid moiety and three 
corresponding esters of pyrethric acid (Pyrethrins II) which have a CH3OC(O) on the acid 
moiety.  The alcohol constituent of the ester has three natural variations: pyrethrolone (in 
pyrethrin I and II), cinerolone (in cinerin I and II) and jasmolone (in jasmolin I and II) 
(Elliot & Janes, 1973).  All six structures can be seen in Figure 1.8.  Collectively, Pyrethrins I 
and II constitute 45-55% of pyrethrum extract with the remainder of the extract usually 
being comprised of sterols, triterpenols, alkanes, fatty acids from triglycerides and 
carotenoids (Maciver, 1995) (Table 1.2).  It is known that pyrethrins are altered by heat and 
light with heat inducing rearrangement and the formation of less active isopyrethrins and 
light inducing severe degradative changes (Maciver, 1995). 
 
Table 1.2  Chemical formulae and relative proportions of the six naturally occurring 
pyrethrin esters in a typical 50% extract of pyrethrum  
(Casida, 1973) 
 Constituent Chemical 
formula 
Proportion of ester in a typical 50 
% extract (%) 
Molecular weight 
Pyrethrins I 
(24.7%) 
Pyrethrin I C21H28O3 19.0 328.4 
Cinerin I C20H28O3   3.7 316.4 
Jasmolin I C21H30O3   2.0 330.4 
Pyrethrins II 
(25.3%) 
Pyrethrin II C22H28O5 17.5 372.4 
Cinerin II C21H28O5   5.8 360.4 
Jasmolin II C22H30O5   2.0 374.4 
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Figure 1.8  Individual pyrethrin esters that together make up „pyrethrum‟ 
(Casida & Quistad, 1995b) 
 
1.4.2 Mode of action 
Pyrethrins are fast acting contact nerve poisons that „knock down‟ susceptible insects leaving 
them paralysed (Klaassen et al., 1996, Tomlin, 2000).  The insecticide stimulates repetitive 
nerve discharges leading to paralysis although some insects can recover from the initial 
knock down effects if the dose is too low. 
 
The observed effects of the pyrethrins is mediated by binding to the sodium channel (see 
section 1.1.1).  Pyrethrins cause multiple action potentials in the nerve cells by delaying the 
closure of an ion channel (Costa, 1997). This disruption of the sodium channel leads to 
repetitive discharges by the nerve cell which causes paralysis and death (Crosby, 1995).  
Pyrethrins have also been shown to cause female mosquitoes to lose the ability to orientate 
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themselves thus preventing coordination for feeding by acting as blockers of neurosensing 
food searching mechanisms in female adult mosquitoes (Maciver, 1963, Maciver, 1964). 
 
1.4.3 Residues, persistence and toxicity  
Storage 
The storage conditions of pyrethrins are very important.  Atkinson et al., (2004) found that 
prolonged storage of harvested pyrethrum crops in storage sheds results in substantial (ca. 
65%) losses of pyrethrin esters (mainly pyrethrin-I and II esters).  After an initial rapid loss, 
pyrethrin content stabilised and it was reported that high temperatures increased the rate of 
degradation with moisture, oxygen and microbial activity playing minor roles (Atkinson et al., 
2004).  The authors suggested that in vivo the plant structure provides chemical or physical 
protection to the pyrethrins.  This is supported by the findings by Morris et al. (2006) that 
pyrethrins in planta do not degrade as rapidly as extracted pyrethrins.   
 
Environmental 
The loss of activity of extracted pyrethrins is a disadvantage for their use as an insecticide. 
They are rapidly degraded in sunlight (Ray, 1991, Crosby, 1995) although use of UV-
inhibiting agents can prolong activity. However, the benefits of protecting from pest re-
infestation must be weighed up against the concern over impact on beneficial species.  
Antonious et al. (2001) investigated the residues of pyrethrin-I and pyrethrin-II and PBO in 
soil for a PBO and pyrethrin sprayed potato crop grown in the field.  They compared 
different soil treatments and found that the residues in soil were higher in compost 
treatments than in no mulch treatments.   
 
Pyrethrin compounds are broken down in water and although their solubility is low they are 
highly toxic to fish and tadpoles - affecting their skin touch receptors and balance organs 
(Tomlin, 2000).  Pyrethrins are also moderately toxic to birds, including water birds such as 
ducks and can be toxic to beneficial insects (e.g. honeybees) and many aquatic invertebrates 
(Tomlin, 2000). Studies by Taiwo and Oso (1997) have shown that treatment of agricultural 
soils with pyrethrins caused an increase in the abundance of soil bacteria and a decrease in 
abundance of soil fungi.  The number of species present was less in the treated soils than in 
the untreated soils, with the end result being a reduction in the amount of important soil 
nitrogen.  Another study, conducted by the Central Rice Institute in India, showed that 
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pyrethrin treatment of rice fields reduced nitrogen fixation in the soil by up to 80% (Nayak et 
al., 1980). 
 
Animal/Human exposure 
After use, commercial preparations of pyrethrins can remain in the air and be deposited onto 
surfaces giving possible exposure of humans by inhalation or absorbance through the skin 
(Class & Kintrup, 1991).  However,  pyrethrin-I can be readily attacked in biological systems 
and thus, while pyrethrins are highly fat soluble, they are easily metabolised (Ray & Forshaw, 
2000) and seem therefore unlikely to accumulate in the body or food chain.  Antonious 
(2004) investigated the half-life of pyrethrins on field-grown peppers and tomatoes and 
reported that residues were generally higher on the leaves than on the fruits, and that the 
half-life values on the pepper and tomato fruits did not exceed 2 hours.  Thus where concern 
exists over synthetic pesticide residues on crops intended for human consumption, 
pyrethrins may be a suitable alternative, reducing the risk of human exposure to synthetic 
pesticide residues. 
 
1.4.4 Pyrethrins and synergists 
Most known synergists of pyrethrins contain an MDP ring (Casida, 1970).  Sesame oil was 
found to increase the activity of pyrethrins and was patented as a synergist by Eagleson 
(1940).  Further studies have shown that it is only the sesamin and sesamolin components 
that are synergistically active (Figure 1.5) (Haller et al., 1942a, Haller et al., 1942b, Beroza, 
1954) with sesamolin being found to be more potent than sesamin (Gersdorff et al., 1954).  
Limited studies have been performed on these compounds since the 1950s.  Sesamex (Figure 
1.9), with a structure analogous to sesamolin has been reported to possess very good 
synergistic activity (Mitchell, 1959). 
 
 
 
Figure 1.9  Structure of sesamex 
 
The idea that PBO could be used to synergise pyrethrins for the control of pests in stored 
products was introduced by Dove (1947).  Page and Blackith (1950) found that the 
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insecticidal activity of the pyrethrins, and their stability, could be increased by the addition of 
PBO.  Over the years there has been much research into the synergism of pyrethrins by 
PBO, some of which was reviewed by Casida and Quistad (1995b).  A wide range of 
PBO/pyrethrin-based insecticidal products have been developed, many of which are licensed 
for household use including fly sprays and mosquito coils.  
 
1.5 Synthetic pyrethroids 
For many decades, scientists have worked on improving the properties of natural pyrethrins 
by making analogs that are more potent, more stable and less expensive.  „Pyrethroids‟ is a 
generic term for the pyrethrins and their synthetic analogs.  Many synthetic pyrethroids have 
been made and the structures of some of those in common use are shown in Figure 1.10.  
The mode of action of pyrethroids is the same as that of the natural pyrethrins, acting on the 
sodium channel of the nervous system and causing overstimulation of the nerves and thus a 
loss of nervous control.  Pyrethroids are used against a range of insect pests of ornamentals, 
fruits, vegetables and other crops, also for household use and control of public health pests 
as well as being used in animal houses and as an animal ectoparasiticide.  Like natural 
pyrethrins, pyrethroids are generally toxic to birds, fish and bees.   
 
Synthetic pyrethroids are classified into type I or II pyrethroids depending on the presence 
or absence of a cyano moiety (-CN) at the α-position (Soderlund, 1995), with type II having 
this group (e.g. cypermethrin, deltamethrin) and type I being without the group (eg 
permethrin).  Type I pyrethroids cause poisoning of the peripheral nerves, seen as 
hyperexcitation/hyperactivity, loss of muscle coordination and whole body tremors.  Type II 
pyrethroids affect the central nervous system, causing uncontrolled movements and tremors.  
These have a more prolonged effect and produce higher levels of knock down.  Nasuti et al. 
(2003) noted that basic action of the two types of pyrethroids on the sodium channel is 
similar, although the degree of modification of the sodium currents is different, with single 
sodium currents being prolonged to a greater extent with type II‟s than type I‟s. 
 
A range of synthetic pyrethroids is shown in Figure 1.10 and the modifications for improved 
performance have been (reviewed by Khambay, 2002).  Briefly, some of the key 
modifications to the alcohol moiety are a benzyl group to replace the cyclopentenone, or an 
oxygen as a bridge instead of CH2, or in the acid moiety, dichlorovinyl to replace 
dimethylvinyl.  These are reported to give improved stability in terms of both metabolism 
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and photodegradation.  The volatility of pyrethroids has been improved by the use of 
polyfluorinated alcohol groups which gives greater control over flying insects.  Some 
synthetic pyrethroids show more persistence and a greater stability in the environment as a 
result of halides replacing the methyl group of the natural pyrethrins. 
 
Type I Type II 
 
 
Allethrin 
 
 
Cypermethrin 
 
 
 
Bifenthrin 
 
 
 
Alpha- cypermethrin 
 
 
 
Permethrin 
 
 
 
Deltamethrin 
 
Figure 1.10  Structures of some common synthetic pyrethroids 
(Tomlin, 2000) 
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1.6 Aims and objectives of the project 
 
The overall aim of this PhD project was to explore the use of the synergist Piperonyl 
Butoxide (PBO), and/or alternative botanical synergists, to increase the efficacy of natural 
pyrethrins against insect-pests. 
 
Specific objectives: 
a. To determine if adding PBO as a pre-treatment prior to the application of pyrethrins 
(Chapter Three) can increase the efficacy of natural pyrethrins against Myzus persicae, 
Bemisia tabaci and Musca domestica; compared to the more conventional method of using a 
tank mix treatment (Chapter Three); 
b. To optimise the pre-treatment time for PBO on Myzus persicae (Chapter Three); 
c. To investigate if microencapsulated PBO and pyrethrins enhances the efficacy of natural 
pyrethrins against Myzus persicae (Chapter Three); 
d. To develop a new biochemical assay to screen potential synergists in vitro for their ability 
to inhibit esterase activity and to validate this assay by revealing the inhibition of 
esterases by PBO in vitro (Chapter Four); 
e. To identify a potential new synergist(s) by first screening different compounds in vitro to 
investigate the putative synergist‟s ability to inhibit esterases (Chapter Five) and P450s 
(Chapter Five) and by in vivo studies looking at the putative synergists ability to penetrate 
the insect cuticle and then inhibit resistance associated esterases/P450s thus increasing 
the efficacy of natural pyrethrins against Myzus persicae (Chapter Five) and Musca domestica 
(Chapter Five). 
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2 CHAPTER TWO:  GENERAL MATERIALS AND METHODS 
This chapter describes the insects used in the study and their rearing conditions (section 2.1), 
the details about the insecticide and synergist formulations used (section 2.2) as well as a list 
of different chemicals used in experiments (section 2.3).  Standard experimental methods are 
described in detail (section 2.4), with specific methods being described in the relevant 
chapters.  Methods of data analysis are also described in this chapter (section 2.5). 
2.1 Insects  
This section describes the rearing methods for the insects used in the experiments for this 
PhD project.  The insect species used in each experiment were chosen based on the ease of 
rearing and availability, as well as suitability for the experimental methods used.  Myzus 
persicae (section 2.1.1) were chosen because they are easy to rear in large numbers and suitable 
for both leaf dip (section 2.4.7.1) and topical application bioassays (section 2.4.7.2); Bemisia 
tabaci (section 2.1.2) are easy to rear and suitable for leaf dip bioassay experiments, and Musca 
domestica (section 2.1.3) are relatively straight forward to rear and suitable for topical 
application bioassays.  Where synergist/insecticide solutions were dissolved in acetone, a 
topical application technique was used, whereas for water soluble formulations, a leaf-dip 
assay was used. 
2.1.1 Myzus persicae 
A resistant clone (794jz) was originally collected in Worcestershire (UK) in 1982 from a 
glasshouse.  It contains R3 levels of the resistance-associated esterase (E4) that catalogue it as 
being extremely resistant. This was determined by immunoassay (Devonshire et al., 1986).  It 
is also RR for kdr, based on direct DNA sequencing of PCR-amplified sodium channel gene 
fragments from aphid genomic DNA i.e. homozygous for the single base change causing an 
amino acid substitution from a leucine to a phenylalanine in the IIS4-IIS6 region, (mutation: 
L1014F) (Martinez-Torres et al., 1999).  A standard susceptible clone (4106a) was collected in 
2000 from a potato crop (determined using the methods described above). 
 
Parthenogenetic stock cultures of the two aphid clones (4106a and 794jz) were reared as 
described previously (Moores et al., 1994).  Briefly, clones were bred without insecticidal 
selection, and maintained on approximately 2-week-old Chinese Cabbage seedlings (Brassica 
rapa L. var. campestris cv. Wong-Bok) (Brassicaceae) in white fine-netted cages with a plastic 
base.  Cultures were reared in controlled environment rooms at 18 ± 2 C, 16 h : 8 h L : D 
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cycle.  The seedlings were planted 3 per pot, and 3 pots were used in each cage, watered 
from a tray below.  New cages were set up at approximately 10 day intervals by removing 
three leaves from infested plants and placing them onto the new seedlings.  Clones were then 
left for 2-3 weeks before the aphids were harvested and frozen at -20 C for use in the 
purification of E4 (section  2.4.2).  The frequent replacement of plants avoided aphid-
overcrowding and the production of winged morphs.   
 
The aphids used for bioassay were reared, without insecticidal selection, in Blackman boxes 
(Blackman, 1971) as described by Sawicki et al. (1980).  Two adults were placed in each box 
and their esterase levels tested four days later, with the nymphs being left to mature.  With 
respect to the resistant clone, boxes containing any nymphs from revertant aphids (Sawicki et 
al., 1980, Ffrenchconstant et al., 1988, Field et al., 1999) (based on results from esterase tests) 
were discarded.  The aphids were used for bioassay 11-15 days after boxes were set up.   
2.1.2 Bemisia tabaci 
Fours strains of B. tabaci were used in this study, with populations being set up from those 
that had been reared (without insecticidal selection) at Rothamsted Research.  Chloraka is a 
Q-type pyrethroid resistant strain that was collected from cucumber plants in Cyprus in 2003 
(Bingham et al., 2007).  Pirgos is a B-type pyrethroid resistant strain originally collected in 
Cyprus in 2003 (Bingham et al., 2007), and Mex-2-GRB is a laboratory cross between a B-
type Mexican and a B-type American strain.  Sud-S is the standard susceptible strain that was 
originally collected from the Sudan in 1978 (Bingham et al., 2007). 
 
Stock cultures of three pyrethroid-resistant and one susceptible whitefly strains (Chloraka, 
Pirgos, Mex2-GRB and Sud-S respectively) were reared on cotton plants (Gossypium hirsutum 
cv. Deltapine 16) (Malvaceae).  Strains were bred without insecticidal selection, and 
maintained on approximately four-week-old cotton seedlings in white fine-netted cages with 
a plastic base.  Cultures were reared in controlled environment rooms at 26 ± 2 C, 16 h : 8 
h, light:dark cycle.  The seedlings were planted 1 per pot, and 2 pots were used in each cage, 
watered from a tray below.  New cages were set up at approximately 28 day intervals by 
collecting a number of individuals from infested plants and placing them onto the new 
seedlings.  Strains were then left to lay eggs on the new plants and the subsequent adults 
collected approximately 4 weeks later for use in bioassays.  To ensure good insect quality, 
only adults less than 10 days old were used for in vitro and in vivo studies. 
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2.1.3 Musca domestica  
WHO is a susceptible standard reference strain developed and maintained at the WHO 
Collaborating Laboratory at the Department of Animal Biology, University of Pavia, Italy. 
The house flies used in the present investigation were progeny of a batch of pupae received 
at the Danish Pest Infestation Laboratory in 1988 (Kristensen, pers. comm.). 
 
The strain 381zb was collected in Denmark in 1978. It is an organophosphate-, carbamate- 
and pyrethroid-, multiresistant strain. The strain is submitted to periodic selection with 
topically applied permethrin and topically applied dimethoate. It is postulated that 
glutathione S-transferase and P450 monooxygenase activities, which are a part of the general 
detoxification system, are elevated in this strain and that this strain also contains the super-kdr 
mutation of the Na-channel gene causing resistance to pyrethroids (Kristensen, pers. comm.).  
This strain has been reported previously to be 1800-fold resistant to permethrin (Kristensen 
et al., 2004). 
 
Musca domestica were reared generally following Kristensen et al. (2006). Briefly, at all stages 
the flies were reared at 27 ± 1 C in a 16:8 h, light:dark cycle.  The adults (400-500) were 
kept in cages with an aluminium frame with a rectangular base (13.5 x 30 cm) and circular 
ends (24 cm diameter), covered with a clear polythene bag (perforated) (50 cm x 90 cm), 
closed with an elastic band.  On emergence from pupae, flies were fed on water, lump sugar, 
and a 1:1 mixture of dried milk powder and icing sugar (w/w).  Ten days after the pupae 
were collected (approximately 7 days after emergence as adults), flies were given a milk feed 
for 24 h with a concertinaed paper towel (surface for egg laying) in the dish containing whole 
milk.   After 24 h the milk was removed and the paper towel placed into a bucket containing 
larval medium. 
 
Larval medium was prepared in the larvae containers (5 L buckets) and was designed to 
mimic horse/cow dung.  The medium contained fresh yeast (10 g) and malted extract (15 g) 
mixed with approximately 50 ml warm water before diluting further with 1.25 L warm water.  
This was mixed into bran (400 g) and lucerne meal (200 g).  The buckets containing larvae 
and medium were covered with a breathable paper sheet and stored at 27 C.  For the first 
two days they were not touched, after 3 days, the medium was stirred daily with the stirring 
ceasing when the larvae began to pupate (after approximately 7 days). 
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Flies reared for bioassay were given only water and cube sugar for the first 4 days post 
emergence.  The milk/icing sugar mixture was supplied after 5 days so that the flies were all 
at the same stage of sexual development for bioassays.  Flies were used for bioassay 9-11 
days post-emergence. 
 
2.2 Insecticides and synergists 
Three pyrethrum extracts were supplied by Botanical Resources Australia (BRA; Devonport, 
Tasmania), one of approximately 50 % (w/v) pyrethrins (technical), one of approximately 1 
% (w/v) pyrethrins in an emulsifiable concentrate (EC) (dissolvable in water), and the third 
also an EC formulation of approximately 1 % pyrethrins and 4 % PBO (w/v).  A 90 % 
(w/v) PBO technical grade synergist was purchased from Sigma-Aldrich UK.  A separate 4 
% PBO EC (w/v) was made up according to a confidential BRA formulation using 
components provided by BRA with the exception of the PBO which was purchased from 
Sigma.  Two samples of microencapsulated pyrethrins were provided by CNR Istituto di 
Chimica Biomolecolare (Italy).  One sample consisted of ~12.5 % pyrethrins in a γ-
cyclodextrin complex, the other consisted of ~10% pyrethrins in a β-cyclodextrin complex. 
2.3 Chemicals 
All chemicals were stored at room temperature and purchased from Sigma-Aldrich (UK) 
unless otherwise stated: 
 Di-sodium hydrogen orthophosphate dodecahydrate (Na2HPO4.12H2O) 
 Anhydrous potassium phosphate monobasic (KH2PO4) 
 Sodium dihydrogen orthophosphate (dihydrate) (NaH2PO4.2H2O) 
 Ethylenediaminetetracetic acid (EDTA) ((HO2CCH2)2NCH2CH2N(CH2CO2H)2) 
 Dithiothreitol (DTT) (stored at 4 C) (HSCH2CH(OH)CH(OH)CH2SH) 
 Phenylthiourea (PTU) (C6H5NHCSNH2) 
 Phenylmethanesulfonyl fluoride (PMSF) (C7H7FO2S) 
 Sucrose (C12H22O11) 
 7-ethoxycoumarin (C11H10O3) 
 Dihydronicotinamide adenine dinucleotide phosphate tetrasodium salt (NADPH) (stored 
at -20 C) (C21H30N7O17P3.4C6H13N) 
 Fast Blue RR salt (stored at 4 C) (C15H14ClN3O3) 
 1-naphthyl-acetate (stored at -20 C) (CH3CO2C10H7) 
 acetylthiocholine iodide (ATChI) (stored at -20 C) ((CH3)3N(I)CH2CH2OCOCH3) 
 5,5‟-dithiobis(2-nitrobenzoic acid)   (DTNB) ([-SC6H3(NO2)CO2H]2) 
 Paraoxon (stored at 4 C) (O2NC6H4OP(O)(OC2H5)2) 
 Eserine (stored at 4 C) (C15H21N3O2) (> 98 %) 
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 Azamethiphos (Stored at 4 C) (C9H10ClN2O5PS) (analytical standard)  
 Triton X-100 (especially purified for membrane research) (purchased from Roche 
Diagnostics GmbH) 
 
2.4 Experimental methods 
See Appendix 1 for preparation of buffers and substrates. 
This sections describes the experimental methods used throughout the PhD project, and are 
specifically referred to in the relevant chapters of the thesis. 
2.4.1 Insect homogenisation 
Insects were homogenised in 0.02 M phosphate buffer (pH 7.0) in a tube (1.5 ml) using a 
plastic pestle.  Myzus persicae (25), approximately 50 B. tabaci, and 10 M. domestica heads were 
homogenised, each in a total of 1.5 ml of buffer.  
2.4.2 Purification of carboxylesterase E4 
Purification of E4 generally followed the protocol described by Devonshire(1977).  Briefly, 
frozen (-20 C) M. persicae (5.8g) were homogenised in 20 ml 0.02 M phosphate buffer (pH 
7.0) in a glass homogeniser using a motorised pestle.  The homogenate was cooled on ice and 
centrifuged at 10,000 g for 2 minutes (Eppendorf centrifuge 5810R: in Beckman centrifuge 
tubes).  The supernatant was loaded onto a Sephadex™ G-25 Fine column (Amersham 
Biosciences) (d:4 x h:15 cm).  Protein was eluted from the column using 0.02 M Tris/HCl 
buffer (pH 8.5) and collected in a conical flask.  The elute was then loaded onto an anion 
exchange column containing a pre-swollen micro-granular anion exchanger (DEAE-
Sepharose™ Fast Flow, Amersham Biosciences) (d:3 x h:10 cm) and eluted at 1 ml / min 
with a linear salt gradient of 0.02 M Tris/HCl (pH 8.5) to 0.02 M Tris/HCl (pH 8.5) plus 
0.35 M NaCl (total volume of 400 ml).  Fractions (5 ml) were collected and assayed for 
esterase activity (section 2.4.3), and the fractions with the highest activity were pooled then 
de-salted and buffer exchanged with 0.02 M phosphate buffer (pH 7.0) and concentrated to 
approximately 20 ml in a filtration concentrator (Amicon, Hertfordshire UK).  The purified 
E4 was then stored at -20 C in aliquots until required. 
2.4.3 Kinetic assay of esterase activity using 1-naphthyl acetate 
Measurement of total esterase activity 
Total esterase activity was measured in 96-well NUNC microplates (Fisher Scientific) using a 
colourimetric assay modified from Grant et al. (1989).  Esterase activity was determined by 
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measuring the rate of hydrolysis of the model substrate, 1-naphthyl acetate to 1-naphthol and 
acetic acid (Figure 2.1) as described by Gunning et al. (1998).   
 
A microplate was prepared with 25 µl of 0.02 M phosphate buffer (pH 7.0) in each well, 25 
µl insect homogenate and 200 µl substrate.  The plate was read on a Tmax kinetic Microplate 
Spectrophotometer (Molecular Devices Corporation; Menlo Park, California) at 450 nm at 
10 second intervals for 10 minutes.  Softmax Pro version 4.6 (Molecular Devices 
Corporation) was used to provide kinetic plots, the slopes of which were fitted by linear 
regression.  Controls consisting of substrate only were also performed and values achieved 
were subtracted from those of the samples. 
 
 
 
Figure 2.1  The hydrolysis of 1-naphthyl acetate to 1-naphthol and acetate by esterase 
enzymes 
1-naphthol reacts with FBRR (a diazonium salt) to produce a complex.  The faster the rate of production of the complex, the higher the 
level of esterase activity. 
 
 
The resistance status of aphids reared in Blackman boxes was checked by placing one aphid 
per well in a microplate and homogenising in 50 µl phosphate buffer using a multi-
homogeniser.  The homogenate (25 µl / well) was then transferred to a new microplate when 
the above protocol was then followed. 
 
2.4.4 Assay to measure AChE activity 
Kinetic reactions to measure the activity of acetylcholinesterase (AChE) in insect 
homogenates were performed according to Devonshire and Moores (1984) using a method 
developed initially by Ellman et al. (1961).  Acetylthiocholine iodide (ATChI), a synthetic 
substrate for AChE, is broken down to thiocholine and acetate by AChE (Figure 2.2).  The 
liberated thiocholine then reacts with dithiobisnitrobenzoate (DTNB), to give 2-
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nitrobenzoate-5-mercaptothiocholine and 2-nitro-5-thiobenzoate (Figure 2.3).  The 
enzymatic hydrolysis of the ATChI is determined colourimetrically by the characteristic 
absorbance of 2-nitro-5-thiobenzoate at 405nm for 10 minutes. 
 
 
 
Figure 2.2 The reaction whereby ATChI is broken down by AChE into thiocholine 
and acetate  
 
 
 
Figure 2.3  The reaction of dithionitrobenzoate (DTNB) with the liberated 
thiocholine.   
 
To measure AChE activity, a microplate was prepared with 25 µl insect homogenate, 75 µl 
0.02M phosphate buffer (pH 7.0), 100 µl DTNB (1.5 mM) and 100 µl ATChI (1.5 mM), 
unless otherwise stated in the relevant experimental sections, and read on a Tmax kinetic 
Microplate Spectrophotometer at 405nm at 10 second intervals for 10 minutes.   
2.4.5 „Esterase interference‟ assay 
Purified E4 was incubated with either PBO in acetone (3 mM final concentration, from a 0.3 
M stock) or acetone only (to give E4 + 1% acetone), overnight at 4 C.  A 96-well microplate 
CH3COSCH2CH2N
+
(CH3)3 I
- 
 
(CH3)3N
+
CH2CH2SH + CH3CO2
-
 
Acetylthiocholine iodide 
AChE 
thiocholine acetate 
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was prepared as follows: 25 µl 0.02 M phosphate buffer (pH 7.0) was pipetted into every well 
and 3 µl 10-6 M azamethiphos pipetted into the first well, which contained an additional 22 µl 
of buffer.  A 2-fold serial dilution of azamethiphos was performed by pipetting 25 µl from 
the first column to the next up to the penultimate column, from which the 25 µl was 
discarded.  The last column contained an additional 25 µl buffer only to act as a control.  To 
the wells of row A: 50 µl buffer was added to each well, to row B: 15 µl E4 and 35 µl 
phosphate buffer were added, and to row C: 15 µl E4 + 3 mM PBO and 35µl phosphate 
buffer.  The E4 was left to stand in the wells for 1 h at room temperature.  The resulting 
azamethiphos concentrations in the wells were (in nM): 20, 10, 5, 2.5, 1.25, 0.62, 0.31, 0.16, 
0.78, 0.039, and 0.020.  Musca domestica homogenate was prepared according to section 2.4.1 
with 0.1 % Triton X-100.  Homogenate (25 µl) was added to each column and left to stand 
for 15 minutes at room temperature, followed by 80 µl 1.5 mM DTNB (see appendix 1) and 
80 µl 1.5 mM ATChI (see appendix 1).  The plates were read as described in Section 2.4.4. 
 
Note: Housefly heads were used, rather than whole bodies, and were homogenised in Triton 
X-100 to release the enzyme (AChE) from the membrane.  In the presence of Triton X-100, 
AChE behaves kinetically as a single homogeneous enzyme (Devonshire, 1975). 
2.4.6 Assay to measure cytochrome P450 activity 
This assay involves two different steps: first the P450s from lamb‟s liver are prepared 
(section 2.4.6.1), then the assay to measure the activity of the P450s is performed (section 
2.4.6.2). 
2.4.6.1 Preparation of P450s from lamb‟s liver 
For the screening of putative synergists in chapter five, mixed function oxidases from lamb‟s 
liver were used.  A 1 g section of fresh lamb‟s liver was diced and wash in ice-cold buffer (0.1 
M sodium phosphate buffer (pH 7.6) containing 1 mM EDTA, 1 mM DTT, 1 mM PTU, 1 
mM PMSF, 1.46 M sucrose).  The liver was then homogenised in 1 ml of the above buffer 
(on ice) in a Teflon/glass homogeniser.  An aliquot of buffer was then diluted to three-fifths 
of its original concentration and used to dilute the homogenate to a 10 ml volume.  This 
homogenate was then centrifuged at 10,000 g for 15 minutes.  The supernatant was then 
centrifuged in a Beckman ultracentrifuge at 105,000 g for 1 hour.  The supernatant from the 
ultracentrifugation step was then discarded and the pellet resuspended in 1 ml of the three-
fifths diluted sodium phosphate buffer (described above) by using a syringe.  This MFO 
preparation was then stored at -80 C in 100 µl aliquots until required. 
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2.4.6.2  Activity assay: O-deethylase toward 7-ethoxycoumarin (ECOD) 
Substrate (20 mM 7-ethoxycoumarin, Figure 2.4) was prepared by dissolving 7-
ethoxycoumarin in 1 ml 100 % ethanol.  This was then diluted in 0.1 M sodium phosphate 
buffer (pH 7.8) to make 0.5 mM 7-ethoxycoumarin.  NADPH (dihydronicotinamide adenine 
dinucleotide phosphate tetrasodium salt, Mr = 833.35) (9.6 mM) was prepared in 0.1 M 
sodium phosphate buffer (pH 7.8). 
 
Figure 2.4  7-Ethoxycoumarin 
(Mr = 190.20) 
 
To determine the volume of liver homogenate to use in the assay, various volumes of 
enzyme and diluted sodium phosphate buffer (section 2.4.6.1) were aliquoted onto a white 
96-well microplate with three replicates, each giving a final volume of 50 µl.  Control wells 
contained 50 µl diluted sodium phosphate buffer (pH 7.6) only.  To each well, 80 µl 0.5 mM 
7-ethoxycoumarin was added and the plate was incubated at 30 C for 3 minutes.  To each 
well, 10 µl 9.6 mM NADPH was then added and the plate read at an excitation wavelength 
380 nm, emission wavelength 460 nm using a Victor2 1420 multilabel counter (Wallac, 
Milton Keynes, UK) every five minutes, for one hour.  The volume of homogenate to use in 
further assays was chosen based on its ability to give a linear response throughout the assay. 
 
2.4.7 Biological assays 
Biological assays were performed by two different methods, either a leaf-dip method (section 
2.4.7.1), or a topical application method (section 2.4.7.2).  The approach used was dependent 
upon the insect studied and the compounds being tested.  Where compounds were water 
soluble a leaf-dip approach was performed whereas compounds dissolved in acetone were 
applied by a topical application technique.  For both methods, at least five concentrations of 
insecticide were tested, plus a control (no insecticide), and each one was replicated three 
times. 
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2.4.7.1 Leaf-dip 
Myzus persicae – EC formulations and microencapsulations  
Chinese cabbage leaf discs (38mm diameter) were treated with dilutions of pyrethrins 
dissolved in distilled water from an emulsifiable concentrate (EC) (v/v) or a 
microencapsulated formulation (w/v).  Both were dissolved in distilled water and serial 
dilutions were made using distilled water (v/v).  For the EC formulations, a control of the 
EC formulation minus the active insecticide was also tested at the equivalent of the highest 
concentration.  
 
The discs were transferred onto 17 ml 1 % agar (made up with boiling tap water) in 30 ml 
pots (3 cm x 4.5 cm diameter) where they were laid, adaxial surface down to dry in a fume 
hood.  Each treatment was replicated three times.  Fluon was applied around the top inner 
surface of the pots using a cotton bud.  Ten aphids were placed onto each leaf disc and the 
pot was covered with a plastic lid with a hole in the top covered by a fine wire mesh for 
ventilation.  Bioassay dishes were placed in a room with conditions matching those for the 
insect rearing.  Mortality was scored after 72 h and moribund insects were counted as dead.  
 
For a PBO pre-treatment, the aphids were first placed on leaf discs that had been treated 
with PBO EC (from a stock of 4 %) at a pre-determined concentration (4 times that of the 
insecticide) for the pre-determined length of time before being transferred to pyrethrin-
treated leaf discs.   
 
For a tank mix treatment the PBO and pyrethrins (Py) were premixed by BRA in a ratio of 
4:1 (PBO:Py) and applied using the same approaches as for the pyrethrins that were 
described previously.  
 
Bemisia tabaci – EC formulations 
Cotton leaf discs (38 mm diameter) from the same species of plants used for rearing, were 
treated with pyrethrins from an emulsifiable concentrate (EC) dissolved in distilled water 
(v/v) and serial dilutions were made using distilled water (v/v).  A control of the EC 
formulation minus the active insecticide was also tested at the equivalent of the highest 
concentration.  
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The discs were transferred onto 7.5 ml 1 % agar (made up with boiling tap water) that filled 
the base of a Petri-dish (0.6 cm x 4 cm diameter) where they were laid, adaxial surface down 
to dry in a fume hood.  Each treatment was replicated three times.  Whiteflies were collected 
by battery operated pooter, briefly anaesthetised with CO2 and placed onto a freezer block 
covered by a cloth.  Females were collected by mouth pooter and briefly anaesthetised with 
CO2.  Approximately 10-20 female whiteflies were then distributed onto each leaf disc. The 
discs were covered with a close fitting lid (0.8 cm x 4 cm diameter) that had 4 small net 
covered air vents (0.4 cm diameter circles) and the dishes were then placed upside down.  
Bioassay dishes were placed in a room with conditions matching those for the insect rearing.  
Mortality was scored after 48 h (moribund insects were also counted as dead). 
 
For a PBO pre-treatment, a four week old cotton plant was sprayed with 500 ppm PBO EC 
(v/v) (prepared using distilled water) and left to dry in a fume hood for an hour.  Female 
whiteflies were collected as described above and then released onto the plant in a cage for 9 
h.  The whiteflies were then collected and distributed onto pyrethrin treated leaf discs as 
described above. 
 
For a tank mix treatment the PBO and pyrethrins were premixed by BRA in a ratio of 4:1 
(PBO:Py) and applied using the same approaches as for the pyrethrins that were described 
previously.  
 
2.4.7.2 Topical application 
Myzus persicae 
Leaf discs (38 mm diameter) were cut from Chinese Cabbage cv Wong Bok and placed, 
untreated, onto 17 ml 1 % agar and the pots set up as described above. Ten aphids were 
placed onto each leaf disc and left to „settle‟ for at least 30 min.  The aphids were then dosed 
individually with 0.25 µl of treatment (uncalibrated volume), in acetone, using a Burkard 
micro-applicator (Burkard Scientific; Uxbridge, Middlesex) and 1 ml glass syringe with a 25 g 
stainless steel needle.  Mortality was scored after 72 h (moribund insects were counted as 
dead). 
Musca domestica 
Male and female M. domestica were collected and separated for bioassays. Musca domestica were 
collected from rearing cages by battery operated pooter.  The flies were then briefly 
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anaethetised using CO2 and sexed with males/females being separated for bioassay.  Flies 
(15-25) were put into bioassay dishes which comprised a round, clear plastic tub (10 cm 
diameter x 3 cm) with a cylinder of paper acting as breathable sides (286 mm x 85 mm, rolled 
and stapled to fit inside plastic dish).  Half of a 10 cm Petri-dish was used as a lid.  The flies 
were given a milk soaked cotton wool pad for 24 h prior to bioassay, and water and cube 
sugar for the duration of their time in the bioassay pot.  Prior to dosing, the flies were chilled 
at 4 C for 30 min – 1 h and then briefly anaethetised with CO2 for dosing.  Individual flies 
were dosed topically with 1 µl compound in acetone (uncalibrated volume) on the dorsal 
thorax (avoiding the wings), using a Burkard micro-applicator and 1 ml glass syringe with a 
25 g stainless steel needle.  The control flies were weighed before they were dosed with 
acetone only.  All flies were kept in normal rearing conditions for the bioassay period.  The 
number of dead flies was recorded after 24 h and the LC50 in ppm / 20 mg fly calculated 
from the LC50 results achieved using PoloPlus and the weight of the control flies.  Mortality 
was scored after 24 h (moribund insects were counted as dead). 
 
2.5 Analysis of data 
Depending upon the experiment performed, different methods were used to analyse the 
data, as described below. 
2.5.1 Novel esterase assay data 
Data were analysed using Grafit (Leatherbarrow, R.J., Version 3.09b, Erithacus Software, 
Horley) to draw graphs of the data, fit curves (4-parameter logistic) and ultimately calculate 
the IC50 for the novel esterase assay (chapter 4).  Confidence limits for the novel esterase 
assay were calculated using the formula shown in Appendix II.  Methodology for processing 
data from the novel esterase assay was developed in accordance with advice from Salvador 
Gezan (Rothamsted Research, Harpenden, UK). 
2.5.2 Cytochrome P450 assay data 
The rate of increase in P450 activity over time for each replicate within each compound was 
calculated using Microsoft Excel (Office XP Edition). Then, the mean and SE of the mean 
of the rates were calculated for each putative synergist. Methodology for processing data 
from the P450 assay was developed in accordance with advice from Stephen Powers 
(Rothamsted Research, Harpenden, UK).  Briefly, data were loaded into Excel, and each 
replicate was plotted, to check for linearity over time. Linear regression was then applied to 
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estimate the rate of increase for each replicate. The mean rate of the replicates for each 
putative synergist was calculated, and the efficacy of each one was demonstrated by 
expressing the mean rate as a percentage of the control (P450 + acetone).  The standard 
errors shown for these values were calculated using the formula for the variance of a ratio 
(see Appendix III.) 
 
2.5.3 Bioassay data 
Raw bioassay data was inputted into PoloPlus (v 1.0, LeOra Software) which converts doses 
into logarithms and calculates the LC10, 50 and 90, the slope, chi squared and degrees of 
freedom.  Only the LC50 and subsequently calculated resistance factors and effective 
synergism ratios are displayed in data tables in this thesis but the data from the PoloPlus 
outputs can be found in the tables in the appendices.  PoloPlus estimates natural response 
when control mortality occurs in the bioassays.  If no mortality is observed among the 
controls then the natural response is assumed to be zero (Robertson et al., 2007).  The slope 
gives an indication of the heterogeneity, with steeper slopes being more homogeneous, and 
also gives an indication of the potency of the insecticide (a more potent insecticide can be 
seen by a steeper slope).  PoloPlus was also used to compare data sets derived from different 
treatments on the same insect strain/clone.  The equality test determines whether the slopes 
and intercepts of the regression lines are the same.  If they are, the treatment effects are 
deemed not to be significantly different.  If the hypothesis of equality is rejected, the 
treatment response lines are significantly different.  Summaries of LC50 values (derived from 
PoloPlus) and corresponding resistance ratios, effective synergism ratios and synergistic 
factors can be found in relevant sections in relevant experimental chapters.  A summary of 
the PoloPlus outputs can be found in the appendices (Appendix IV for Chapter Three, and 
Appendix V for Chapter Five). 
 
Resistance factors (RF) and effective synergism ratios (ESR) were calculated using the 
equations shown below: 
 
RF (resistance factor) = LC50 (for x treatment) resistant clone 
LC50 (for x treatment) susceptible clone 
 
 
ESR (effective synergism 
ratio) 
= LC50 for any given treatment and clone 
LC50 susceptible clone, insecticide only 
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Because the size of adult M. domestica varies, a lethal dose was calculated rather than a lethal 
concentration.  This was calculated for a standard 20 mg fly using the following formula:  
LC50 (ppm) 
(for a standard 
20 mg fly) 
= LC50 (ppm) x 20** 
Ave. weight (mg)* 
 
*Ave. weight = average weight of one fly based on weight of control flies used in test (mg) 
** x20:  for a 20 mg standard fly 
 
This calculation was performed as there is a size difference of approximately 25 % between 
male and female flies, (with females being larger).  This is thought to create a similar dilution 
factor of any chemical substance entering the fly (M. Kristensen pers. comm.).  Observations in 
this study, and by Kristensen (pers. comm.) indicate that taking the weight of the flies into 
account usually gives similar LD50 values for males and females. 
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3 CHAPTER THREE:  ENHANCING THE EFFICACY OF NATURAL 
PYRETHRINS USING PIPERONYL BUTOXIDE  
3.1 Introduction 
Biological assays are important for establishing the in vivo effect of a synergist and insecticide 
on an insect species.  Although piperonyl butoxide (PBO) (or an alternative synergist) may 
give promising results in vitro, it is not until these compounds are tested on live insects that 
their ability to successfully penetrate the insects‟ cuticle and thus act on their target metabolic 
enzymes, can be determined.   
 
The bioassay technique using a suitable dose range is very important for establishing the 
concentration of insecticide required to give 50% mortality in a population of insects (LC50).  
For each insect species, preliminary experiments were performed to identify the optimal 
parameters for pyrethrins and PBO/pyrethrin treatments.  Various bioassay techniques were 
tested and the final methods chosen were described in section 2.4.7.  The insects studied in 
this chapter are M. persicae, B. tabaci and M. domestica.   
 
As discussed in Chapter One, PBO is now known to inhibit non-specific esterases and 
insecticide action can be enhanced by a mixture of insecticide and synergist.  However, 
studies have shown that it is only by allowing sufficient time for the synergist to penetrate 
the insect and inhibit the metabolic enzymes, prior to exposure to insecticide (temporal 
synergism), that maximum control is obtained.  This has been demonstrated with various 
agricultural pests (Young et al., 2005, 2006, Bingham et al., 2007, Bingham et al., 2008).  In 
this chapter the use of PBO, in a combination treatment (tank mix) with pyrethrins, and as a 
pre-treatment, prior to treatment with pyrethrins are compared.  
 
This chapter describes: 
 the determination of the LC50 for pyrethrins against M. persicae, B. tabaci and M. 
domestica to give base-line data for comparisons; 
 the testing of the efficacy of a tank mix of PBO and pyrethrins against M. persicae, B. 
tabaci and M. domestica to assess if a tank mix increases the efficacy of natural 
pyrethrins; 
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 the testing of the effect of a PBO pre-treatment prior to treatment with pyrethrins 
on M. persicae, B. tabaci and M. domestica to assess if a pre-treatment increases the 
efficacy of natural pyrethrins, compared to a tank mix; 
 the use of PBO/pyrethrin microencapsulations on M. persicae to assess their effect on 
the efficacy of natural pyrethrins; 
 bioassays using a synthetic pyrethroid (alpha-cypermethrin) to act as a comparison to 
natural pyrethrins. 
 
The bioassays on M. domestica were performed at the Danish Pest Infestation Laboratories 
(DPIL) in Denmark under the supervision of Michael Kristensen.  All other experiments 
were performed at Rothamsted Research. 
 
3.2 Materials and Methods 
3.2.1 Bioassays 
Bioassays (pyrethrins only, PBO/pyrethrins tank mix and PBO pre-treatment) were 
performed on adult insects according to methods described in sections 2.4.7.1 and 2.4.7.2.  
Important specific details for bioassays, or unique experiments not already described in 
Chapter Two are described below.  
3.2.2 Determining the optimum pre-treatment time for PBO, followed by 
pyrethrins, for Myzus persicae 
Bioassays were performed according to section 2.4.7.2.  Adult M. persicae (794jz clone) were 
dosed topically with 480 ppm PBO in acetone at intervals to give different pre-treatment 
times ranging from 30 minutes to 10 hours.  All M. persicae were then dosed with 120 ppm 
pyrethrins in acetone after their allotted pre-treatment time.  Mortality was scored 72 hours 
after the pyrethrins treatment.  A tank mix treatment (480:120 ppm PBO:pyrethrins) was 
used as a comparison. 
3.2.3 Assessing the effect of a pre-treatment of PBO on the efficacy of natural 
pyrethrins 
Bioassays were performed according to methods described in sections 2.4.7.1 and 2.4.7.2.  
The pre-treatment times used were 5 hours for M. persicae, 9 hours for B. tabaci and 3 hours 
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for M. domestica.  The ratio of PBO to pyrethrins was 4:1 for all M. persicae and B. tabaci 
experiments and 5:1 for M. domestica. 
3.2.4 Assessing the effect of pyrethrin microencapsulations 
Beta- and gamma-microencapsulated pyrethrins were tested on M. persicae in a leaf dip 
bioassay according to methods described in section 2.4.7.1.  Where PBO was used, the ratio 
of PBO to microencapsulated pyrethrins was 4:1. 
3.2.5 Bioassays with alpha-cypermethrin 
Bioassays were performed on M. persicae according to methods described in section 2.4.7.2.  
The pre-treatment time was 5 hours and for all experiments involving PBO, the ratio of 
PBO to alpha-cypermethrin was 4:1. 
 
3.3 Results and discussion 
Ratios of PBO:pyrethrins of 4:1 for M. persicae and B. tabaci were chosen based on cost 
benefits and results of previous studies (Young et al., 2006).  A ratio of 5:1 was used for M. 
domestica as this had been used at the Danish Pest Infestation Laboratories and enabled direct 
comparisons of these experiments with previous work (whilst working in the laboratory in 
Denmark).  Results for M. domestica (for a pyrethrins only treatment, and a PBO/pyrethrins 
tank mix treatment) concurred with those found previously by Kristensen et al. (pers. comm.) 
indicating that the insect strains were unchanged. 
 
When pyrethrins were applied at a high concentration, each insect species showed a similar 
response.  Generally, insects were unable to move in a coordinated manner and often lost the 
ability to feed.  
 
The data shown in Table 3.1 (a-d) are the summaries of LC50 values for each insect species 
studied, and the corresponding RFs and ESRs were calculated using the equations shown in 
section 2.5.3.  The LC50 data are derived from the raw data inputted into PoloPlus.  The 
summary of the PoloPlus output can be found in Appendix IV.  The data is first discussed in 
terms of the base-line data (pyrethrins only treatments), then the effect of a tank mix of PBO 
and pyrethrins on the efficacy of pyrethrins (section 3.3.1), and following that, a discussion 
of the effect of a PBO pre-treatment in comparison to both pyrethrins alone, and to a tank 
mix (section 3.3.2).  Where a P-value is given, it denotes the result of a test for the hypothesis 
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of equality based upon the slopes and intercepts of the bioassay data, as explained in section 
2.5.3. 
 
Table 3.1  Lethal concentration for 50 % mortality (LC50), resistance factors (RF) and 
effective synergism ratios (ESR) for a) Myzus persicae using a topical application 
technique; bi) male Musca domestica using a topical application technique; bii) 
female Musca domestica using a topical application technique; c) Myzus persicae 
using a leaf-dip technique; d) Bemisia tabaci using a leaf-dip technique.   
For M. domestica, rather than a LC50, the LD50 for a 20mg standard fly is given. The corresponding appendix 
table number is given next to the table sub-headings in brackets. S: susceptible; R: resistant.  Clone/strain 
names are given underneath each sub-table. 
 
a) Myzus persicae, topical application bioassay (Table A-IV-Ia) 
Treatment LC50 (ppm) RF ESR 
S R S R S R 
Pyrethrins only 37.2 1630.7 1.0 43.8 1.0 43.8 
PBO/pyrethrins tank mix (4:1) 6.8 121.7 1.0 17.9 0.2 3.3 
PBO pre-treatment / Pyrethrins (4:1) 46.3 192.7 1.0 4.2 1.2 5.2 
S: 4106a clone; R: 794jz clone 
bi) Musca domestica (male), topical application bioassay (Table A-IV-Ib) 
Treatment LD50 (ppm) RF ESR 
S R S R S R 
Pyrethrins only 659.4 8513.8 1.0 12.9 1.0 12.9 
PBO/pyrethrins tank mix (5:1) 46.2 365.3 1.0 7.9 0.07 0.55 
PBO pre-treatment / pyrethrins (5:1) 81.3 404.5 1.0 5.0 0.12 0.62 
S: WHOij2; R: 381zb 
bii) Musca domestica (female), topical application bioassay (Table A-IV-Ib) 
Treatment LD50 (ppm) RF ESR 
S R S R S R 
Pyrethrins only 755.7 11251.9 1.0 14.9 1.0 14.9 
PBO/pyrethrins tank mix (5:1) 48.6 589.3 1.0 12.1 0.06 0.78 
PBO pre-treatment / pyrethrins (5:1) 71.2 570.7 1.0 8.0 0.09 0.76 
S: WHOij2; R: 381zb;  
c) Myzus persicae, leaf-dip bioassay (Table A-IV-Ic) 
Treatment LC50 (ppm) RF ESR 
S R S R S R 
Pyrethrins only 22.7 365.6 1.0 16.1 1.0 16.1 
PBO/pyrethrins tank mix (4:1) - 64.1 - NC - 2.8 
PBO pre-treatment / pyrethrins (4:1) - 46.1 - NC - 2.1 
S: 4106a clone; R: 794jz clone; NC: not calculable 
d) Bemisia tabaci (female), leaf-dip bioassay (Table A-IV-Id) 
Treatment 
LC50 (ppm) RF ESR 
S R1 R2 S R1 R2 S R1 R2 
Pyrethrins only 10.1 629.5 >1000 1.0 62.3 NC 1.0 62.3 NC 
PBO/pyrethrins tank mix (4:1) 11.1 173.8 37.4 1.0 15.7 3.4 1.1 17.2 3.7 
PBO pre-treatment / pyrethrins 
(4:1) 
10.5 199.8 95.1 1.0 19.0 9.1 1.0 19.8 9.4 
S: Sud-S; R1: Mex2-GRB; R2: Pirgos; NC: not calculable 
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Results of the topical application technique of pyrethrins on M. persicae can be seen in Table 
3.1a.  These results show that the susceptible clone (4106a) has a LC50 of 37.2 ppm and the 
resistant clone (794jz) has a LC50 of 1630.7 ppm, with a difference of 1593.5 ppm between 
these two clones.  The RF and ESR for the resistant clone are both 43.8 which means that 
the resistant clone requires 43.8 times more pyrethrins than the susceptible clone for the 
same level of mortality (50 %). 
 
Results of the topical application of pyrethrins on M. domestica can be seen in Table 3.1bi and 
bii.  These results show that the susceptible strain (WHOij2) has a LC50 of 659.4 ppm (males) 
and 755.7 ppm (females).  The resistant strain (381zb) has a LC50 of 8513.8 ppm (males) and 
11251.9 ppm (females).  The RF and ESR values are 12.9 for males and 14.9 for females 
indicating that the LC50 for resistant males is 12.9 times greater than for the susceptible 
males, and for females it is 14.9 times greater. 
 
Results of the leaf dip bioassays on M. persicae can be seen in Table 3.1c.  The susceptible 
clone (4106a) has a LC50 of 22.7 ppm and the resistant clone has a LC50 of 365.6 ppm which 
is 342.9 ppm greater than the susceptible clone.  The RF and ESR for the 794jz clone are 
16.1 thus 16.1 times more pyrethrins are required to kill the resistant clone than the 
susceptible clone using the leaf dip technique.  The LC50 of the resistant clone using the leaf 
dip technique is lower than that of the topical application technique.  
 
Results of the leaf dip bioassays on B. tabaci can be seen in Table 3.1d.  The susceptible strain 
(Sud-S) has a LC50 of 10.1 ppm.  One resistant strain (Mex2-GRB) has a LC50 of 629.5 ppm 
which makes it 619.5 ppm greater than the susceptible strain, and with an RF and ESR of 
62.3.  The other resistant strain (Pirgos) was not killed in the dose range tested and hence the 
LC50 is known to be >1000 ppm and the RF and ESR are not calculable. 
3.3.1 The effect of a tank mix of PBO and pyrethrins 
The summary of data from bioassays investigating the effect of a tank mix of PBO and 
pyrethrins can be seen in Table 3.1a-d.   
 
Results for a topical application of a PBO/pyrethrins tank mix to M. persicae can be seen in 
Table 3.1a.  Treatment of the susceptible clone (4106a) with the tank mix saw a reduction in 
LC50 from 37.2 ppm to 6.8 ppm which is a 30.4 ppm difference.  This indicates that in the 
apparently susceptible clone, the background metabolic defences are knocked out by the 
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presence of the PBO.  There is a significant difference between the results for the pyrethrins 
only treatment and the tank mix treatment.   The resistant clone (794jz) saw a decrease in 
LC50 from 1630.7 ppm to 121.7 ppm which is a difference of 1509 ppm.  This saw a 
corresponding fall in the RF which was reduced from 43.8 to 17.9, and a decrease in the ESR 
from 43.8 to 3.3.  The pyrethrin only treatment and tank mix treatment results are 
significantly different (P<0.05) (see section 2.5.3) and show a large decrease in LC50 when 
PBO is present.  Although this decrease in LC50 has occurred, the ESR is greater than 1.0 
and this shows that the resistant clone has a higher LC50 when treated with the 
PBO/pyrethrin tank mix, than the susceptible clone treated with pyrethrins alone. 
 
For M. domestica, the bioassay data, which can be seen in Table 3.1bi and bii, shows no 
significant differences between the LC50 values for males and females, for either pyrethrins 
alone or for tank mix treatments, regardless of the strain studied, shown by the overlapping 
confidence limits.  The exception to this was in the resistant strain tank mix treatment which 
showed a significant difference between males and females (P<0.05).  Separating flies into 
sexes before bioassay therefore may not be essential, although it is common practice and the 
preferred method.   
 
As can be seen in Table 3.1bi and bii, the decrease in LC50 comparing pyrethrins alone and 
the tank mix, was significant for both male and female M. domestica, and for both the resistant 
(381zb) and susceptible (WHOij2) strains (P<0.05), indicating that metabolism of pyrethrins 
was occurring in susceptible M. domestica.  The resistant strain saw a decrease in LC50 from 
8513.8 ppm to 365.3 ppm for males, and 11251.9 ppm to 589.3 ppm for females.  The 
decreases in RF were from 12.9 to 7.9 for males and 14.9 to 12.1 for females.  These had 
corresponding decreases in ESR values from 12.9 to 0.55 for males and 14.9 to 0.78 for 
females which show that with a PBO/pyrethrin tank mix the resistant strain has a lower LC50 
than the susceptible strain treated with pyrethrins alone. 
 
The susceptible strain of M. domestica also saw a decrease in LC50 values for both males and 
females, and corresponding decreases in ESR values so indicating that background metabolic 
defences were disabled by the presence of PBO in the tank mix treatment, thus enhancing 
the effect of the pyrethrins. 
 
Results for a tank mix leaf dip treatment on M. persicae can be seen in Table 3.1c.  Results 
show a significant reduction (P<0.05) in LC50 for the resistant clone (794jz) from 365 ppm 
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with a pyrethrins only treatment to 64 ppm with a tank mix.  This had a corresponding ESR 
decrease from 16.1 to 2.8 which means that the resistant clone still has a higher LC50 than the 
susceptible clone treated with pyrethrins EC only. 
 
The resistant clone of M. persicae, treated with pyrethrins EC as a leaf dip application, had a 
RF of 16.1, which is low compared to 43.8 for technical pyrethrins in a topical application.  
The susceptible clone also had a lower LC50 using the leaf dip of pyrethrins EC compared to 
technical pyrethrins.  The LC50 values for topical and leaf dip of pyrethrins EC were very 
different, 1630 ppm and 365 ppm respectively.  Thus it appears that components of the EC 
formulation reduced the LC50 either by inhibiting resistance-associated enzymes and/or 
aiding penetration of pyrethrins across the cuticle.  This is discussed further in Chapter 5. 
 
Results for tank mix treatments as leaf dip bioassays on B. tabaci can be seen in Table 3.1d.  
Results show that for the susceptible B. tabaci (Sud-S) a tank mix of PBO and pyrethrins had 
no significant effect on the LC50 (P>0.05) when compared with pyrethrins alone.  However, 
there was a clear difference in LC50 values for the Mex2-GRB strain which can be seen as a 
decrease from 629.5 ppm to 173.8 ppm.  This had a corresponding decrease in RF from 62.3 
to 15.7, and a decrease in ESR from 62.3 to 17.2.   
 
Unfortunately it was not possible to achieve an LC50 for pyrethrins alone for the Pirgos strain 
of B. tabaci using the dose range of these experiments, and higher concentrations could not 
be used because the pyrethrins EC left the leaf disc with a sticky residue.  The Pirgos strain 
had an ESR of 3.7 when a tank mix was used so although an LC50 was not achievable for a 
pyrethrin only treatment, it is clear that the tank mix has a beneficial effect on the efficacy of 
the pyrethrins since with the presence of PBO, pyrethrins were able to kill this resistant 
strain.  Thus overall, these results show the benefit of a tank mix on the efficacy of natural 
pyrethins against both resistant strains of B. tabaci tested but the tank mix treatment on the 
resistant strain does not reduce the LC50 values to less than those for the pyrethrin only 
treatment on the susceptible strain. 
 
Overall the results for all 3 insect species show that for resistant insects a tank mix of PBO 
and pyrethrins gave a significant reduction in LC50 values compared to pyrethrins alone, 
suggesting that in all cases the tank mix would be a better for field use than pyrethrins only, 
but this was only better than the susceptible strain treated with pyrethrins only, for M. 
domestica.  
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3.3.2 The effect of a pre-treatment of PBO prior to treatment with pyrethrins 
(compared to a tank mix of PBO and pyrethrins) 
Bioassays using a range of PBO pre-treatment times showed that for M. persicae PBO applied 
5 hours prior to treatment with pyrethrins was the most effective at increasing mortality 
(Figure 3.1).  Thus, 5 hours was used as the pre-treatment time for subsequent M. persicae 
experiments.  For B. tabaci a pre-treatment time of 9 hours was chosen for practical reasons 
and it is close to the 11 hours found to be the most effective by Young et al. (2006).  For M. 
domestica a 3 hour pre-treatment time was chosen based on the time available to complete the 
experiments whilst visiting DPIL in Denmark. 
 
 
Figure 3.1  The effect of a PBO pre-treatment (prior to application of natural 
pyrethrins) on the mortality of resistant adult Myzus persicae (794jz clone), 72 hours 
after dosing with pyrethrins 
Error bars show the standard deviation from the mean. 
 
Considering both the resistant and susceptible clones of M. persicae, the reduction in the LC50 
using a tank mix was greater than that using a pre-treatment.  This was unexpected since 
previous work had demonstrated that a PBO pre-treatment was more effective for synthetic 
pyrethroids.  It appears that for natural pyrethrins PBO could be enhancing the penetration 
of the pyrethrins through the insect cuticle and this effect is greatly diminished in the 5hr 
pre-treatment, i.e., although the optimum time for the inhibition of esterases by PBO is 5 
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hours, the effect of enhanced penetration through the cuticle is greater than the effect of 
inhibiting the esterases.  The results indicate that the enhanced penetration effect declines 
rapidly (mortality is reduced by more than 50 % after a 1 hour PBO pre-treatment).  The 
subsequent rise in mortality, to a peak at 5 hours could be due to the inhibitory binding 
effect that PBO has on the esterases (Figure 3.1). 
 
Results for M. persicae with a topical application of technical PBO and pyrethrins can be seen 
in Table 3.1a.  The susceptible clone saw an increase in LC50 from 37.2 ppm without a pre-
treatment, to 46.3 ppm with a PBO pre-treatment (discussed below).  The resistant clone 
(794jz) showed a decrease in LC50 of 1438 ppm, from 1630 ppm to 192.7 ppm with the pre-
treatment of PBO followed by application of pyrethrins.  The RF decreased from 43.8 to 4.2, 
and the ESR decreased from 43.8 to 5.2.  From the RF, it appears that the pre-treatment was 
more effective than the tank mix.  However, the ESR value for a tank mix is 3.27 thus there 
is an 8.4-fold difference in the ESR for a pre-treatment compared to pyrethrins alone, and a 
13.3-fold difference in the ESR for a tank mix compared to pyrethrins alone, indicating 
strongly that the tank mix is more effective.  However, the ESR is above 1.0 for both tank 
mix and pre-treatment thus control in the field would require more insecticide than the 
susceptible clone.   
 
Analysis using PoloPlus revealed a significant difference between the pre-treatment and tank 
mix on the resistant clone (P<0.05) for the topical application treatment.  The discrepancy 
between the RF suggesting that the pre-treatment is more effective, and the ESR showing 
the tank mix to be more effective, is due to the higher LC50 for the susceptible clone after a 5 
h pre-treatment with PBO.  This is because the RF is calculated using comparable treatments 
of the resistant and susceptible clones (see section 2.5.3) whereas the ESR looks at the 
difference between any given treatment and clone compared with the susceptible clone 
treated only with insecticide (see section 2.5.3).   
 
The higher LC50 seen in the susceptible clone of M. persicae (4106a) after a 5 hour PBO pre-
treatment compared with pyrethrins alone (Table 3.1a) could be due to the recovery of 
background enzymes, or possibly, an induction of more enzymes due to the PBO pre-
treatment.  However, statistical analysis showed the difference between the pyrethrins only 
treatment and a PBO pre-treatment followed by pyrethrins on the susceptible clone to be 
significant (P<0.05).  
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Induction of P450 activity by PBO has been found in mammals and insects (Skrinjar.M et al., 
1971, Yu & Terriere, 1974, Kinsler et al., 1990) but since Myzus persicae resistance is 
established to be due to over-expressed esterases it is felt this is unlikely to be an issue in this 
case. Similarly, Willoughby et al. (2007) found PBO induced expression of glutathione S-
transferase genes in Drosophila melanogaster, but this was only at the gene level and no evidence 
of increased levels of proteins were given.  Nevertheless, the possibility that PBO is inducing 
one or more detoxification enzymes in the current study cannot be discounted and would 
require further investigation.   
 
The results of the susceptible clone demonstrate the importance of calculating the ESR 
rather than RF, as discussed in Chapter Two.  For the susceptible clone there are very low 
levels of metabolic enzymes and therefore the enhanced penetration effect of PBO is more 
important than its ability to inhibit the enzymes.  As a result, the LC50 of the susceptible 
clone is not reduced as much as it is for the resistant clone.  Therefore in the susceptible 
clone with a pre-treatment of PBO prior to application of pyrethrins, the RF decreases but 
the ESR increases. 
 
Results for pre-treating resistant M. domestica (strain 381zb) with PBO prior to application of 
pyrethrins can be seen in Table 3.1bi and bii. For males there was a decrease in LC50 from 
8513.8 ppm to 404.5 ppm, and for females the reduction in LC50 was from 11251.9 ppm to 
570.7 ppm.  These LC50 values had corresponding reductions in RF, from 12.9 for the 
pyrethrins only treatment to 5.0 for the PBO pre-treatment followed by pyrethrins for males, 
and from 14.9 for the pyrethrins only treatment to 8.0 for the PBO pre-treatment followed 
by pyrethrins for females.  Both had corresponding reductions in ESR of over 19-fold.  
Statistical analysis of the results showed that a pre-treatment reduced the LC50 significantly, 
compared with a pyrethrins only treatment (P<0.05).   
 
Results for the susceptible strain of M. domestica show that a pre-treatment of PBO decreased 
the LC50 by 578.1 ppm, from 659.4 ppm for pyrethrins only treatment, to 81.3 ppm for a 
pre-treatment on males (Table 3.1bi).  A decrease of 684.5 ppm, from 755.7 ppm for 
pyrethrins only, to 71.2 ppm for a pre-treatment (Table 3.1bii) was seen for females.  When 
compared to a tank mix, the results showed that in susceptible M. domestica the tank mix 
worked more effectively than the pre-treatment (P<0.05).   
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In the resistant strain of M. domestica (381zb), the tank mix and pre-treatment gave similar 
results with overlapping confidence limits for the LC50 values.  The pre-treatment time for 
M. domestica was not optimised and if optimised, may improve the pre-treatment result 
further.  However, the results do correspond to those results found in the M. persicae 
bioassays whereby the tank mix was more effective than the pre-treatment at enhancing the 
efficacy of pyrethrins. 
 
Results for the leaf dip bioassay using a pre-treatment of PBO EC five hours prior to 
treatment with pyrethrins EC on M. persicae, can be seen in Table 3.1c.  With a pre-treatment, 
the LC50 was reduced from 365 ppm to 46.7 ppm.  Although the RF is not calculable for this 
experiment (as the susceptible clone was not given a pre-treatment) the ESR showed a 
reduction from 16.1 to 2.1 which means that although there was nearly an 8-fold decrease in 
the amount of insecticide required for 50 % mortality, this isn‟t as low as is required by the 
susceptible clone with a pyrethrins only treatment.  There was no significant difference 
between results for the tank mix and the PBO pre-treatment.   
 
Results for leaf-dip bioassays on B. tabaci can be seen in Table 3.1d.  Results show that a pre-
treatment of PBO gave no significant effect on Sud-S, the susceptible strain.  However, there 
was a significant difference in LC50 values between a pyrethrin only treatment and PBO pre-
treatment for the Mex2GRB strain (P<0.05) whereby the LC50 was reduced by 429.7 ppm, 
from 629.5 ppm to 199.8 ppm.  For this strain, the RF was reduced from 62.3 to 19 and the 
ESR was reduced more than 3-fold from 62.3 to 19.8.  The pre-treatment did therefore 
improve the efficacy of the pyrethrins, but not to the same extent that the pyrethrin only 
treatment has on the susceptible strain.  The LC50 for the Pirgos strain was reduced from 
>1000 ppm to 95 ppm.  For the pyrethrins only treatment the RF and ESR were not 
calculable but the ESR was reduced from „uncalculable‟ down to 9.4 with a pre-treatment.  
This means that the pre-treatment on the Pirgos strain was more effective than then pre-
treatment on the Mex2-GRB strain, perhaps due to different metabolic defences occurring in 
each strain, and more being eliminated in Pirgos by the pre-treatment than in Mex2-GRB.  
For both strains, the tank mix was more effective than the pre-treatment. 
 
Overall, the results show that although a PBO pre-treatment can significantly enhance the 
effect of natural pyrethrins, the effect is either less than, or not significantly different from 
the effect of a PBO and pyrethrin tank mix.  This was in contrast to the results found 
previously for PBO with synthetic pyrethroids (Young et al., 2006, Bingham et al., 2007). 
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3.3.3 The effect of pyrethrin microencapsulations 
The effect of pyrethrin microencapsulations was tested on resistant M. persicae and the results 
can be seen in Table 3.2.  When pyrethrins were incorporated into microencapsulations with 
either β-cyclodextrin or γ-cyclodextrin formulations, neither could kill the resistant clone of 
M. persicae using the dose range tested.  At the highest concentrations tested there was a white 
chalky residue of the formulation left on the leaf discs.  It is highly likely that the actual 
concentration of pyrethrins on the leaf disc was less than the calculated concentration as the 
solubility of the compounds is very low.  Solubility of the β-cyclodextrin formulation is 0.4 
mg/ml but the highest concentration used was 250 times greater than what is realistically 
soluble.  Likewise, solubility of the γ-cyclodextrin formulation is 0.2 mg/ml and the highest 
concentration used was 625 times greater.  As a consequence, the results achieved can only 
be considered as indicators of the effect of microencapsulated pyrethrins.  It would be 
interesting to look at formulations with improved solubility in the future.  
 
Table 3.2  Lethal concentration for 50 % mortality (LC50), resistance factors (RF) and 
effective synergism ratios (ESR) for a) Myzus persicae treated with β-cyclodextrin 
microencapsulated pyrethrins (leaf dip bioassay); and b) Myzus persicae treated with 
γ-cyclodextrin microencapsulated pyrethrins (leaf dip bioassay) 
The corresponding appendix table number is given next to the table sub-headings in brackets. S: susceptible; R: 
resistant.  Clone/strain names are given underneath each sub-table. 
 
a) Myzus persicae treated with β-cyclodextrin microencapsulated pyrethrins (leaf dip bioassay) (Table 
A-IV-II) 
Treatment LC50 (ppm) RF ESR 
S R S R S R 
Pyrethrins only 583.4 >10000 1.0 NC 1.0 NC 
PBO (EC) / pyrethrins tank mix (4:1) - 50.2 - NC - 0.086 
PBO (top app) / Pyrethrins (4:1) - 137.9 - NC - 0.236 
S: 4106a clone; R: 794jz clone; NC: not calculable 
b) Myzus persicae treated with γ-cyclodextrin microencapsulated pyrethrins (leaf dip bioassay) (Table 
A-IV-II) 
Treatment LC50 (ppm) RF ESR 
S R S R S R 
Pyrethrins only >1000 >10000 NC NC NC NC 
PBO (EC) / pyrethrins tank mix (4:1) - 64.9 - NC - NC 
PBO (top app) / Pyrethrins (4:1) - 261.4 - NC - NC 
S: 4106a clone; R: 794jz clone; NC: not calculable 
 
The susceptible clone of M. persicae had a LC50 of 583 ppm using β-cyclodextrin (Table 3.2a), 
however with the γ-cyclodextrin formulation, 50 % mortality could not be achieved within 
the dose range tested (Table 3.2b).  The LC50 for the susceptible clone using a β-cyclodextrin 
formulation was 25 times greater than when using BRA recipe pyrethrins in an emulsifiable 
concentrate and 1.5 times greater than the LC50 for the resistant clone (also treated with a 
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leaf dip of pyrethrins EC) (Table 3.2a).  It appears that the pyrethrins are more effectively 
released from the β-cyclodextrin complex since the susceptible clone survived a γ-
cyclodextrin formulation but not the β-cyclodextrin formulation.  Likewise, with the addition 
of PBO (both EC and topical application), the resistant clone had a lower LC50 when the β-
cyclodextrin formulation was used than with the γ-cyclodextrin formulation.   
 
The addition of PBO (both PBO EC and topical application of technical PBO) to the 
microencapsulated pyrethrins reduced the LC50 for the resistant clone to less than the LC50 
for the susceptible clone treated with microencapsulated pyrethrins alone.  The decrease in 
the ESR was only calculable for the β-cyclodextrin formulations (as the γ-cyclodextrin 
formulation did not kill the susceptible clone in the dose range tested) and this gave a 
dramatic effect for both PBO EC and topical application.  Where the LC50 was reduced from 
>10000 ppm down to 50.2 ppm for a PBO EC and microencapsulated treatment, and 137.9 
ppm for a topically applied technical PBO treatment with microencapsulated pyrethrins as a 
leaf dip, the ESR values were reduced from 1.0 to 0.086 and 0.236 respectively.  This means 
that the addition of PBO to a microencapsulated formulation has the ability to make the 
resistant clone more susceptible than the susceptible clone treated with pyrethrins alone.   
 
Although an ESR was not calculable for the γ-cyclodextrin results (because there was no 
LC50 value for the susceptible clone with γ-cyclodextrin), it was clear that the LC50 for the 
resistant clone was reduced to less than that for the susceptible clone, showing that both 
formulations have the ability to make the resistant clone of M. persicae more susceptible than 
the laboratory standard susceptible clone.  This is probably due to a physical effect whereby 
the microencapsulations are not releasing the pyrethrins from the complex and into solution, 
but the addition of PBO can alter the structure of the encapsulation, possibly by breaking up 
the cyclodextrin complexes.  The very low ESR seen for the PBO and β-cyclodextrin 
complex is not because the LC50 values are particularly low, but because the LC50 for the 
susceptible clone with pyrethrins only microencapsulation is high compared to the other 
results. 
 
Thus, these results suggest that for microencapsulated pyrethrins PBO can help the 
pyrethrins to be released from the microencapsulation complexes.  The LC50 values are lower 
for the PBO EC and microencapsulated pyrethrins treatment (both β- and γ-) compared to a 
topical application of PBO and microencapsulated pyrethrin treatment, but both methods 
showed a large reduction in the LC50 compared to microencapsulated pyrethrins alone.  It is 
Chapter Three Enhancing the Efficacy of Natural Pyrethrins using Piperonyl Butoxide 
 
54 
not possible to give a numerical value to this decrease in LC50 since it was not possible to 
achieve an LC50 without PBO.  With the PBO EC, the PBO was physically mixed into the 
microencapsulated formulations, whereas with the topical application of PBO, the PBO was 
applied directly onto the aphid.  For both a leaf dip and a topically applied treatment, PBO 
may also be acting as a synergist by inhibiting the metabolic defences in the insects but the 
higher LC50 for the topically applied treatment suggests that the main effect is that of a 
physiochemical reaction upon the encapsulation matrix. 
 
The LC50 values obtained in the microencapsulated pyrethrin experiments were very similar 
to those seen in PBO/pyrethrins EC leaf dip bioassays.  Taking into account the enhanced 
synergism using PBO EC with microencapsulated pyrethrins, the lower LC50 values and RFs 
using pyrethrin EC, as opposed to technical pyrethrins, and the greater levels of synergism 
when using PBO EC compared to technical, it appears that the components of the EC 
formulation enhanced the effects of the pyrethrins.  This is further discussed in Chapter Five 
where the components of the EC formulation were tested for their ability to inhibit 
resistance-associated esterases and P450s, and evaluated as synergists in vivo in bioassays. 
 
3.3.4 The effect of a PBO pre-treatment or tank mix with alpha-cypermethrin 
The results reported here have shown that a PBO pre-treatment followed by natural 
pyrethrins was no more effective than a tank mix.  This was in contrast to previous studies 
that involved either a PBO pre-treatment followed by treatment with a synthetic pyrethroid 
(Young et al., 2006, Bingham et al., 2007), or a microencapsulation of PBO and a synthetic 
pyrethroid (Bingham et al., 2007).  Bioassays using a topical application of PBO and alpha-
cypermethrin were therefore performed to confirm the integrity of the technical PBO and 
can be seen in Table 3.3.  These were similar experiments to those reported by Bingham et al. 
(2007) with the same insect species, Myzus persicae, and the same resistant clone, where a pre-
treatment of PBO reduced the LC50 for alpha-cypermethrin more than the tank mix.   
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Table 3.3  Lethal concentration for 50 % mortality (LC50), resistance factors (RF) and 
effective synergism ratios (ESR) for Myzus persicae treated with α-cypermethrin 
(topical application bioassay). 
(see appendix IV, Table A-IV-III) 
Treatment LC50 (ppm) RF ESR 
S R S R S R 
α-cypermethrin 0.495 3230.2 1.0 6525.7 1.0 6525.7 
PBO/α-cypermethrin tank mix (4:1) - 810.8 - NC - 1637.9 
PBO pre-treatment/α-cypermethrin  
(4:1) 
- 169.9 - NC - 343.2 
S: 4106a clone; R: 794jz clone; NC: not calculable 
 
Using a leaf dip approach, Bingham et al. (2007) reported that to achieve 50 % mortality the 
794jz clone needed 3460 ppm of alpha-cypermethrin when it was applied alone; 62.3 ppm 
for a tank mix with PBO; and 10.9 ppm for a pre-treatment with PBO.  As can be seen in 
Table 3.3, using a topical application the LC50 values were very different to those reported by 
Bingham et al., (2007) but in both cases there was a similar trend, with the pre-treatment 
being significantly more effective than a tank mix (P<0.05). 
 
These experiments have shown that there are differences in the effect of PBO either as a 
tank mix with pyrethrins or as a pre-treatment prior to pyrethrins, compared with a PBO 
tank mix or pre-treatment with the synthetic pyrethroid alpha-cypermethrin.  This may be 
due to PBO giving a greater penetration enhancement with pyrethrins than with the synthetic 
compound. 
 
3.4 General discussion 
General observations from all bioassays correspond with previous findings that pyrethrins 
have a rapid action whereby insects are knocked down and paralysis occurs, leading to death 
when the dose is sufficiently high (Stevenson, 1959).  This is because pyrethrins have an 
almost immediate effect of blocking nerve transmission.  It has been reported, and was 
observed in the experiments reported here, that at sub-lethal doses pyrethrins can also cause 
paralysis but the insect is able to recover, normally within a few hours, and the length of time 
of the paralysis may reflect the time required for the detoxification of the pyrethrins 
(Stevenson, 1959).   
 
In the present studies it was shown that with the addition of PBO, the effect of pyrethrins 
was enhanced for both resistant and susceptible insects.  The action on the susceptible 
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insects is probably due to the background esterases and/or P450s being blocked by PBO.  In 
resistant insects the esterases/P450s which are present in elevated levels are also blocked by 
PBO.  Thus, in the absence of the synergist, the pyrethrins are quickly detoxified and 
therefore the treatment with the synergist must be made either at the same time, or in 
advance of the pyrethrins treatment. 
 
The same paralysis effect on the insect was seen for both the pyrethrins and the 
PBO/pyrethrins mixes, which indicates that PBO is functioning by inhibiting the 
detoxification of the pyrethrins rather than by forming a complex with the pyrethrins.   
 
The results in this chapter have indicated that there are different levels of synergism 
occurring in the different insect species.  This may be because the level of detoxification 
mechanisms (esterases/P450s) are different in each species or it may be related to the 
potency of the pyrethrins in different species. 
 
This work used both topical application and leaf-dip bioassay techniques.  It is important to 
remember that a topical application, where the insecticide is absorbed directly through the 
insects‟ cuticle, bypasses any detoxification that would normally take place in the insects‟ 
digestive tract.  Therefore bioassay results from experiments using a leaf-dip technique 
cannot be compared directly with those using topical application and vice versa. 
 
Although PBO enhanced the effect of pyrethrins in all insects species studied, of the 3 insect 
species tested, M. domestica was the only one where using PBO as a tank mix or pre-treatment 
reduced the ESR to less than 1, showing that for this strain and species, less insecticide 
would be required to kill resistant insects than would be required to kill the susceptible strain. 
 
This work has tested the effect of PBO and pyrethrins compared with PBO and a synthetic 
pyrethroid.  Previous results have indicated that target-site insensitivity or knockdown 
resistance (kdr) and super-kdr do not affect pyrethrins in the same way, or to the same level, 
as they affect synthetic pyrethroids (Farnham et al., 1987).  Results in this chapter exemplify 
this by a lower LC50 for natural pyrethrins than for synthetic pyrethroids on insects with kdr.   
 
Davies et al. (2007) suggest kdr is caused by a change in the conformation of the target 
protein, the voltage-gated sodium channel rather than a mutation on the binding site itself.  
This conformational change, caused by an amino acid substitution (induced at the L1014 
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residue on domain II, S6) (Davies et al., 2007) means that the protein changes shape and as a 
result the insecticide may not fit/bind to the protein as well as it would in an unmutated one.  
The change in the protein caused by kdr is more apparent for synthetic pyrethroids than for 
natural pyrethrins.  This is thought to be because many synthetic pyrethroids tend to be 
much larger molecules, due to the phenoxybenzoyl moiety in the alcohol part, whereas the 
smaller and less bulky pyrethrins can still fit into the channel (albeit not as well as they might 
without the mutation) and thus are still able to act on the nervous system.  Therefore, in light 
of results found here, in the absence of target site resistance synthetic pyrethroids would be 
the insecticides of choice.  In the absence of resistance mechanisms, a synthetic pyrethroid 
will usually be more potent than natural pyrethrins.  However, if kdr or super-kdr are present, 
there is potential for the pyrethrins to be the more potent xenobiotic.  Therefore, if target-
site resistance is present, pyrethrins would be a good choice accompanied by PBO if 
metabolic resistance mechanisms are also present. 
 
This chapter has discussed the use of PBO as a synergist with pyrethrins.  On the whole 
results have shown that a tank mix of PBO and pyrethrins is as effective/more effective than 
a pre-treatment of PBO followed by treatment with pyrethrins.  
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4 CHAPTER FOUR: DEVELOPMENT OF A NEW BIOCHEMICAL 
ASSAY TO DEMONSTRATE THE INHIBITION OF ESTERASES BY 
PBO IN VITRO 
4.1 Introduction 
Both bioassays and field work have already shown that piperonyl butoxide (PBO) is an 
effective inhibitor of insect esterases in vivo (Young et al., 2005, 2006, Bingham et al., 2007, 
Bingham et al., 2008).  Biochemical assays provide fast and efficient methods of detecting 
esterase activity in single insects and can, in theory, determine whether or not the esterases 
can be inhibited by PBO.      
 
Such assays can reduce the need for extensive, time consuming and laborious biological 
assays by providing an alternative initial screening technique to identify resistance associated 
with elevated esterases.  This chapter considers the robustness of a standard 
spectrophotometric assay for detecting esterase activity (and the effect of PBO on the 
esterases), and the subsequent development of a new „esterase interference assay‟ better able 
to demonstrate the inhibition of resistance-associated esterases.  The principle behind the 
new assay is described in Figure 4.1.  Esterase activity is measured indirectly: The insecticide 
acts on the target site and is detected as low AChE activity.  With the addition of esterases, 
they will sequester the insecticide before it is able to act on the target site and this will be 
indicated by high AChE activity.  Incubation of a synergist with the esterases will block their 
activities, enabling the insecticide to act on its target site.  This will be indicated by low 
AChE activity.  The developmental stages of the assay are discussed in section 4.2. 
 
In contrast to this new assay, the standard spectrophotometric assay measures directly how 
esterase activity is affected by a serial dilution of PBO across a microplate but this is 
sometimes unable to detect PBO activity (Figure 4.2).  
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Figure 4.1  The interactions between the insecticide, target site, synergist and 
esterase enzymes, used as the basis for the „esterase interference assay‟. 
In this assay esterase activity is detected indirectly by measuring AChE activity.  A negative symbol denotes an inhibitory action. 
* measured by activity on a model substrate (ATChI) 
 
In this assay the AChE was supplied as a homogenate of M. domestica with Triton X-100 
(0.1%) added to solubilise the membrane-bound AChE.  The Triton X-100 was only added 
to the housefly homogenate and was not incubated with any esterases from other sources 
(e.g. E4) because experiments to investigate the use of 0.1 % Triton X-100 in the phosphate 
homogenisation buffer (to aid the release of the esterases into solution), had indicated that 
the Triton X-100 interfered with the binding of PBO to the esterase (p59 Bingham, 2007).   
 
4.1.1 Materials and methods 
Unless otherwise stated, the phosphate buffer referred to in the following methods was 0.02 
M phosphate buffer (pH 7.0). 
4.1.1.1 Standard spectrophotometric assay 
A 96-well microplate was prepared as follows: 50 µl phosphate buffer was added to each 
well, with an additional 22 µl buffer and 3 µl 0.3 M PBO (in acetone) added to the wells of 
the first column.  A three fold serial dilution of PBO was made across the plate by pipetting 
25 µl from the first column to the next, up to the penultimate column, from which the 25 µl 
was discarded.  The last column contained an additional 25 µl buffer only to act as a control 
Insecticide 
e.g. azamethiphos 
Target site 
e.g. AChE* 
Synergist 
e.g. PBO 
Esterase 
enzymes 
e.g. E4 
- - 
- 
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(no PBO).  A row containing a serial dilution of acetone was used as the acetone control.  
Insect homogenate (25 µl) was added to each well and the plate left to stand for 15 minutes 
at room temperature.  The resulting concentrations of PBO in the wells were 9000, 3000, 
1000, 333.3, 111.1, 37.04, 12.35, 4.115, 1.372, 0.457 and 0.152 µM.  After this time, the 
esterase substrate (200 µl 1 mM 1-naphthyl-acetate: see appendix I) was added to each well.  
The control well was used to calculate the inhibition of the esterases by PBO.    The plates 
were read as described in section 2.4.3.  In addition, pure E4 (see section 2.4.2) was 
incubated with PBO overnight as described above and the plate was read following the same 
protocol.   
 
4.1.1.2 Development of the new „esterase interference assay‟ 
Various initial experiments were performed in the development of this assay.  Firstly, the 
ATChI and DTNB, were examined both together and separately for any absorption at 405 
nm without any AChE present and neither showed any activity.   A serial dilution of acetone 
showed that acetone does not affect the level of AChE activity detected and an experiment 
using three different concentrations of housefly homogenate, diluted with phosphate buffer 
plus 0.1 % Triton X-100, (undiluted homogenate, 2-fold diluted homogenate, 5-fold diluted 
homogenate) showed that inhibition of AChE is not affected by the concentration of the 
housefly homogenate.  Acetone was incubated with E4 overnight but did not show any 
inhibitory effect on the E4.  Following these initial experiments, each step in the assay was 
optimised as follows: 
 
Step 1: Selecting the AChE inhibitor 
A 96-well microplate was prepared as follows: 50 µl phosphate buffer was pipetted into every 
well with a three-fold serial dilution of each AChE inhibitor to be tested across the plate 
starting with 3 µl in the first well, which contained an additional 22 µl of buffer.  A three-fold 
serial dilution of each inhibitor was then made by pipetting 25 µl from the first column to the 
next up to the penultimate column, from which the 25 µl was discarded.  The last column 
contained an additional 25 µl buffer only to act as a control (no AChE inhibitor).  A further 
25 µl phosphate buffer was added to each column.  A M. domestica homogenate was prepared 
as described in section 2.4.1 with 0.1% Triton X-100 and 25 µl was added to each column 
and left to stand for 15 minutes at room temperature and then 100 µl 1.5 mM DTNB and 
100 µl 1.5 mM ATChI were added (appendix I).  The plates were read as described in Section 
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2.4.4.  The AChE inhibitors tested were azamethiphos (10-5 M), eserine (10-2 M and 10-5M) 
and paraoxon (10-2 M and 10-5 M).  
 
Step 2: Assessing the effect of E4 on AChE inhibition 
A 96-well microplate was prepared as follows: 50 µl phosphate buffer was pipetted into every 
well with a three-fold serial dilution of azamethiphos in acetone (10-5 M) starting with 3 µl in 
the first well, which contained an additional 22 µl of buffer.  A three-fold serial dilution of 
azamethiphos was made by pipetting 25 µl from the first column to the next up to the 
penultimate column, from which the 25 µl was discarded.  The last column contained an 
additional 25 µl buffer only to act as a control (no azamethiphos).  To each row varying 
volumes of purified E4 (50, 40, 30, 20, 10, and 0 µl) and phosphate buffer (0, 10, 20, 30, 40, 
50 µl respectively) were added to give a combined final volume of 50 µl E4+phosphate 
buffer in each well.  The plate was left to stand at room temperature for 15 minutes.  A M. 
domestica homogenate was prepared according to section 2.4.1 with 0.1% Triton X-100 and 
this AChE source was added to each well (25µl) and left to stand for 10 minutes at room 
temperature, followed by the addition of 100 µl 1.5 mM DTNB and 100 µl 1.5 mM ATChI 
to each well (appendix I).  The plates were read as described in Section 2.4.4.  The 
experiment was repeated with a 2 hour incubation of the E4 and azamethiphos. 
 
Step 3: Assessing the effect of PBO on the E4 
Purified E4 was incubated with 3 mM PBO overnight at 4 C.  A 96-well microplate was 
prepared as described in step 2 above but with a row containing 50 µl E4 in each well, and a 
row containing 50 µl phosphate buffer, with an additional row on the microplate where each 
well contained 50 µl E4 + 3 mM PBO and 35 µl phosphate buffer. 
 
Step 4: Optimisation of the assay 
From the results of steps 1-3, the whole assay was optimised to use as little E4 as possible.  
The final protocol was: 
 
Purified E4 was incubated with either PBO in acetone (3 mM final concentration, from a 0.3 
M stock) or acetone only (to give E4 + 1% acetone), overnight at 4 C.  A 96-well microplate 
was prepared as follows: 25 µl 0.02 M phosphate buffer (pH 7.0) was pipetted into every well 
and 3 µl 10-6 M azamethiphos pipetted into the first well, which contained an additional 22 µl 
of buffer.  A 2-fold serial dilution of azamethiphos was performed by pipetting 25 µl from 
the first column to the next up to the penultimate column, from which the 25 µl was 
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discarded.  The last column contained an additional 25 µl buffer only to act as a control.  To 
the wells of row A: 50 µl buffer was added to each well, to row B: 15 µl E4 and 35 µl 
phosphate buffer were added, and to row C: 15 µl E4 + 3 mM PBO and 35µl phosphate 
buffer.  The E4 was left to stand in the wells for 1 h at room temperature.  The resulting 
azamethiphos concentrations in the wells were (in nM): 20, 10, 5, 2.5, 1.25, 0.62, 0.31, 0.16, 
0.78, 0.039, and 0.020.  Musca domestica homogenate was prepared according to section 2.4.1 
with 0.1 % Triton X-100.  Homogenate (25 µl) was added to each column and left to stand 
for 15 minutes at room temperature, followed by 80 µl 1.5 mM DTNB (see appendix 1) and 
80 µl 1.5 mM ATChI (see appendix 1).  The plates were read as described in Section 2.4.4.  
The assay was repeated starting with 0.03 M and 0.003 M stock PBO. 
 
4.2 Results and Discussion 
It has been reported that the sensitivity of resistant M. persicae, B. tabaci and H. armigera to 
insecticides as diverse as pyrethroids, carbamates and neonicotinoids can be increased by a 
pre-treatment of PBO (Young et al., 2005, 2006, Bingham et al., 2007, Bingham et al., 2008)  
This suggests that the synergist was blocking the enhanced metabolic activity, although in 
vitro assays have failed to show its effect (Gunning et al., 1998).  This was re-tested and the 
results of a standard spectrophotometric assay are shown in Figure 4.2.  There was no 
appreciable inhibition of esterase activity for either M. domestica or M. persicae, although the 
blockade of esterases from both B- and Q-type B. tabaci was seen.  This corresponded to 
previous in vivo studies of B-type B. tabaci but disagrees with in vivo studies on M. persicae 
(Young et al., 2005, 2006, Bingham et al., 2007).  Furthermore, an overnight incubation of 
pure E4 with PBO also failed to show inhibition of the enzyme (results not shown). 
 
Figure 4.2  Inhibition of esterases from 
different insect species, by PBO.  (Substrate: 
1-naphthyl acetate)   
Open circle: M. domestica, closed circle: M. persicae, open square: B-type B. 
tabaci, closed square: Q-type B. tabaci. 
 
Error bars shown illustrate the standard deviation derived from three 
replicates 
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Thus, the standard spectrophotometric assay is not always suitable for demonstrating PBO-
mediated inhibition of esterases since such inhibition cannot always be detected in vitro even 
when inferred from in vivo results (see Chapter Three). 
 
One conclusion from this could be that when PBO binds to the esterases of some insects, it 
does not do so at the hydrolytic active site of the esterase, and the inhibition cannot always 
be revealed by a conventional in vitro spectrophotometric assay (Figure 4.2) (Khot et al., 
2008).  It may be that different insects have slightly different sized/shaped esterases.  It is 
hypothesised, as illustrated in the conceptual model, (Figure 4.3) that in some insects the 
spatial distance between the two binding sites allows both the PBO and the substrate to bind 
(Figure 4.3a) e.g. M. persicae and M. domestica.  In others the spatial distance between the two 
binding sites is small so that when the PBO is bound, binding of the substrate is blocked 
(Figure 4.3b) e.g. B. tabaci.  Only in the latter case would the PBO inhibition be measurable 
by use of a model substrate.  This could explain why a standard esterase assay will reveal 
PBO-mediated inhibition of esterases from some insects but not others.  However, since the 
esterase/PBO „complex‟ has always been found to prevent the insecticide binding (Figure 
4.3c) PBO is acting as a synergist in vivo regardless of the spatial positions of the two binding 
sites. 
 
Figure 4.3  Diagrammatic representation of the binding of the substrate, PBO and 
insecticide to esterase enzymes 
a: PBO binds to the esterase but does not cover the active site for the substrate; b: PBO binds to the esterase: 
substrate is unable to bind; c: the binding of the insecticide covers both binding sites. 
 
This chapter focussed on the development of an assay to demonstrate the inhibition of 
esterases by PBO in vitro using the approach shown in Figure 4.1 where AChE activity is 
measured to indirectly detect the level of esterase activity.  It had been reported that the 
 
esterase PBO 
a. b. c. 
insecticide substrate 
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resistance-associated esterase from M. persicae (E4) had the ability to both hydrolyse and 
sequester xenobiotic compounds (Devonshire et al., 1983) hence this was chosen as the 
esterase for the assay.  Initial experiments tested various AChE inhibitors: eserine, paraoxon 
and azamethiphos (Figure 4.4).  They showed that paraoxon was not a suitable candidate for 
the assay as the concentration required was too high relative to the volume of E4 that would 
be required to sequester the AChE inhibitor.  Eserine showed potential to act as the AChE 
inhibitor in the assay but on the addition of E4 it was evident that E4 was not able to 
sequester the eserine (results not shown).  Azamethiphos did inhibit the AChE and E4 had 
the ability to sequester azamethiphos in volumes suitable for use in the assay. 
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Figure 4.4  Inhibition of AChE by 
eserine, paraoxon and azamethiphos.   
Grey square and open square: eserine from stock concentration 
of 10-2 M and 10-5 M respectively, grey triangle and open 
triangle: paraoxon from stock concentration of 10-2 M and 10-5 
M respectively; open circle: azamethiphos from stock 
concentration 10-6 M. 
 
 
Thus azamethiphos was selected as the AChE inhibitor.  The next stage was to test different 
volumes of E4 to identify how much would be required to sequester the azamethiphos 
(rendering it unable to act on the AChE).  Five dilutions of pure E4 were tested (Figure 4.5 
and Table 4.1)  The results showed that the greater the molar proportion of esterase to 
azamethiphos, the higher the concentration of azamethiphos required to inhibit the AChE, 
demonstrating directly that E4 sequesters the azamethiphos. 
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Figure 4.5  E4 protection of the 
inhibition of M. domestica AChE 
activity by azamethiphos. 
Open circle: No E4.  Closed circle through to light grey circle 
(five shades): 50, 40, 30, 20, and 10 µl E4 used in the assay. 
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Table 4.1  Concentration of azamethiphos required for 50 % inhibition of AChE 
activity  (IC50) in the presence and absence of E4. 
Volume of E4 per well (µl) IC50 (nM) SE 
0 1.12 0.02 
50 37.89 0.71 
40 18.27 1.41 
30 8.41 0.48 
20 4.27 0.25 
10 3.64 0.20 
SE refers to the standard error of the IC50 value derived from the fitted curve. 
 
 
The assay was then tested using E4 incubated with different concentrations of PBO (3 mM, 
0.3 mM and 0.03 mM) to see how much was needed to get complete inhibition of the E4 
(Figure 4.6).  Both 0.3 mM and 3 mM PBO gave similar results, whilst with 0.03 mM there 
was little esterase blockade. Since the primary purpose of the assay was to explain the lack of 
esterase inhibition seen in a conventional assay it was decided that E4 + 3 mM PBO would 
provide the optimum concentration to use.  Although this may seem high, it is equivalent to 
0.1% PBO which is the concentration that has been used for previous in vivo experiments 
and trials (Young et al., 2005, 2006).  This part of the assay showed that the addition of PBO 
to the E4 prevented the esterase from binding to the azamethiphos, so enabling the inhibitor 
to act on the target site (Figure 4.6). 
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Figure 4.6 Inhibition of Musca 
domestica AChE activity with E4 and 
E4 plus PBO. 
Open circle: no E4 (AChE only); closed circle: E4; open square: 
E4 + 3 mM PBO; light grey square: E4 + 0.3 mM PBO; dark grey 
square: E4 + 0.03 mM PBO. 
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Table 4.2  Concentration of azamethiphos required for 50% inhibition of AChE 
activity (IC50) in the presence and absence of E4, and in the presence of E4 + PBO. 
Corresponds to Figure 4.6.  Percentages relate to Figure 4.7. 
 
Sample IC50 (nM) SE 
AChE only (No E4) 0.19 0.01 
E4 7.92 0.44 
E4+3mM PBO 0.46 0.02 
E4+0.3mM PBO 0.55 0.06 
E4+0.03mM PBO 3.40 0.25 
SE refers to the standard error of the IC50 value derived from the fitted curve. 
 
The molarities of the azamethiphos and E4 present in the reactions were calculated to 
compare the relative quantities required for the inhibition.  Calculating the molar amounts of 
azamethiphos and E4 at the point at which AChE activity is just inhibited, i.e. the point at 
which azamethiphos has overcome the sequestering effects of the esterase, gave a result of 
around 5 pmoles of E4 and 1.5 pmoles azamethiphos. This suggests a near-stoichiometric 
binding between E4 and azamethiphos. The molar amount of PBO present is appreciably 
higher (4 nmoles). The assay curve and hence blockade of E4 was not significantly different 
when the assay was repeated with an incubation of E4 + 0.3 mM PBO, but blockade was 
almost absent using an incubation of 0.03 mM PBO (Figure 4.6). However, to be certain of 
this inhibitory effect, 3 mM PBO in the incubation was judged to be the most robust 
concentration to use as it gave an excess of PBO. 
 
Theoretically, a high-throughput method could be created by using a „diagnostic window‟ i.e. 
the concentration at which AChE activity is at a maximum when E4 is present and at a 
minimum with no E4 or E4 + PBO.  This would enable fast screening of potential synergists 
and reduce the volume of E4 required for the assay by comparing the E4, and E4 + synergist 
against only one concentration of azamethiphos.  The concentration of azamethiphos to be 
used would be based on the point just before the sigmoid curve approaches zero AChE 
activity (%) displaying the protection that the E4 gives to the AChE (illustrated by the box in 
Figure 4.7).  Thus, providing the diagnostic window is known (i.e. the concentration of 
azamethiphos to use) only the three wells highlighted by the box would need to be run in the 
assay.  The AChE activity of the three points highlighted in Figure 4.7 are shown in Figure 
4.8.  These show that a diagnostic window can be used confidently to accurately determine 
the efficacy of an unknown synergist.  
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Figure 4.7  The diagnostic window for 
creating a higher throughput method 
in order to select a potential synergist.   
Open circle: no E4; closed circle: E4; grey circle: E4 + 3 mM 
PBO.  Error bars shown illustrate the standard deviation 
derived from three replicates. 
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Figure 4.8  AChE activity of the three 
points from the diagnostic window 
highlighted in Figure 4.7. 
Error bars shown illustrate the standard deviation derived from 
three replicates. 
  
The development of the novel assay described in this section is used in the next chapter, 
Chapter Five, to screen a range of putative synergists for their ability to inhibit resistance-
associated esterases.  In order to use the assay to screen putative synergists, the IC50 results 
must be converted into a percentage (from here on termed the „Index‟ value - I) so that 
synergists could be screened on different days or with different stocks of E4 and still be 
comparable.  This is because although the protocol is standardised, the IC50 values achieved 
will always vary slightly depending on the stock of the E4 and the exact time of the 
incubation of the E4 with the azamethiphos on the microplate.  Comparing results as I 
values (percentages) (Table 4.3) allows for these variations.  The lower the I value for the 
putative synergist, the better esterase inhibitor it is in vitro. 
Table 4.3  Concentration of azamethiphos required for 50% inhibition of AChE 
activity (IC50) in the presence and absence of E4, and in the presence of E4 + 3 mM 
PBO, with Index values shown, calculated as described in the text. 
Corresponds to Figure 4.6.  Percentages relate to Figure 4.7. 
Sample IC50 (nM) SE % 
AChE only (No E4) 0.19 0.01 0 
E4 7.92 0.44 100 
E4+3mM PBO 0.46 0.02 3.49 
SE refers to the standard error of the IC50 value derived from the fitted curve. 
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5 CHAPTER FIVE: SCREENING PUTATIVE SYNERGISTS  
5.1 Introduction 
Using the „esterase interference‟ assay developed and optimised in Chapter 4, a range of 
compounds were screened as potential esterase inhibitors.  The compounds were chosen 
based on their structure or previous reports of insect control properties.  This work was 
carried out in collaboration with Botanical Resources Australia (BRA) who provided the 
essential oils, and the Chemistry Division at the University of Tasmania, who provided 
extracts of a number of Tasmanian plants. 
 
As the 3D structure of resistance-associated esterases is unknown, it is not easy to predict the 
structure of any putative inhibitors/synergists, other than to surmise that it would be 
beneficial for there to be an ester bond present which the esterase can attack.  Most of the 
putative synergists tested here were essential oils and plant extracts that were selected by 
BRA (with some suggestions from Rothamsted) based on biological activity and the 
structures of active components (where known).  Some were chosen because they were 
known for their insecticidal properties (e.g. neem seed oil) and some because they were 
plants native to Tasmania. 
 
Compounds that inhibited esterases at the same or an equivalent efficacy as PBO were 
further screened for their ability to inhibit P450 activity. Samples that inhibited both esterase 
and P450 activity were further tested in vivo to assess their effect as a synergist in 
combination with pyrethrins.  
 
PBO has been used as a synergist for pyrethrins for many years and the aim of these 
experiments was to find a novel alternative.  Most of the compounds tested were of a natural 
or organic nature to comply with the growing consumer demand for these types of products.  
 
This chapter describes the screening of compounds: 
 In vitro for their ability to inhibit resistance associated esterases (section 5.3.1) using 
the assay developed and described previously in Chapter Four; 
 In vitro for their ability to inhibit cytochrome P450s (section 5.3.2); 
 In vivo for their ability to penetrate the insect cuticle and inhibit metabolic defences.  
These experiments assess the effect the putative synergists have on the natural 
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pyrethrins and thus whether the efficacy of the pyrethrins can be enhanced in Myzus 
persicae (section 5.3.3) and Musca domestica (section 5.3.4). 
5.2 Materials and Methods 
5.2.1 Measuring a putative synergist‟s ability to inhibit esterases: „Esterase 
interference assay‟ 
Purified E4 was incubated with 0.1 % putative synergist (in acetone) overnight at 4 C.  A 
96-well microplate was prepared as described in section 4.1.1.2, step 4.  
 
5.2.2 Measuring a putative synergist‟s ability to inhibit P450s 
Lamb‟s liver P450 preparation (section 2.4.6.1) (7.5 µl) plus 41.5 µl diluted sodium phosphate 
buffer (pH 7.6) prepared as described in section 2.4.6.1 and 1 µl of 10 % synergist in acetone 
were added to the wells of a 96-well white microplate.  The plate was incubated at room 
temperature for 15 minutes before the addition of 80 µl of 0.5 mM 7-ethoxycoumarin.  The 
plate was incubated at 30 C for a further 3 minutes before the addition of 10 µl of 9.6 mM 
NADPH.  The plate was read using an excitation wavelength of 380 nm and an emission 
wavelength of 460 nm (in a PerkinElmer microfluorometric reader) every 5 minutes for one 
hour. 
 
Each synergist was tested in triplicate together with controls of buffer only and homogenate 
plus 1 µl acetone. 
 
5.2.3 Investigating the effect of putative synergists in vivo 
Putative synergists that performed well as esterase and P450 inhibitors were selected for trial 
in vivo against M. persicae and M. domestica.  These two insect species were selected because the 
compounds used were dissolved in acetone and thus a topical application technique was 
required, and both M. persicae and M. domestica bioassay well using the topical application 
technique. 
 
Myzus persicae 
Bioassays were performed as described in section 2.4.7.2.  Briefly, adult insects (794jz clone) 
were placed onto untreated leaf discs (Chinese cabbage) and dosed by topical application 
with 0.25 µl compounds in acetone.  Mortality was scored after 72 hours.  The ratio of 
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synergist:pyrethrins was 4:1.  These experiments were also performed using the putative 
synergist and alpha-cypermethrin in a ratio of 4:1, and putative synergist, PBO and pyrethrins 
in a ratio of 4:4:1. 
 
Musca domestica 
Bioassays were performed on female flies (381zb strain) as described in section 2.4.7.2.  
Briefly, insects were dosed (by topical application) with 1 µl treatment in acetone.  Mortality 
was scored after 24 hours.  The ratio of synergist:pyrethrins was 5:1.  These experiments 
were also performed using a tank mix of putative synergist, PBO and pyrethrins in a ratio of 
5:5:1. 
 
5.2.4 The putative synergists 
Table 5.1 shows the properties of the putative synergists used in the experiments described 
in this chapter.  The chemical structures of active components (where known) of the oils and 
plant extracts tested for synergism of pyrethrins are shown in Figure 5.1. 
 
Chapter Five Screening putative synergists 
 
71 
Table 5.1  Details of oils and plant extracts tested for synergistic potential.  Relates to 
structures in Figure 5.1 
(Table continues onto 3 pages and is arranged alphabetically by common name) 
Information from (Harbourne, 1996) 
Common 
name (used 
throughout 
chapter)   
Description of sample  
(source) 
Speculated inhibitors of 
interest (if known) 
Chemical formula 
(molecular weight) 
Type of chemical 
 Extracts of Correa alba var alba 
(Rutaceae) 
(BRA/UTas) 
  
 Extracts of Acradenia frankliniae 
(Rutaceae) 
(BRA/UTas) 
  
 Extracts of Correa stackhousiana 
(BRA/UTas) 
  
Angelica Essential oil of roots of Angelica 
archangelica, Heracleum spp. and 
Selinum vaginatum (Umbelliferae) 
(Auroma) 
Angelicin  
C11H6O3  
(186.17) 
(also known as Isopsoralen) 
 
 
Furanocoumarin 
Aniseed Essential oil of seeds of Japanese 
star anise, Illicium anisatum 
(Illiciaceae) 
(Bronson and Jacobs) 
Anisatin 
C15H20O8 
(328.32) 
 
Sesquiterpenoid 
lactone 
Azadirachtin Purified, powder form 
(Bhupinder Khambay, Rothamsted 
Research) 
C35H44O 
(720.72) 
Nortriterpenoid 
(Limonane) 
Bergamot Essential oil, Citrus bergamia 
(Rutaceae) 
(Auroma) 
Bergamottin  
C21H22O4 
(338.40) 
(also known as Bergaptol 
geranyl ether; 5-
Geranyloxypsoralen; Bergaptin) 
 
Furocoumarin 
Citronella java (Bronson and Jacobs) Citronellal  
C10H8O 
(154.25) 
(also known as 3,7-dimethyloct-
6-enal; Rhodinal) 
Monoterpenoid 
Cypress (Auroma)   
Dill Essential oil, Anethum graveolens 
(Umbelliferae) 
(Essential Oils of Tasmania Pty.Ltd.) 
Dillapiole  
C12H14O4 
(222.24) 
(also known as Dill apiole; 
Dillapiol) 
 
Phenylpropanoid 
Ethoxylated 
castor oil* 
(BRA)   
Eucalyptus Essential oil, distilled from fresh 
leaves of Eucalyptus globulus and 
some other Eucalyptus spp. 
(Myrtaceae) 
(Banalasta Lavender Farm) 
1,8-Cineole  
C10H18O 
(154.25) 
(also known as Eucalyptol; 
Cajeputol; 1,8-Epoxy-p-
menthane) 
 
Monoterpenoid 
Fennel Essential oil 
(Essential Oils of Tasmania Pty.Ltd.) 
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Common 
name (used 
throughout 
chapter)   
Description of sample  
(source) 
Speculated inhibitors of 
interest (if known) 
Chemical formula 
(molecular weight) 
Type of chemical 
Garlic Essential oil, Allium sativum 
(Alliaceae) 
(Auroma) 
Diallyl disulfide  
C6H10S2 
(146.28) 
(also known as Allyl disulfide; 
Di-2-propenyl disulfide) 
 
 
 
Sulphur 
compound 
Lavender Essential oil 
(Bronson and Jacobs) 
  
Lemon-scented 
Boronia 
Extracts of Boronia citriodora 
(Rutaceae) 
(BRA/UTas) 
  
Linoleic acid Sigma-Aldrich UK C18H32O2 
(280.45) 
Unsaturated 
omega-6 fatty acid 
Manuka (BRA)   
Mountain 
Correa 
Extracts of Correa lawrenciana 
(Rutaceae) 
(BRA/UTas) 
  
Myristicin >97% pure 
(Sigma-Aldrich UK) 
Myristicin 
C11H12O3 
(192.21) 
 
Phenylpropanoid 
Neem (seed 
oil) 
Oil from seeds of neem tree, 
Azadirachta indica (Meliaceae) 
(Auroma) 
Azadirachtin  
C35H44O 
(720.72) (see, azadirachtin) 
 
Nortriterpenoid 
(Limonane) 
Nutmeg Essential oil, Myristica fragrans 
(Myristicaeae) 
(Auroma) 
Myristicin 
C11H12O3 
(192.21) 
 
Phenylpropanoid 
Oleic acid* 2 pure samples:  
(BRA and Sigma-Aldrich UK) 
Oleic acid  
(282.46 ) 
(also known as cis-9-
Octadecenoic acid; Elainic acid) 
 
Fatty acid 
Parsley (53% 
and 86% 
myristicin) 
Essential oil from seeds of parsley 
Petroselinum crispum (Umbelliferae) 
(Essential Oils of Tasmania Pty.Ltd.) 
Apiole  
C12H14O4 
(222.24) 
(also known as Apiol; apioline; 
Parsley camphor) 
and myristicin (see nutmeg) 
 
Phenylpropanoid 
Parsley Extracts of Petroselinum crispum  
(BRA/UTas) 
As above  
Pepper Essential oil from unripe fruit of 
wild pepper, Piper cubeba 
(Piperaceae) and roots and shoots 
of Aristolochia triangularis 
(Aristolochiaceae) 
(Auroma) 
Cubebin 
C20H20O6 
(356.38) 
 
lignan 
Peppermint  Essential peppermint oil, Mentha 
piperita 
(Essential Oils of Tasmania Pty.Ltd.) 
Menthol  
C10H20O 
(156.27) 
(also known as Mentol; 
peppermint camphor; 
menthacamphor) 
 
monoterpenoid 
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Common 
name (used 
throughout 
chapter)   
Description of sample  
(source) 
Speculated inhibitors of 
interest (if known) 
Chemical formula 
(molecular weight) 
Type of chemical 
Peppermint 
eucalyptus 
 See peppermint and eucalyptus  
Piperonyl 
butoxide 
(PBO) 
Synthetic, 96% pure 
(Endura SpA, Italy) 
PBO 
C19H30O5 
(338.4) 
 
Rose blossom Boronia pilosa 
(Rutaceae) 
(BRA/UTas) 
  
Rosemary Essential oil from leaves of 
Rosemary (sp. unknown) (Bronson 
and Jacobs) 
Palustrol  
C15H26O 
(222.37) 
(also known as 1-
aromadendranol) 
 
Sesquiterpenoid 
Sesame 
vegetable oil 
(Auroma) Composed of the following 
fatty acids: 
Palmitic (7-12 %) C16H32O2 
(256.42) 
 
Fatty acid 
palmitoleic (trace – 0.5 %) 
C16H30O2 
(254.41) 
 
Fatty acid 
stearic (3.5 – 6.0 %) C18H36O2 
(284.48) 
 
Fatty acid 
oleic (35 – 50 %) 
(see above) 
Fatty acid 
linoleic (35 – 50 %) 
(see above) 
Fatty acid 
linolenic (trace – 1 %) 
 
Fatty acid 
eicosensoic (trace – 1 %) Fatty acid 
Stinkwood Zieria arborescens (Rutaceae) 
(BRA/UTas) 
  
 
Sources of samples: Auroma (Victoria, Australia); Bronson & Jacobs (NSW, Australia); Essential oils of Tasmania (Tasmania, Australia); 
Banalasta lavender farm (Tamworth, Australia); BRA/UTas – provided by Adrian Blackman (University of Tasmania, Hobart, Tasmania, 
Australia) 
* denotes that the compound named is a component of the BRA  emulsifiable concentrate formulation. 
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In the following results and discussion section, the University of Tasmania extractions are 
referred to using the following abbreviations; 
 
for the sample names: 
Af Acradenia frankliniae 
Bc Boronia citriodora  
Bp Boronia pilosa 
Ca Correa alba var alba 
Cl Correa lawrenciana 
Cs Correa stackhousiana 
Py Petroselinum crispum  
Za Zieria arborescens 
 
for the method of extraction of the sample: 
A steam distilled essential oil 
B1 solvent extract – petroleum spirits fraction 
B2 solvent extract – dichloromethane fraction 
B3 solvent extract – aqueous methanol fraction 
 
For certain samples that were further fractionated to possibly identify which ones gave 
extracts with highest synergistic activity, „fr‟ is used to denote the fraction number. 
 
Figure 5.1 Structure of speculated inhibitors of interest for putative synergists listed 
in Table 5.1 
(Arranged alphabetically, continues on 3 pages) 
1,8-cineole 
 
Angelicin 
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Anisatin 
 
Apiole 
 
Azadirachtin 
 
Bergamottin 
 
 
Citronellal 
 
 
Cubebin 
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Diallyl disulfide 
 
 
 
Dillapiole 
 
Linoleic acid 
  
 
Menthol 
 
Myristicin 
 
Oleic acid 
 
 
Palmitic acid 
 
 
Palmitoleic acid 
 
 
PBO 
 
Stearic acid 
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5.2.5 Calculations 
Following bioassays, the “synergistic factors” were calculated using the following equation: 
 
SF (synergistic factor) = LC50 insecticide only (for x clone or strain) 
LC50 synergised insecticide (for x clone or strain) 
 
 
Using the SF enabled a direct comparison of the compounds tested and also had the 
advantage that studies performed only on a resistant population could be compared. 
5.3 Results and discussion 
This section is divided into four parts, with a general discussion at the end.  The four 
sections cover the efficacy of the putative synergists: as esterase inhibitors in vitro (section 
5.3.1); as P450 inhibitors in vitro (section 5.3.2); in vivo against M. persicae (section 5.3.3), and in 
vivo against M. domestica (section 5.3.4).  A summary of the findings is given before the 
individual experimental results sections to aid the understanding of the decisions made about 
which samples should be tried in each of the experiments.  Table 5.2 is a summary of all of 
the putative synergists tested in chapter five.  Where a sample performed within the 
confidence limits of PBO in the esterase interference assay (section 5.3.1), they were selected 
for their in vitro ability to inhibit P450s from lambs liver.  Some samples were selected for the 
P450 assay (and subsequent bioassays) despite not performing as well as PBO because 
Botanical Resources requested that certain samples be further investigated.  
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Table 5.2  Summary of the performance of each of the putative synergists tested in 
chapter five.   
 indicates that a sample was in the same range as/more potent than PBO; * indicates that a sample 
was not as effective as PBO; (B) indicates that Botanical Resources requested the sample be looked at 
further. 
 
In vitro 
Esterase Interference assay 
(section 5.3.1) 
In vitro 
P450 
assay 
 
In vivo 
Myzus Persicae 
(4:1 synergist: 
pyrethrins) 
In vivo 
Myzus 
Persicae 
(4:1 
synergist:a
lpha-
cypermeth
rin) 
In vivo 
Myzus 
Persicae 
(4:4:1 
synergist:P
BO: 
pyrethrins) 
In vivo 
Musca 
domestica 
(4:1 synergist: 
pyrethrins) 
In vivo 
Musca 
domestica 
(4:4:1 
synergist:PB
O:pyrethrins) 
(section 5.3.1) (section 
5.3.2) 
(section  
5.3.3.1) 
(section 
5.3.3.2) 
(section 
5.3.3.3) 
(section 
5.3.4.1) 
(section 
5.3.4.2) 
Af-A       
Af-B1       
Af-B2       
Af-B3       
Angelica       
Aniseed       
Azadirachtin       
Bc-A       
Bc-B1  *     
Bc-B2       
Bc-B3       
Bergamot organic  (B) *     
Bp-A       
Bp-B1       
Bp-B2       
Bp-B3       
Ca-A       
Ca-B1       
Ca-B2       
Ca-B2-fr1       
Ca-B2-fr10       
Ca-B2-fr2       
Ca-B2-fr3       
Ca-B2-fr4       
Ca-B2-fr5       
Ca-B2-fr6       
Ca-B2-fr7       
Ca-B2-fr8       
Ca-B2-fr9       
Ca-B2-frB2       
Ca-B3       
citronella       
Cl-A       
Cl-B1  *     
Cl-B2       
Cl-B3       
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In vitro 
Esterase Interference assay 
(section 5.3.1) 
In vitro 
P450 
assay 
 
In vivo 
Myzus Persicae 
(4:1 synergist: 
pyrethrins) 
In vivo 
Myzus 
Persicae 
(4:1 
synergist:a
lpha-
cypermeth
rin) 
In vivo 
Myzus 
Persicae 
(4:4:1 
synergist:P
BO: 
pyrethrins) 
In vivo 
Musca 
domestica 
(4:1 synergist: 
pyrethrins) 
In vivo 
Musca 
domestica 
(4:4:1 
synergist:PB
O:pyrethrins) 
(section 5.3.1) (section 
5.3.2) 
(section  
5.3.3.1) 
(section 
5.3.3.2) 
(section 
5.3.3.3) 
(section 
5.3.4.1) 
(section 
5.3.4.2) 
Cs-A       
Cs-B1       
Cs-B2       
Cs-B3       
Cypress       
Dill       
Eth. Castor Oil * *     
Eucalyptus radiata       
Fennel       
Garlic       
Lavender       
Linoleic acid  *   *  
Manuka       
Methyl methoxy butanol       
Myristicin       
Neem seed oil  *   *  
Nutmeg       
Oleic acid  *     
parsley (53% myristicin)  (B) *     
Parsley (86% myristicin)       
Pepper (black)       
Peppermint       
Peppermint Eucalyptus       
Py-A       
Py-B1       
Py-B2       
Py-B3       
Rosemary       
Sesame       
Za-A       
Za-B1       
Za-B2  *     
Za-B2-fr1       
Za-B2-fr2       
Za-B2-fr3       
Za-B2-fr4       
Za-B2-fr5       
Za-B2-fr6       
Za-B2-fr7       
Za-B2-fr8       
Za-B2-fr9       
Za-B3 *      
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5.3.1 Esterase inhibition (in vitro) 
The esterase interference assay was used to indirectly determine how well a sample can 
inhibit esterase activity (E4) by measuring AChE activity (refer to Chapter 4, Figure 4.1).  
Results of this assay are shown in Table 5.3, which displays the index value, standard error, 
lower limits and upper limits for each sample. The index (I) values shown in Table 5.3  
represent the samples‟ potential as an esterase inhibitor (see end of section 4.2).  I equates to 
the percentage AChE activity remaining, with values closest to zero showing the most potent 
esterase inhibiting action.  It is obtained by calculating the IC50 values (see end of section 4.2) 
for each compound (using Grafit) and the putative synergists activity is calculated as a 
percentage of E4 activity (where the IC50 value for E4 = 100 % and for no E4 = 0%).  The 
lower the I value, the better the sample is as an esterase inhibitor in vitro. 
 
The results reveal that all except two (methyl methoxy butanol and Bp-B3) of the putative 
synergists show potential for esteratic synergistic activity (Table 5.3).  It is not surprising that 
methyl methoxy butanol did not perform well as it is an alcohol.  It was tested because it is a 
component of the BRA EC formulation present dissolve the other components. 
 
Many of the samples screened were prepared by the University of Tasmania, and some 
fractions from each plant used for extractions were as good as/better than PBO apart from 
those fractionated from extracts of Boronia pilosa.  Of the University of Tasmania samples, the 
more potent E4 inhibitors were those in the petroleum spirits fractions (B1) and the 
dichloromethane fractions (B2).  The B2 fractions from Zieria arborescens and Correa alba were 
further fractionated by the University of Tasmania into 10 fractions.  In the case of Zieria 
arborescens, 7 out of 10 were comparable to PBO at inhibiting esterases in vitro.  For the Correa 
alba further fractionated B2 samples, 4 out of 10 were comparable to PBO.  These are shown 
in performance order in Figure 5.2.  
 
Each solvent used in the extractions will have extracted chemicals of a certain lipophilicity 
from the plant samples.  Generally, the petroleum spirits fractions (B1) fractions contained 
an E4 inhibitor(s) regardless of the plant used and this may be an important factor for 
consideration in the future if further extractions are to be made.  It is important to note that 
the samples extracted from Tasmanian plants (provided by BRA/UTas) were extracted from 
individual plants.  Therefore the samples that look promising would need further evaluation 
to ensure that extracts from other plants of the same species have the same enzyme 
inhibiting potential. 
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Table 5.3  Index value (I) and corresponding standard errors for AChE activity of 
E4+putative synergists.   
I is the IC50 value obtained from Grafit, shown as a percentage of E4 and No E4, where E4 = 100% activity 
and No E4 = 0% activity. (I equates to % AChE activity remaining).  SE: standard error of the fit of the curve 
(calculated by Grafit, then corrected into a percentage thus in the same format as the Index value); LL/UL95%: 
95% confidence limits (lower limits/upper limits). Samples with I values or errors less than 4.26 % (the upper 
limit for PBO) are shown in Figure 5.2.  PBO is indicated in bold. 
 
Putative synergist I (%) SE (%) LL95% UL95% 
Cl-B2 0.01 0.48 -0.99 1.02 
Za-B2-fr3 0.39 0.16 0.06 0.71 
Neem 0.41 1.22 -2.14 2.95 
Za-B2 0.88 0.35 0.16 1.60 
Bc-B2 1.04 0.79 -0.61 2.69 
Za-B2-fr9 1.14 0.17 0.79 1.50 
Za-B3 1.28 0.35 0.55 2.02 
Oleic acid* 1.43 0.32 0.76 2.11 
Linoleic acid 1.53 0.36 0.78 2.29 
Bc-B1 1.92 1.16 -0.49 4.32 
Za-B2-fr1 2.31 0.18 1.94 2.68 
Ca-B2-fr3 2.34 0.22 1.89 2.79 
Ca-B2-fr2 2.41 0.22 1.95 2.87 
Cl-B1 2.50 0.36 1.75 3.24 
Za-B2-fr2 2.56 0.28 1.98 3.13 
Ca-B2 2.62 0.77 1.02 4.22 
Bp-A 2.71 0.24 2.21 3.21 
Za-B2-fr6 3.01 0.34 2.30 3.73 
Ca-B2-fr10 3.11 0.28 2.52 3.69 
Za-B1 3.33 0.45 2.39 4.26 
PBO 3.40 0.25 2.89 3.92 
Eth. Castor Oil* 3.42 0.32 2.76 4.08 
Za-B2-fr8 3.54 0.16 3.22 3.86 
Za-B2-fr7 3.76 0.30 3.13 4.38 
Ca-B2-fr6 3.96 0.38 3.18 4.74 
Ca-B2-fr9 4.74 0.31 4.10 5.38 
Ca-B2-fr5 4.76 0.26 4.23 5.30 
Ca-B2-fr7 4.93 0.27 4.37 5.50 
Cs-B1 4.98 0.94 3.03 6.94 
Ca-B2-frB2 5.01 0.29 4.40 5.62 
Za-B2-fr4 5.07 0.36 4.31 5.83 
Pyrethrins (from 50% extract) 5.29 0.62 4.01 6.57 
Py-B1 5.55 0.73 4.02 7.07 
Ca-B2-fr8 6.11 0.35 5.38 6.85 
Af-B2 6.22 2.02 2.01 10.42 
Bp-B1 6.28 0.43 5.38 7.17 
Myristicin 6.63 0.36 5.88 7.38 
Za-B2-fr5 6.75 0.38 5.95 7.54 
Azadirachtin 7.01 0.74 5.48 8.55 
Peppermint 7.03 0.92 5.12 8.94 
Bc-B3 7.29 0.86 5.50 9.07 
Bp-B2 7.31 0.74 5.77 8.86 
Cs-B2 7.62 0.97 5.61 9.63 
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Putative synergist I (%) SE (%) LL95% UL95% 
Py-B2 8.74 1.05 6.56 10.92 
Af-B1 9.01 0.56 7.85 10.17 
Pyrethrins II 9.02 1.49 5.92 12.12 
Ca-B1 9.11 1.04 6.96 11.27 
Lavender 9.83 1.17 7.40 12.26 
Cs-A 9.86 1.09 7.59 12.12 
Py-A 10.19 1.39 7.30 13.08 
parsley (53% myristicin) 10.41 1.37 7.56 13.27 
Ca-B2-fr4 11.41 1.26 8.78 14.04 
Cl-B3 11.49 1.16 9.08 13.90 
Nutmeg 11.57 1.09 9.30 13.84 
Sesame 11.87 1.47 8.81 14.93 
Aniseed 11.98 1.61 8.63 15.34 
Cypress 12.49 1.45 9.47 15.51 
Pyrethrins I 12.69 2.07 8.37 17.00 
Manuka 13.43 1.23 10.87 16.00 
Garlic 14.44 1.20 11.94 16.95 
Parsley (86% myristicin) 14.97 1.24 12.39 17.54 
Peppermint Eucalyptus 15.38 1.58 12.09 18.68 
Za-A 15.84 1.46 12.80 18.88 
citronella 16.60 1.54 13.39 19.81 
Ca-B3 17.20 1.63 13.82 20.59 
Bergamot organic 21.14 1.65 17.71 24.56 
Ca-A 21.21 2.20 16.64 25.79 
Af-A 22.42 1.15 20.04 24.80 
Fennel 22.43 1.15 20.04 24.83 
Bc-A 22.56 1.41 19.64 25.49 
Py-B3 27.30 3.12 20.81 33.79 
Pepper (black) 31.23 4.26 22.37 40.09 
Angelica 31.68 2.12 27.26 36.10 
Cs-B3 35.06 2.39 30.08 40.03 
Alpha-cypermethrin 35.69 2.52 30.44 40.93 
Dill 35.81 2.44 30.74 40.89 
Ca-B2-fr1 36.44 2.61 31.01 41.87 
Cl-A 37.59 2.88 31.60 43.58 
Rosemary 40.83 4.96 30.51 51.15 
Af-B3 47.05 2.61 41.62 52.48 
Eucalyptus radiata 51.62 3.89 43.54 59.70 
Methyl methoxy butanol* 94.18 5.28 83.20 105.15 
Bp-B3 98.92 14.58 68.59 129.25 
Af is from Acradenia frankliniae; Bc is from Boronia citriodora; Bp is from Boronia pilosa; Ca is from Correa alba var alba; Cl is 
from Correa lawrenciana; Cs is from Correa stackhousiana; Py is from Petroselinum crispum; Za is from Zieria arborescens; A: steam 
distilled essential oil; B1: solvent extract – petroleum spirits fraction; B2: solvent extract – dichloromethane fraction; B3: 
solvent extract – aqueous methanol fraction;  fr denotes a further fractionated sample.  * denotes that the compound named 
is a component of the BRA  emulsifiable concentrate formulation. 
 
Samples that showed potent esterase inhibition in vitro that were not extracts from 
Tasmanian plants were neem seed oil, oleic acid, linoleic acid and ethoxylated castor oil.  All 
of these samples were comparable to PBO in vitro (Figure 5.2).  Oleic acid and ethoxylated 
castor oil are both components of the BRA EC formulations and their performance in this in 
vitro test, with both samples showing potential for inhibiting esterases, offers an explanation 
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for the lower LC50 values found in Chapter Three when comparing leaf dip bioassays using 
EC formulations, compared to topical application of technical pyrethrins for M. persicae. 
 
 
Figure 5.2  Graphical representation of I values (refer toTable 5.3) for esterase 
inhibition of samples selected for trial in P450 assay. 
I is the IC50 value obtained from Grafit, shown as a percentage of E4 and No E4, where E4 = 100% activity and No E4 = 0% activity. (I  
equates to % AChE activity remaining).  Error bars indicate the error of the fit of the curve (calculated by Grafit and reformatted to fit the 
percentage representation of the I value). 
Interestingly, azadirachtin (the main component of neem) was not as effective as the neem 
seed oil.  It is possible that there are components, other than azadirachtin, in the neem seed 
oil that also inhibit esterase activity or work synergistically with azadirachtin. 
 
Generally if the lower confidence limit of a sample was less than or equal to PBO‟s upper 
limit (I = 3.92 %) then it was selected for the P450 assay.  Samples were also selected if their 
upper confidence limit was less than or equal to PBO‟s upper confidence limit.  In addition, 
it was decided that some of the less potent esterase inhibitors would be tested in vivo, 
regardless of in vitro results, (for example, nutmeg, parsley and bergamot) (see 5.3.2) 
 
As well as screening putative synergists, the esterase interference assay was also useful to 
evaluate the esterase inhibiting action of pyrethrins and alpha-cypermethrin.  This was of 
interest because as discussed in Chapter 3, resistance to pyrethrins was less than expected 
considering resistance factors of the synthetic pyrethroids reported previously (Bingham et 
al., 2007, Bingham, 2007).  Pyrethrins showed a better ability to inhibit esterases than the 
Pyrethrins I and II extracts.  This may be due to the presence of the other components in the 
combined extract.  Collectively, Pyrethrins I and II constitute 45-55% of pyrethrum extract 
with the remainder usually being comprised of sterols, triterpenols, alkanes, fatty acids from 
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triglycerides and carotenoids (Maciver, 1995).  From these results it can be concluded that 
esterases bind to pyrethrins, thus confirming esterases as a resistance mechanism for 
pyrethrins. This also means that pyrethrins, or perhaps more accurately, the constituents of 
the pyrethrin extract, have the potential to act as their own synergist since the in vitro 
synergism of the pyrethrin extract with E4 is greater than the individual pyrethrin I or II 
extracts.  The synergism between the pyrethrin extract and E4 may contribute to the lower 
resistance factors compared with synthetic pyrethroids, as well as the difference in response 
to kdr mutations discussed Chapter Three.  Alpha-cypermethrin showed some esterase 
inhibiting potential but this was not in the same range as the pyrethrin samples. Although 
esterases are a resistance mechanism for alpha-cypermethrin, and this, together with the fact 
that synthetic pyrethroids are affected by kdr mutations helps explain the higher resistance 
factors for synthetic pyrethroids. 
5.3.2 P450 inhibition (in vitro) 
Compounds were screened for their P450 inhibiting potential by incubating them with P450s 
from lamb‟s liver and measuring their activity compared to an uninhibited control.  The 
following samples showed complete inhibition of P450 activity: Bc-B2; Bp-A; Ca-B2; Ca-B2-
fr3; Cl-B1; Za-B1; Za-B2; Za-B2-fr1; Za-B2-fr2; Za-B2-fr3; Za-B2-fr6; Za-B2-fr7; Za-B2-
fr8.  Alpha-cypermethrin did not show any P450 inhibiting potential.  Other samples gave 
intermediate levels of inhibition and results for these samples are shown in Table 5.4 and 
Figure 5.3.  The lower the percentage activity of the control, the better the sample at 
inhibiting P450 activity and thus the greater potential for being a useful synergist. 
 
The finding that some samples from Boronia citriodora, Boronia pilosa, Correa alba var alba, Correa 
lawrenciana, and Zieria arborescens gave complete inhibition of P450s suggest that extracts from 
these plants, and linoleic acid, oleic acid and neem seed oil may be very useful as insecticide 
synergists, especially where an insects‟ resistance mechanism is P450-based.  Results from 
these experiments again confirm that components of the BRA EC formulation may be acting 
as synergists, thus enhancing the efficacy of the pyrethrins in the EC formulations and thus 
when insects are bioassayed using a leaf dip of pyrethrins EC, the LC50 achieved is lower than 
expected. 
 
The low inhibition of P450 activity by PBO is perhaps surprising, although it has been noted 
previously that PBO is a more potent esterase inhibitor than oxidase inhibitor (Moores 
pers.comm.). 
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Table 5.4  Ability of selected putative synergists to inhibit P450s from lamb‟s liver. 
For full list, see text. 
Putative synergist 
% activity of 
the control 
Standard 
error 
Bc-B1 1.9 0.38 
Ca-B2-fr2 3.1 0.30 
Za-B2-fr9 12.5 2.56 
Cl-B2 14.7 3.75 
Ca-B2-fr10 17.0 5.13 
Linoleic acid 19.1 12.46 
Oleic acid 25.5 8.59 
Neem seed oil 29.0 6.56 
Ca-B2-fr6 30.9 3.19 
Af-B2 31.0 6.18 
Bergamot 36.9 0.39 
Parsley (53% myristicin) 47.0 5.59 
Cs-B1 54.3 7.87 
Pyrethrins II 59.8 7.98 
Pyrethrins (from 50 % 
extract) 61.3 8.71 
PBO 63.7 3.85 
Eth. Cast. Oil 68.6 3.38 
Pyrethrins I 77.7 9.89 
Za-B3 93.0 10.98 
Bc is from Boronia citriodora; Ca is from Correa alba var alba; Cl is from Correa lawrenciana; Cs is from Correa stackhousiana; Za is from Zieria 
arborescens; B1: solvent extract – petroleum spirits fraction; B2: solvent extract – dichloromethane fraction; fr denotes a further fractionated 
sample 
 
 
Figure 5.3 Level of inhibition of standard P450 sample (from lamb‟s liver) by various 
putative synergists, shown as a percentage activity of P450 sample only 
Relates to Table 5.4 
Error bars show the standard error 
 
Bc is from Boronia citriodora; Ca is from Correa alba var alba; Cl is from Correa lawrenciana; Cs is from Correa 
stackhousiana; Za is from Zieria arborescens; B1: solvent extract – petroleum spirits fraction; B2: solvent extract – 
dichloromethane fraction; fr denotes a further fractionated sample.  „Pyrethrins‟ sample is from a 50% extract. 
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5.3.3 The effect of putative synergists against Myzus persicae (794jz clone) in 
vivo 
As for chapter three, the raw bioassay data was inputted into PoloPlus and a summary of the 
outputted data is shown here.  PoloPlus was used to derive the LC50 values in order to 
calculate ESRs and SFs.  The rest of the data from the Polo outputs is shown in Appendix V. 
5.3.3.1 Putative synergist:pyrethrins tank mix (4:1) 
Following in vitro screening of putative synergists for their ability to inhibit esterases and 
P450s (sections 5.3.1 and 5.3.2), samples were screened in vivo against Myzus persicae (794jz 
clone) which have an esterase-based metabolic resistance to pyrethroids/pyrethrins, for their 
ability to increase the efficacy of pyrethrins.  The samples selected for in vivo bioassay were 
those which showed some ability to inhibit esterases and P450s in vitro (sections 5.3.1 and 
5.3.2) and taking into account Botanical Resources‟ request for a compound that would not 
require new licensing, e.g. food products that are already accepted as safe for human 
exposure. 
 
The in vivo assays used a tank mix of putative synergist and pyrethrins (rather than a pre-
treatment) because previous results (Chapter 3) showed a tank mix to be at least as effective 
as a pre-treatment, if not better.  Also, it is possible that each compound will have a different 
pre-treatment time thus using a tank mix treatment oversees the need to optimise this for 
preliminary testing. 
 
Samples tested in a tank mix with pyrethrins were bergamot essential oil, citronella, 
ethoxylated castor oil, linoleic acid, neem seed oil, oleic acid, parsley seed oil (53 % 
myristicin), peppermint oil, and BRA/UTas samples: Bc-B1, Cl-B1, Za-B2.  Peppermint and 
citronella were two of the samples selected for in vivo trials as representatives of samples 
which showed some ability to inhibit esterases in vitro, but not in the SE limits of PBO.  
These in vivo trials were performed to demonstrate that any synergism found would not 
match that of PBO as neither of these compounds was as good as PBO at inhibiting 
esterases in vitro.  In both cases tank mixes with pyrethrins did not cause mortality at levels 
greater than those seen with pyrethrins alone (data not shown) showing that the novel in vitro 
assay described in chapter four is a reliable indicator of a samples‟ ability to inhibit esterases 
in vivo.  
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Table 5.5  Lethal concentration for 50 % mortality (LC50), effective synergism ratio 
(ESR) and synergistic factor (SF) for putative synergists against Myzus persicae 
(794jz clone) as a tank mix with pyrethrins (4:1) 
See appendix V, Table A-V-I 
Treatment 
LC50 
(ppm) 
ESR  SF 
Pyrethrins only* 1630.7 43.8 - 
PBO* 121.7 3.3 13.4 
Ethoxylated castor 
oil 
342.6 9.2 4.8 
Za-B2 350.5 9.4 4.7 
Linoleic acid 413.0 11.1 3.9 
Neem seed oil 463.0 12.4 3.5 
Oleic acid 541.0 14.5 3.0 
Cl-B1 611.5 16.4 2.7 
Parsley seed oil (53) 802.9 21.6 2.0 
Bc-B1 822.5 22.1 2.0 
Bergamot 1068.2 28.7 1.5 
* for reference (data from Chapter Three) 
 
As shown in Table 5.5, none of the compounds tested reduced the LC50 to below that 
achieved with PBO meaning that PBO was still the better synergist with pyrethrins.  
Ethoxylated castor oil and Za-B2, were the most effective of all the samples tested in vivo, 
with LC50 values of 342.6 ppm and 350.5 ppm respectively.  However, these both gave an 
ESR 3-times that for a PBO/pyrethrins tank mix, and a SF 3-times less than a 
PBO/pyrethrins tank mix.  The higher the SF, the higher the synergism thus with the most 
promising samples having a SF 3-times less than that of PBO, there was still opportunity to 
increase the efficacy of the pyrethrins. 
 
The finding that some of the putative synergists were not as effective in vivo as they were in 
vitro suggests that the in vivo activity is not the result of esterase inhibition alone.  Thus these 
results agree with the hypothesis proposed in Chapter Three, that pyrethrins do not 
penetrate the insect cuticle as readily as many other insecticides. It seems that PBO therefore 
has a more marked effect than the putative synergists screened here because of its ability to 
enhance penetration, rather than just inhibit metabolic defences. This hypothesis assumes 
that the putative synergists do not have the „penetration enhancement‟ ability, or that if they 
do, it is less effective than for PBO. 
5.3.3.2 Putative synergist:alpha-cypermethrin tank mix (4:1) 
Following the initial studies looking at the effect of the putative synergist with pyrethrins in a 
tank mix, experiments were repeated using a tank mix of synergist and alpha-cypermethrin 
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(Table 5.6) to compare both penetration qualities and esterase inhibition qualities of the 
synergists.  Previous results (Chapter Three) indicated that with alpha-cypermethrin, PBO 
acts by inhibiting metabolic defences (seen by increased synergism with a PBO-pre-treatment 
compared to a tank mix treatment) rather than by enhanced penetration.  It was therefore 
decided to test the putative synergists with alpha-cypermethrin and thus obtain information 
about the putative synergists ability to metabolise the esterases.  The results are shown in 
Table 5.6.   
 
Samples tested in a tank mix with alpha-cypermethrin were bergamot, ethoxylated castor oil, 
linoleic acid, neem seed oil,  oleic acid, parsley seed oil (53 % myristicin), peppermint oil and 
the following BRA/UTas samples: Bc-B1, Cl-B1 and Za-B2.  Tank mixes of alpha-
cypermethrin with either Bc-B1, Za-B2, bergamot or peppermint oil did not give mortality 
sufficient for a LC50 to be calculated for the dose range used.  These results were surprising 
because the initial in vivo trials with pyrethrins had suggested that Za-B2 would give greater 
synergism with alpha-cypermethrin at the dose range chosen.  The reason that it did not 
perform well in vitro is not known. 
 
Table 5.6  Lethal concentration for 50 % mortality (LC50), effective synergism ratio 
(ESR) and synergistic factor (SF) for putative synergists against Myzus persicae 
(794jz clone) as a tank mix with alpha-cypermethrin (4:1) 
See appendix V, Table A-V-II 
Treatment 
LC50 
(ppm) 
ESR SF 
Alpha-cypermethrin 
only* 
3230.2 6525.2 - 
PBO* 810.8 1638.0 4.0 
Neem seed oil 177.6 358.8 18.2 
Linoleic acid 247.7 500.4 13.0 
Parsley seed oil (53) 282.1 569.9 11.5 
Ethoxylated castor oil 282.9 571.5 11.4 
Cl-B1 386.8 781.4 8.4 
Oleic acid 400.2 808.5 8.1 
* for reference (data from Chapter Three) 
 
The LC50 for alpha-cypermethrin alone was 3230.2 ppm.  With PBO in a tank mix, the LC50 
was reduced to 810.8 ppm.  As can be seen from the results displayed in Table 5.6, neem 
seed oil, linoleic acid, parsley seed oil (53 % myristicin), ethoxylated castor oil, Cl-B1 and 
oleic acid all synergised alpha-cypermethrin more effectively than PBO, with LC50 results 
ranging from 177.6 ppm to 400.2 ppm.  These samples had SFs at least twice as good as 
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PBO (oleic acid), and up to 4.5-times better than PBO (neem seed oil).  Thus these samples 
all showed the ability to enhance the effect of alpha-cypermethrin when used in a tank mix. 
 
The results of the experiments using a tank mix of putative synergist and alpha-cypermethrin 
agree with the hypothesis stated previously that the pyrethrins benefit from the ability of 
PBO to enhance penetration of pyrethrins through the insect cuticle.  Compounds that did 
not show synergism to the same extent as PBO in vivo with pyrethrins, show increased levels 
of synergism when applied as a tank mix with alpha-cypermethrin.  This indicates that these 
compounds are inhibiting esterase activity in the insect, as predicted by the in vitro testing.   
 
5.3.3.3 Putative synergist:PBO:pyrethrin tank mix (4:4:1) 
Following experiments using putative synergists in tank mixes with pyrethrins and alpha-
cypermethrin (independently), the next logical step was to test a mixture of PBO with a 
putative synergist and pyrethrins to determine if the presence of PBO would help the 
penetration of the pyrethrins through the cuticle, then the combined synergism from PBO 
and the other compound would inhibit metabolic defences.  Three samples were tested in 
this way: neem seed oil; linoleic acid; and ethoxylated castor oil.  These were chosen because 
they were each one of the most effective for both the synergist:pyrethrin treatments and the 
synergist:α-cypermethrin treatments.   
 
Table 5.7  Lethal concentration for 50 % mortality (LC50), effective synergism ratio 
(ESR) and synergistic factor (SF) for putative synergists against Myzus persicae 
(794jz clone) as a tank mix with PBO and pyrethrins (4:4:1) 
See appendix V, Table A-V-III 
Treatment 
LC50 
(ppm) 
ESR SF 
Pyrethrins only* 1630.7 43.8 - 
PBO* 121.7 3.3 3.3 
Neem seed oil 65.4 1.8 24.9 
Linoleic acid 86.0 2.3 18.9 
Ethoxylated castor 
oil 
113.9 3.1 14.3 
* for reference (data from Chapter Three) 
 
Results from the multiple combination bioassay treatments (putative synergist, plus PBO, 
plus pyrethrins) are shown in Table 5.7.  These results reveal a dramatic increase in the level 
of synergism after a synergist:PBO:pyrethrins (4:4:1) treatment for all samples tested, 
compared to the synergist:pyrethrins (4:1) treatment (Table 5.5) for the same samples.   
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The LC50 for pyrethrins alone was 1630.7 ppm, with an ESR of 43.8 meaning that 43.8-times 
more insecticide was required to give 50 % mortality in the resistant clone of M. persicae 
compared to the susceptible clone (4106a) (see Chapter Three, Table 3.1a).  The tank mix 
treatment of PBO and pyrethrins reduced the LC50 to 121.7, the ESR to 3.3 and gave a SF of 
3.3.  Where a tank mix of putative synergist was combined with PBO and pyrethrins in a 
4:4:1 ratio, all three samples showed a decreased ESR compared to a PBO/pyrethrins tank 
mix.  Neem seed oil gave the highest level of synergism, reducing the LC50 to 65.4 ppm 
which is approximately 50 % of that of a PBO:pyrethrin (4:1) treatment.  This had an ESR of 
1.8 and a SF of 24.9.  This shows that a mixture of neem seed oil, PBO and pyrethrins gives 
a much higher SF than a PBO/pyrethrins tank mix and thus improves synergism and 
increases the efficacy of the natural pyrethrins  The next most effective putative synergist 
was linoleic acid which gave a SF of 18.9, and then ethoxylated castor oil which gave a SF of 
14.3.  In summary, all three samples when combined in a mixture with PBO and pyrethrins 
show great potential for increasing the efficacy of natural pyrethrins.  Further testing to 
establish financial viability of such mixtures would need to be performed in order to take this 
result further. 
 
5.3.4 The effect of putative synergists against Musca domestica (381zb strain) 
in vivo 
Following in vitro screening of putative synergists (sections 5.2.2 and 5.3.2), samples were 
tested against Musca domestica with a mixed metabolic resistance to pyrethroids/pyrethrins 
(see section 2.1.3), for their ability to increase the efficacy of pyrethrins in vivo.  Samples were 
selected for in vivo trial based on results from sections 5.3.1 and 5.3.2.  Two of the more 
effective P450 inhibitors from in vitro assays, neem seed oil and linoleic acid, were selected 
for screening in vivo.  
 
5.3.4.1 Putative synergist:pyrethrins tank mix (5:1) 
The results of bioassays using a tank mix of synergist:pyrethrins (5:1) on M. domestica are 
shown in Table 5.8.  Results indicate that PBO enhances penetration of pyrethrins through 
the cuticle corresponding to results found for M. persicae (section 5.3.3) as although both 
neem seed oil and linoleic acid reduced the LC50 for pyrethrins, from 11251.9 ppm to 4635.1 
ppm and 5657.7 ppm respectively, the reduction of ESR was only 6.1 and 7.5 respectively.  
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For both compounds the SF was at least 7.9-times less than for PBO thus showing PBO to 
be more effective at enhancing the efficacy of natural pyrethrins than either of the two 
putative synergists tested.   
 
Table 5.8  Lethal concentration for 50 % mortality (LC50), effective synergism ratio 
(ESR) and synergistic factor (SF) for putative synergists against female Musca 
domestica (381zb strain) as a tank mix with pyrethrins (5:1) 
See appendix V, Table A-V-IV 
Treatment 
LC50 (ppm/20mg 
fly) 
ESR SF 
Pyrethrins only* 11251.9 14.9 - 
PBO* 589.3 0.78 19.1 
Neem seed oil 4635.1 6.1 2.4 
Linoleic acid 5657.7 7.5 2.0 
* for reference (data from Chapter Three) 
 
5.3.4.2 Putative synergist:PBO:pyrethrins tank mix (5:5:1) 
The results for these experiments can be seen in Table 5.9.  With the addition of PBO to the 
mixture (synergist:PBO:pyrethrins, 5:5:1) the LC50 for each putative synergist was 
approximately 10-fold less than it was for the synergist:pyrethrin mixture with a LC50 of 
425.6 ppm for neem seed oil, and 526.5 ppm for linoleic acid.  Both of these LC50 values 
were lower than that for PBO:pyrethrin tank mix.  However, neither of these mixtures gave 
an LC50 that was significantly different from PBO:pyrethrins alone.  Although these results 
suggest that PBO aids the penetration of neem seed oil, linoleic acid and the pyrethrins, the 
efficacy of the pyrethrins, compared to a PBO:pyrethrins tank mix, is not increased.  
 
Table 5.9  Lethal concentration for 50 % mortality (LC50), effective synergism ratio 
(ESR) and synergistic factor (SF) for putative synergists against female Musca 
domestica (381zb strain) as a tank mix with PBO and pyrethrins (5:5:1) 
See appendix V, Table A-V-V 
Treatment 
LC50 (ppm/20mg 
fly) 
ESR SF 
Pyrethrins only* 11251.9 14.9 - 
PBO* 589.3 0.78 19.1 
Neem seed oil 425.6 0.56 26.4 
Linoleic acid 526.5 0.70 21.4 
* for reference (data from Chapter Three) 
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5.4 General Discussion for Chapter Five 
Methylenedioxyphenyl (MDP) compounds are widespread among plant species (Newman, 
1962); and their presence coincides with many classes of secondary compounds that are 
known to have insecticidal properties and also reported to have the ability to synergise 
synthetic organic insecticides (Casida, 1970, Lichtenstein et al., 1974, Fuhremann & 
Lichtenstein, 1979).  Berenbaum and Neal (1985) proposed that when insects ingest some 
plants, MDPs act as natural synergists which interfere with P450 function after ingestion thus 
leaving the insect more susceptible to the toxic activity of other secondary substances in the 
plant.  Krieger et al. (1971) postulated that this mechanism was present in Chrysanthemum 
cinerariaefolium (Compositae) where sesamin (an MDP synergist) co-exists with the insecticidal 
pyrethrins in the flowerheads.  Janzen (1973) proposed that the presence of these synergists 
may occur to allow plants to reduce the quantity of secondary substances produced without 
reducing the overall toxicity. 
 
PBO contains an MDP ring (Figure 5.1) which is reported to be responsible for P450 
inhibition although it is not thought to play a part in esterase inhibition.  It has been shown 
that the two oxygens on the MDP ring are required for P450 inhibition and the removal of 
one oxygen (PBO analogue 16-5) affects the ability of the compound to inhibit P450s but 
not esterases (Moores et al., 2009).  If the MDP ring did inhibit esterase activity it would be 
expected that myristicin (in nutmeg and parsley) and bergamot would be potent esterase 
inhibitors, although in this study they were less effective than PBO. 
 
a)  
 
b) 
 
Figure 5.4  Structure of a) PBO; b) PBO analogue 16-5 
 
PBO is a known esterase and P450 inhibitor.  This study has shown that PBO inhibits 
esterases leaving approximately 4 % esterase (E4) activity (ie inhibition of 96 %), but only 
inhibits P450 activity by approximately 35 % at that same concentration.  Other effective 
esterase inhibitors are oleic acid, ethoxylated castor oil and neem.  Oleic acid, ethoxylated 
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castor oil and PBO all have a long carbon chain that contains oxygens (C-O) or unsaturated 
oxygens (C=O).  Oleic acid and ethoxylated castor oil both have a long carbon chain with an 
unsaturated portion (C=C).  Since neither oleic acid, nor ethoxylated castor oil have an MDP 
ring it could therefore be postulated that the ethoxy-chain on PBO (and the other structures) 
is responsible for esterase inhibition. 
 
The bioassay results for M. persicae (794jz clone), which has an esterase-based resistance, 
show that a treatment of PBO plus neem or linoleic acid and pyrethrins, show neem and 
linoleic acid to be more potent esterase inhibitors in vivo than PBO, but without PBO they 
cannot penetrate with the pyrethrins to exert their potent effect.  However, M. domestica 
(381zb strain) are thought to have a more GST- and P450-based resistance profile and from 
the bioassay results it appears that both neem seed oil and linoleic acid are better P450 
inhibitors in vitro than in vivo. The in vivo result is unexpected given the success of the 
compounds in vitro as P450 inhibitors.  This may be because the pre-treatment time needs 
optimising for better metabolic defence inhibition in vivo, and investigations into the 
resistance mechanism would also be beneficial. 
  
Essential oil samples from BRA were originally chosen for synergist screening based on their 
chemical structures because many contained an MDP ring or a similar group (e.g. bergamot, 
anise, sage, tea tree, geranium, mint, thyme and rosemary) predicted to give esterase 
inhibition.  Angelica and bergamot were not predicted to be potent P450 inhibitors, as their 
structures, a single oxygen in the MDP ring, are similar to the PBO analogue which Moores 
et al. (2009) showed to have only esterase activity remaining (no P450 activity). 
 
Most of the samples from BRA/University of Tasmania, including Cl-B1 which performed 
well in the alpha-cypermethrin bioassay, were extracts produced from single plants and 
further experiments would be needed to establish if other plants of the same species would 
give the same results.  However, it is encouraging that Cl-B1 has shown synergistic potential 
as it is an extract from a common Tasmanian garden plant. 
 
Parsley seed oil (53 % myristicin) was selected for trial in vivo because BRA were hoping to 
find a food-based synergist and it had performed well in vitro in the esterase inhibition assay 
and reasonably well in the P450 assay.  In vivo, parsley showed potential as a synergist for 
pyrethrins and α-cypermethrin.  Apart from being comprised of 53 % myristicin, the other 
components of the oil are unknown.  The sample containing 86 % myristicin did not 
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perform as well in the esterase inhibition assay as the 53 % sample, perhaps suggesting that 
the myristicin is not the only component of the oil responsible for esterase inhibition.  
However, neither parsley sample was as potent as the pure myristicin sample suggesting that 
pure myristicin is best but in the two parley oil samples there are other compounds present 
that may be important e.g. apiole.  It would be interesting to identify each of the components 
in the two parsley seed oils, and to evaluate them and myristicin in vivo against an insect with 
a resistance mechanism known to be due to the presence of P450s.  Berenbaum and Neal 
(1985) investigated the synergism between myristicin and xanthotoxin (a furanocoumarin) 
and suggested that the action of myristicin is via MDP competitive inhibition of P450s.  
They found myristicin to increase the rate and extent of Heliothis zea (Boddie) 
(Lepidoptera:Noctuidae) mortality at a given xanthotoxin concentration. 
 
Neem seed oil performed well in vitro as both an esterase and P450 inhibitor, and also 
performed well in vivo as a synergist with pyrethrins against Myzus persicae.  This concurs with 
the findings by Lowery et al. (1993) who studied the use of neem for aphid control.  They 
tested pyrethrum because at the time of their study it was the current botanical insecticide of 
choice by producers of organic crops.  The authors used formulated neem seed (expeller) oil 
(NSO) and ethanolic neem seed extracts (NSE), both with known quantities of azadirachtin 
and the authors‟ general conclusions were that the neem-based products were effective 
against several species of aphids both in the laboratory and in the field, but mixtures of NSO 
or NSE and pyrethrum did not increase the efficacy of neem.  Considering their data from 
another perspective (i.e. whether neem increases the efficacy of pyrethrum), it can be seen 
that there was a significant (P < 0.05) reduction in the number of strawberry aphids 
(Fimbriaphis fimbriata (Richards) (Homoptera: Aphididae) and Chaetosiphon fragaefolii (Cockerell) 
(Homoptera: Aphididae) present on plants in one of two trials when a NSO and pyrethrum 
mixture was applied, compared with a pyrethrum treatment alone.  The authors hypothesise 
that the difference in the results between the first and second trials was due to plant size and 
application rate of the treatment, as well as whether both the top and bottom of the leaf 
surfaces were covered.  Experiments investigating the numbers of M. persicae and A. gossypii 
showed a significant (P < 0.05) reduction in aphid numbers when a mixture of NSE and 
pyrethrum was used, compared with pyrethrum alone.  Thus the findings of Lowery et al., 
(1993) although not the focus of their study, confirm those of the present study: that neem 
has synergistic properties when used in conjunction with pyrethrum. 
 
Chapter Five Screening putative synergists 
 
95 
It is known that neem oil is rich in pre-formed secondary metabolites, e.g. azadirachtin, 
phenolics and glycosides etc (Singh et al., 2005). These occur constitutively in entire parts of 
the neem plant and it is thought that they act within the plant as in-built chemical defences to 
pathogen infection and may protect plants against various insect pests.  Properties attributed 
to neem include insect anti-feedant properties (Govindachari et al., 2000); antibacterial and 
anti-inflammatory properties (Kraus, 1995).  Phenolics have been found to have antifungal 
properties (Ravn et al., 1989, Osbourn, 1996, Sarma & Singh, 2003), and antifeedant and 
antibacterial properties (Ravn et al., 1989). 
 
Azadirachtin has an ester bond on the periphery of the molecule which is clearly available for 
attack by esterases.  It is surprising that it was not more potent as an esterase inhibitor in vitro.  
Neem seed oil performed well as an esterase inhibitor both in vitro and in vivo.  As a seed oil it 
has many components, but there is insufficient data available to conclude which of the 
components of neem are the active esterase inhibitors.   
 
Singh et al. (2005) performed High Performance Liquid Chromotography (HPLC) on 
different parts of the neem plant and found the seeds to be rich in phenolic acids.  Both 
“raw” and “ripe” seeds were studied and the same four phenolic acids were detected in each, 
although the level of the acids was greater in “raw” fruit seeds compared with ripe seeds.  In 
order of abundance, the 4 acids identified were Gallic, Chlorogenic, Tannic and Ferulic 
(Figure 5.5).   
 
Tannic acid is a water soluble polyphenol that is present throughout neem plant and is 
reported to have anticarcinogenic, antimutagenic and antioxidant properties (Chung et al., 
1998).  Gallic acid has been reported to have similar properties as tannic acid (Shahrzad & 
Bitsch, 1998) and ferulic acid is thought to have antifungal  (Sarma & Singh, 2003) and 
antioxidant properties (Graf, 1992).  From the results in this study it would be expected that 
gallic, chlorogenic, tannic and ferulic acids might explain the higher synergism seen when 
using neem seed oil compared to azadirachtin.  In the current experiments, azadirachtin was 
not tested in vivo, however it would be interesting to assess the difference in activity between 
the purified azadirachtin and the crude neem seed oil in vivo.  Unfortunately it is not known 
whether the neem seed oil used in this study was produced from “raw” or “ripe” seeds.  
HPLC assay of the neem seed oil would determine the relative abundance of the 4 phenolic 
acids and may provide information as to which are acting as the synergist with pyrethrins. 
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Gallic acid 
 
Chlorogenic acid 
 
Tannic acid 
 
Ferulic acid 
 
Figure 5.5  The structure of the four phenolic acids (gallic acid; chlorogenic acid; 
tannic acid and ferulic acid) identified by HPLC by Singh et al. (2005) present in 
“raw” and “ripe” neem seed oil.  
 
Both linoleic acid and oleic acid performed well in vitro and in vivo in these studies.  Although 
little is known about these compounds, there is a US Patent (5047424) (Puritch & Salloum, 
1991) which includes the use of oleic and linoleic acids as part of “an environmentally safe, 
broad spectrum insecticide”.  The concentrated formulation proposed comprises a 
pyrethroid component (0.2-2 % by weight) plus a mixture of monocarboxylic acids (50 % by 
weight) and the alkali metal salts of the acids.  The acids include oleic acid as a major 
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component and linoleic acid as a minor component (at least 70 % and 6 % by weight of the 
monocarboxylic acids, respectively).  A more recent patent (WO/2007/065026) (Hailu & 
Anderson, 2007) is for an invention whereby “certain solvent blends of mixtures of fatty 
acids alkyl esters advantageously possess synergistic solvency and provide improved solubility 
and uniformity to a pesticide composition”.  The invention describes a pesticide composition 
containing a preferred 25-55 % by weight of a blend of C12-C18 alkyl esters corresponding 
to a formula R1CO-OR2, where R1CO is an aliphatic acyl group (containing 12-18 carbon 
atoms) and R2 is a linear or branched alkyl group containing 1-4 carbon atoms, and a 
biologically active ingredient (the insecticide).  The examples given for solvent blends include 
mixtures of alkyl esters of fatty acids such as lauric, myristic, palmitic, palmitoleic, oleic, 
stearic, linoleic and linolenic acids, with mixtures of methyl esters of fatty acids containing 
12-18 carbon atoms being preferred.  Both of these patents are consistent with this study 
showing that oleic acid and linoleic acid have potential for synergism. 
 
The work discussed in this chapter has highlighted that some plant extracts show promise 
for use as a synergist with natural pyrethrins.  Further experiments are needed to extend 
these findings.  It would be interesting to look at the effect of putative synergists, especially 
neem seed oil and linoleic acid, on house fly strains that have a different resistance 
mechanism in addition to testing them on a wider range of insect species. 
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6 CHAPTER SIX: SUMMARY, DISCUSSION, LIMITATIONS AND 
RECOMMENDATIONS  
 
6.1 Enhancing the efficacy of pyrethrins using Piperonyl Butoxide 
(PBO) 
 Overall, PBO was found to increase the efficacy of natural pyrethrins against the 
resistant strains/clones of all insect species studied.  It was also found to increase efficacy 
against the susceptible strains/clones of some species and is it is thought this is because 
it is blocking the background esterases and/or P450s. 
 A tank mix of PBO and pyrethrins, or a pre-treatment of PBO prior to treatment 
with pyrethrins, significantly reduced the LC50 in resistant M. persicae, M. domestica and 
B. tabaci compared to a pyrethrins only treatment. 
 The optimum pre-treatment time for M. persicae was indicated to be 5 hours. 
 The increased efficacy of natural pyrethrins due to a tank mix of PBO and pyrethrins 
was generally superior to a pre-treatment. 
 The same paralysis effect on the insect was seen for both the pyrethrins and the 
PBO/pyrethrins mixes. 
 Many of the results obtained in this study have indicated that there are different levels of 
synergism occurring in the different insect species. This may be due to qualitative or 
quantitative differences in detoxification mechanisms (esterases/P450s).  
 Microencapsulations of pyrethrins plus PBO showed potential for increasing the efficacy 
of pyrethrins.  Although the use of microencapsulated formulations requires much more 
investigation this study did show that there is some potential for increasing the efficacy 
of pyrethrins, especially if the solubility issues could be overcome.  The principle of a 
modified release formulation, with the addition of compounds capable of stabilising 
pyrethrins in UV light, would greatly enhance the potential of pyrethrins being used in 
agriculture. 
 Results from these studies have shown that the efficacy of natural pyrethrins can be 
increased significantly using PBO as a tank mix, but unlike results with synthetic 
pyrethroids, a pre-treatment of PBO does not improve results further.  It appears that 
for natural pyrethrins PBO could be enhancing the penetration of the pyrethrins through 
the insect cuticle.  Experiments on M. persicae (with an esterase-based resistance 
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mechanism) indicated that the effect of enhanced penetration through the cuticle is 
greater than the effect of inhibiting the esterases totally, and that the enhanced 
penetration effect declines rapidly.  The rise in mortality (observed over time) with a 
PBO pre-treatment could be due to the enhanced inhibitory binding effect that PBO has 
on the esterases. 
 Even without a synergist, if kdr or super-kdr is present, pyrethrins may be more potent 
than synthetic pyrethroids.  Experiments testing the effect of PBO and pyrethrins 
compared with PBO and a synthetic pyrethroid have supported previous reports that kdr 
does not confer resistance against pyrethrins in the same way, or to the same level, as it 
does against synthetic pyrethroids.  This is shown by a lower LC50 for natural pyrethrins 
than for synthetic pyrethroids on insects with kdr.  If kdr is present in a pest population, 
pyrethrins could be a good choice for insect control accompanied by PBO if metabolic 
resistance mechanisms are also present. 
 
6.2 Development and use of a new biochemical assay 
 Standard spectrophotometric assays do not always reveal the inhibition of esterases by 
PBO in vitro and the success of the assay to identify the inhibition of esterases in vitro by 
PBO was hypothesised to be dependent upon the spatial distance between the binding 
sites on the esterase for the PBO and the artificial substrates used in the assays. 
 A new assay was successfully developed to test the hypothesis above, and esterase 
inhibition was detected indirectly by measuring AChE activity in an „esterase interference 
assay‟. 
 The „esterase interference assay‟ was used to screen putative synergists in vitro for their 
ability to inhibit esterases.  The new assay is a high throughput method of screening 
compounds for their ability to blockade esterase sequestration.  It enables large numbers 
of compounds to be tested quickly and easily, saving time and effort on in vivo testing as 
only compounds showing potential in vitro need be tested in vivo. 
 
6.3 Screening putative synergists for use with pyrethrins 
 Following bioassays using an emulsifiable concentrate of pyrethrins, oleic acid and 
ethoxylated castor oil, the two main components of the EC formulations, appeared to 
enhance the effect of pyrethrins in vivo and were found to inhibit esterases and P450s in 
vitro; 
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 Using the „esterase interference assay‟ the following compounds were found to inhibit 
esterases, in vitro, to the same or greater extent than PBO: neem seed oil, oleic acid, 
linoleic acid, ethoxylated castor oil and extracts of Correa lawrenciana, Correa stackhousiana, 
Correa alba var alba, Zieria arborescens, Boronia citriodora, Boronia pilosa, Acradenia frankliniae. 
 Ideally each compound should be tested on purified esterases from the target insect as 
although the use of E4 gives a good indication about how well the synergist may 
perform, it was found in Chapter four that esterases can vary and the spatial positions of 
the binding sites for the synergist and insecticide are important.  With some optimisation 
the esterase interference assay should work with esterases from other insects. 
 The following compounds were found to inhibit P450s, in vitro, to the same or greater 
extent than PBO: neem seed oil, oleic acid, linoleic acid, bergamot, parsley and some 
extracts of Correa lawrenciana, Correa stackhousiana, Correa alba var alba, Zieria arborescens, 
Boronia citriodora, Boronia pilosa, Acradenia frankliniae. 
 A limitation of the P450 assay was the use of lamb‟s liver.  During this study P450s were 
extracted from M. domestica (not described) and although some activity was found, it was 
insufficient to see the differences between in the presence and absence of the synergists.  
Also, insect P450s do not seem to survive well at -20 C and it is not realistic to try to 
extract P450s and screen putative synergists all in one day.  Although the use of 
mammalian P450s and the choice of substrate give a more generalised assay, not 
involving P450s specific to resistance, it was decided that for the purpose of screening 
putative synergists the use of lamb‟s liver was acceptable since PBO and other MDP 
compounds are known to be general P450 inhibitors, effecting insect, vertebrate and 
plant isoforms by forming a metabolic intermediate with the haem moiety (Scott et al., 
2000).  Ideally the P450s should have been extracted and used from the insect being 
studied as variations do occur and future experiments could look at improving the insect 
P450 extraction process and storage. 
 Extracts were chosen on the basis of their structure, or those containing a bioactive 
compound and many contained an MDP ring.  Although the MDP ring is not thought to 
be important in esterase interactions, those which did prove to be effective against 
esterases were certain to be P450 inhibitors because of the presence of this moiety.  
 As a tank mix with pyrethrins, none of the putative synergists tested in vivo performed as 
well as PBO in a tank mix treatment on resistant M. persicae. However, as a tank mix with 
alpha-cypermethrin, most compounds tested gave better synergism than PBO in 
treatment on M. persicae. 
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 As a tank mix with PBO and pyrethrins, neem seed oil, linoleic acid and oleic acid all 
showed the same or better synergism than a PBO and pyrethrins tank mix when used on 
resistant M. persicae. 
 As a tank mix with pyrethrins in treatments on resistant M. domestica, the efficacy of 
pyrethrins was improved but not to the same extent as a tank mix of PBO and pyrethrins 
when using linoleic acid or neem seed oil as the synergist.  However, when incorporated 
into a tank mix with PBO and pyrethrins on M. domestica, the putative synergists 
enhanced the efficacy of pyrethrins to the same extent as a tank mix containing only 
PBO and pyrethrins. 
 In the search for an alternative synergist to use with pyrethrins, various compounds 
showed potential for inhibiting esterase and P450s in vitro.  Like PBO, oleic acid, linoleic 
acid and ethoxylated castor oil all have long carbon chains and it is postulated that their 
success as synergists results from the presence of the ethoxy-chain, which is perhaps 
responsible for esterase inhibition.  Further investigations would enable a clearer picture 
of the potential of the more successful synergists in vivo: linoleic acid, oleic acid, 
ethoxylated castor oil and neem seed oil, as synergists for use with pyrethrins or as 
mixtures with PBO and pyrethrins.  The cost of using these compounds would also 
require consideration.  
 Many of the plant extracts produced by Botanical Resources and the University of 
Tasmania showed, from these preliminary studies, that they have the ability to increase 
the efficacy of natural pyrethrins.  It would be very interesting to extend these studies to 
see if combinations of putative synergists either with each other, or with PBO, could 
further enhance pyrethrin activity.   
 In addition to the theory proposed in chapter five that the putative synergists may be 
enhancing the penetration of pyrethrins through the insect cuticle, future work should 
include bioassays to assess the effects of the synergists alone in bioassays.  Some are 
already known to have insecticidal properties, for example neem (Lowery et al., 1993, 
Govindachari et al., 2000, Mordue (Luntz) & Nisbet, 2000)and thus may in fact be acting 
by a joint effort with pyrethrins by means of insecticidal action rather than inhibition of 
metabolic defences. 
 Future work would include purifying the putative synergists which look to have potential 
and identifying the active components.  This would enable a study to be made using 
molarities rather than percentages (which were used in this study) as the use of 
percentages for calculating the concentration of insecticide is not ideal.  For this study 
the bioassays had to be performed using percentages as a majority of the compounds to 
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be tested were plant extracts/essential oils and therefore not pure.  If the molecular 
weight of the compound being tested was known then molarities could be used to ensure 
that for each synergist being compared, the same number of molecules was being used 
and would therefore make the study a more fair comparison.  Although some 
compounds were pure and therefore could be calculated in molarities, in order to be 
consistent throught the study, all compounds were tested by percentage. 
 
 
6.4 General Limitations 
 Although it was decided the most practical approach for the experiments in this project, 
there are problems associated with keeping a constant ratio of of synergist:insecticide. 
Despite these problems, it was decided to keep a constant ratio as not only was it more 
practical but previous studies had shown different ratios to have very different effects on 
mortality of bioassayed insects (Bingham et al., 2007). The inhibition of metabolic 
systems may be unequal across the range of doses used in the experiments and the effect 
of these may become critical if comparisons are made between strains/clones of insects 
with significantly different dose responses (e.g. resistant and susceptible).  As was the 
case in these experiments, when the susceptible strain/clone was treated, due to the 
lower level of insecticide required, it would receive a far lower amount of synergist 
compared to the resistant strain/clone due to the fixed ratio.  In the resistant 
strain/clone the synergist was applied at comparatively high levels compared to the 
susceptible, and may have been toxic itself at the levels tested.  Ideally each putative 
synergist should have been tested alone in a dose response bioassay to ensure that the 
effects of the synergist were not overestimated as the synergist dose should be high 
enough to cause maximal inhibition of the metabolic systems without causing mortality 
on its own.  It is arguable as to whether synergists should be applied at an equal dose to 
the susceptible and resistant insects since this would change the ratio of 
synergist:insecticide and as mentioned previously, this has been shown to be important. 
 The bioassays used in this study have limitations in how well they represent field use.  In 
the field a plant would be sprayed form above and the inderside of the leaf would not be 
exposed to much of the treatment.  Translaminar flow of insecticide may increase the 
amount of insecticide that reaches the insects on the undersides of the leaves where 
insects naturally prefer to live and feed.  Given that the insects in this study were either 
placed onto leaf dics where the both surfaces had been treated with insectide/synergist, 
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or the treatment was applied directly onto the insects, the result in the field would be 
different as the insects would receive less treatment than they were exposed to in the 
bioassays. 
 
 
6.5 Recommendations 
 To increase the efficacy of natural pyrethrins, a tank mix with PBO is recommended over 
a pre-treatment as efficacy using a tank mix is generally superior, and less labour 
intensive; 
 Improved solubility of pyrethrin microencapsulations with UV stabilisers may enable 
pyrethrins to be used in agriculture (outdoors) and thus should be investigated, although 
efficacy testing for comparison to a tank mix would need to be performed. 
 The „esterase interference assay‟ is a novel and efficient method of screening putative 
synergists for their ability to inhibit esterases in vitro and the P450 assay is an efficient 
method of screening putative synergists for their ability to inhibit P450s in vitro.  Used in 
sequence, these two assays enable a fast and reliable method of screening putative 
synergists before more time and labour intensive in vivo testing. 
 Linoleic acid, ethoxylated castor oil and neem seed oil all performed well in vivo with 
pyrethrins and PBO, and thus investigations into the potential of these on different 
insect species should be continued on insects with different resistance mechanisms and 
different levels of resistance. 
 More detailed investigations using the Tasmanian plant extracts as synergists, in 
combinations with each other and/or with PBO, would be interesting and may give rise 
to a novel organic synergist for use with pyrethrins. 
 Further experimental work to identify the binding sites on the metabolic enzymes 
(esterases/P450s) of each of the putative synergists would enable a greater understanding 
of the synergists‟ mode of action and thus how to maximise their potential for use in 
insect control. 
 It would be beneficial to identify the 3-dimensional structure of esterases, particularly E4 
which is fairly easy to purify, in order to establish the precise characteristics an ideal 
esterase inhibitor would possess.  
 Future work could include identifying the stage of the target insects‟ life cycle at which it 
would be most effective to apply the synergist/pyrethrin mixture. 
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 Overall, this PhD project has found that various compounds have shown potential to 
increase the efficacy of natural pyrethrins.  Further studies may offer improvements in 
crop protection and public-health by the use of natural pyrethrins in combination with a 
novel botanical compound as a synergist which may appeal to the organic farming 
industry.  
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Appendix I – Buffers and substrates 
0.02M pH7.0 phosphate buffer 
3.58g di-sodium hydrogen orthophosphate dodecahydrate 
1.36g potassium dihydrogen orthophosphate 
made up to one litre with distilled water. 
 
Phosphate buffer plus Triton 
0.1% Triton X-100 dissolved in 0.02M pH 7.0 phosphate buffer. 
 
Fast blue RR (FBRR) 
0.015g FBRR made up to 25ml with 0.02M pH 7.0 phosphate buffer, then filtered. 
 
1-naphthyl-acetate 
0.5ml 30mM 1-naphthyl acetate in 15ml FBRR to give a final concentration of 1mM. 
 
ATChI 
0.022g ATChI in 50ml 0.02M pH 7.0 phosphate buffer to give a final concentration of 
1.5mM. 
 
DTNB 
0.015g DTNB in 25ml 0.02M pH7.0 phosphate buffer to give a final concentration of 
1.5mM.  The DTNB is then diluted 20-fold to give a final concentration of 75µM. 
 
0.1 M sodium phosphate buffer (pH 7.6) containing 1 mM EDTA, 1 mM DTT, 1 mM 
PTU, 1 mM PMSF, 1.46 M sucrose 
6.230 g di-sodium hydrogen orthophosphate dodecahydrate, 0.406 g sodium di-hydrogen 
orthophosphate, 0.074 g EDTA, 0.030 g DTT, 0.030 g PThU, 0.034 g PMSF and 100 g 
sucrose were dissolved in distilled water to make a final volume of 200 ml.  The PThU and 
PMSF were dissolved first in 1ml pure ethanol. 
 
0.1 M sodium phosphate buffer (pH 7.8) 
3.277 g di-sodium hydrogen orthophosphate dodecahydrate and 0.133 g sodium di-hydrogen 
orthophosphate were dissolved in a total of 100 ml distilled water. 
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Appendix II – Processing novel esterase assay data  
The IC50 value found using Grafit was converted into a percentage and given a new 
terminology: I (for “Index value”) 
 
The IC50 for „E4‟ was taken as 100 % activity, and for „no E4‟ taken as 0% activity.   
 
The IC50 of the putative synergist sample (now termed I) was converted into a percentage 
by the following formula: 
 
I =  I (synergist) – I (no E4)   ×   100 = y – x1   ×   100 
      I (E4) – I (no E4)    x2 – x1 
 
 
Variance of the index (I) was approximated using the following expression: 
 
var (I) =    1002  [var(y) + var(x1)] 
    (x2-x1)
2 
 
It is important to note that this calculation often gives an underestimated value for the 
variance because the denominator is taken as a fixed quantity in the formula. 
 
Here, var(y) = (se(y))2 where se(y) is the standard error for the IC50 (for the synergist) as 
given by the fit provided using Grafit; and similarly for x1 („no E4‟). 
 
Following this, 
 
se (I)  =  √[var(I)]   
 
        ____   __ 
= √    1002      .  [var(y) + var(x1)]  
       (x2-x1)
2 
 
The 95% Confidence Interval, denoted CI (95%), is given by 
 
I ± t0.05, 21 × se(I) 
 
where t0.05, 21  is the t-value at the p = 0.05 level of significance on 21 degrees of freedom (df). 
These are 21 because there are 33 data points (11 data points for each curve and 3 curves (no 
E4, E4, E4+synergist), less 12 parameters for fitting the 3 logistic curves. 
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Appendix III – Processing cytochrome P450 assay data 
Given the means and standard errors for all the compounds, the ratio of putative synergists 
to the control were calculated. The formula for the variance of this ratio is: 
 
var(a/b) = (a2/b2)[(var(a)/a2)+(var(b)/b2)] 
 
where a is the mean and var(a) is the square of the standard error of the mean for a putative 
synergist, and where b is the mean and var(b) is the square of the standard error of the mean 
for the control. 
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Appendix IV – Bioassay data for Chapter Three 
Data derived from PoloPlus. TM: Tank mix; PT: pre-treatment; Nc: not calculable; R: resistant; S: susceptible; n: number of insects tested; LC50 : insecticide 
concentration required for 50 % mortality in studied population; CL: confidence limits; ppm: parts per million; SE: standard error; 2: chi squared value; df: 
degrees of freedom; RF: resistance factor; ESR: effective synergism ratio. 
 
The number of insects tested is shown in the column marked „n‟ and this refers to the number of insects tested in the doses for which results were inputted 
into PoloPlus. The column labelled „controls‟ indicates the number of insects treated with a control solution only (e.g. water or acetone as appropriate).  The 
LC50 and LC90 are both shown with their corresponding confidence limits (95%).  The slope indicates the heterogeneity of the population.  The Chi square 
value indicates the goodness of fit i.e. how well the data fits the underlying probit model. 
 
Table A-IV-I The effect of a tank mix and pre-treatment of PBO on the efficacy of natural pyrethrins against: a)Myzus persicae (topical 
application technique); b)Musca domestica (topical application technique); c) Myzus persicae (leaf-dip technique); d) Bemisia tabaci (leaf-dip 
technique).   
a)Myzus persicae (topical application technique) 
 Strain/     LC50 (95% CL) LC90 (95% CL)       
Treatment Clone S/R Sex n controls (ppm) (ppm) Slope (+/-SE) 2 df RF ESR 
Pyrethrins only  
(topical application) 
4106a S - 208 60 37.2 (23.0-55.2) 150.8 (93.0-396.6) 2.108  0.317 32.5 19 1.0 1.0 
794jz R - 480 90 1630.7 (1253.9-2061.1) 6086.7 (4407.7-10092.4) 2.240  0.229 80.8 46 43.8 43.8 
PBO/pyrethrins TM (4:1) 
(topical application) 
4106a S - 298 60 6.8 (3.6-10.8) 27.2 (16.5-69.7) 2.127 0.264 79.5 28 1 0.2 
794jz R - 330 70 121.7 (94.3-156.7) 419.1 (300.4-693.8) 2.387  0.220 57.7 31 17.9 3.3 
PBO PT / pyrethrins (4:1) 
(topical application) 
4106a S - 150 30 46.3 (35.602-58.332) 86.2 (66.682-146.989) 4.753  1.084 11.6 13 1.0 1.2 
794jz R - 400 90 192.7 (129.4-271.3) 750.3 (496.6-1484.5) 2.171  0.188 132.4 38 4.2 5.2 
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b)Musca domestica (topical application technique) 
 Strain/     LC50 (95% CL) LC90 (95% CL)       
Treatment Clone S/R Sex n controls (ppm) (ppm) Slope (+/-SE) 2 df RF ESR 
Pyrethrins only  
(topical application) 
WHOij2 S 
M 361 40 659.4 (524.4-834.8) 1851.9 (1372.2-2902.4) 2.86 (0.28) 23.4 16 1.0 1.0 
F 340 40 755.7 (659.4-868.3) 1399.3 (1173.6-1815.4) 4.79 (0.61) 4.6 15 1.0 1.0 
381zb R 
M 200 40 8513.8 (7104.2-9977.6) 17158.5 (14142.4-23121.6) 4.21 (0.62) 6.2 8 12.9 12.9 
F 200 40 11251.9 (9838.2-12685.5) 16342.7 (14189.4-21740.8) 7.91 (1.69) 3.4 8 14.9 14.9  
PBO/pyrethrins TM (5:1)  
(topical application) 
WHOij2  S 
M 360 40 46.2 (41.2-51.0) 76.2 (67.8-90.4) 5.90 (0.78) 9.3 16 1.0 0.07 
F 340 40 48.6 (44.3-53.2) 73.4 (65.3-87.5) 7.17 (0.86) 16.5 15 1.0 0.06 
381zb R 
M 240 40 365.3 (319.2-418.3) 663.9 (558.4-865.1) 4.94 (0.67) 3.3 10 7.9 0.55 
F 242 40 589.3 (509.9-695.1) 1077.7 (846.9-2176.5) 6.30 (1.66) 15.5 10 12.1 0.78 
PBO PT / pyrethrins (5:1) 
(topical application) 
WHOij2 S 
M 278 40 81.3 (73.7-88.8) 115.2 (103.5-136.6) 8.47 (1.15) 13.2 12 1.0 0.12 
F 360 40 71.2 (61.8-78.7) 96.2 (86.0-121.3) 9.81 (1.70) 25.2 16 1.0 0.09 
381zb R 
M 360 40 404.5 (358.0-453.6) 552.6 (489.0-665.9) 9.46 (1.55) 8.2 16 5.0 0.62 
F 360 40 570.7 (442.9-756.8) 1220.2 (879.4-2724.5) 3.884 (0.80) 19.2 16 8.0 0.76 
 
c) Myzus persicae (leaf-dip technique) 
 Strain/     LC50 (95% CL) LC90 (95% CL)       
Treatment Clone S/R Sex n controls (ppm) (ppm) Slope (+/-SE) 2 df RF ESR 
Pyrethrins EC  
(leaf dip) 
4106a S - 150 30 22.7 (10.7-32.5) 74.2 (51.9-157.5) 2.495 0.637 9.4 13 1.0 1.0 
794jz R - 150 30 365.6 (259.5-556.9) 1933.4 (1096.7-5194.7) 1.772 0.276 10.5 13 16.1 16.1 
PBO EC/pyrethrins EC 
TM (4:1)  
(leaf dip) 
794jz R - 150 30 64.1 (44.7-92.5) 211.1 (136.6-456.0) 2.474 0.349 16.9 13 Nc 2.8 
PBO EC PT / pyrethrins 
EC (4:1) 
(leaf dip) 
794jz R F 150 30 46.7 (35.1-59.8) 107.5 (80.5-179.0) 3.538 0.663 7.4 13 Nc 2.1 
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d) Bemisia tabaci (leaf-dip technique) 
 Strain/     LC50 (95% CL) LC90 (95% CL)       
Treatment Clone S/R Sex n controls (ppm) (ppm) Slope (+/-SE) 2 df RF ESR 
Pyrethrins EC  
(leaf dip) 
Sud-S S F 482 73 10.1 (7.0-13.4) 28.1 (20.3-47.8) 2.868  0.273 87.7 28 1.0 1.0 
Mex2-
GRB 
R F 493 81 629.5 (326.5-1581.3) 4780.4 (1817.4-47871.4) 1.455 0.126 142.1 22 62.3 62.3 
Pirgos R F 214 31 >1000        Nc Nc 
PBO EC/pyrethrins EC 
TM (4:1)  
(leaf dip) 
 
Sud-S S F 207 40 11.1 (8.4-14.9) 27.8 (19.5-53.5) 3.215 0.360 29.7 13 1.0 1.1 
Mex2-
GRB 
R F 195 25 173.8 (111.2-316.4) 752.4 (385.9-4038.3) 2.014 0.266 36.2 13 15.7 17.2 
Pirgos R F 265 54 37.4 (30.5 – 46.2) 65.2 (51.6 – 103.2) 5.314 0.703 33.8 16 3.4 3.7 
PBO PT / pyrethrins (4:1) 
(leaf dip) 
Sud-S S F 175 49 10.5 (7.7-14.6) 29.4 (20.0-59.6) 2.874 0.342 25.5 13 1.0 1.0 
Mex2-
GRB 
R F 193 28 199.8 (141.1-343.5) 882.2 (464.9-3573.7) 1.987 0.291 20.8 13 19.0 19.8 
Pirgos R F 289 70 95.1 (72.9-118.9) 171.1 (134.8-261.3) 5.027 0.586 33.4 13 9.1 9.4 
 
Table A-IV-II The effect of microencapsulated pyrethrins (plus/minus PBO) on a resistant and susceptible clone of Myzus persicae 
 Formul
ation 
    LC50 (95% CL) LC90 (95% CL)       
Treatment Clone R/S n controls (ppm) (ppm) Slope (+/- SE) 2 df RF ESR 
Microencapsulated pyrethrins  
β-cyc 
4106a S 180 30 583.4 436.7-871.1 1924.2 1182.3-5151.7 2.473 0.388 20.1 16 1 1 
794jz R 90 30 > 10000       Nc Nc 
γ-cyc 
4106a S 150 30 > 1000        Nc Nc 
794jz R 90 30 > 10000       Nc Nc 
PBO (EC) + microencapsulated 
pyrethrins  
β-cyc 794jz R 150 30 50.2 33.7-65.9 103.8 77.4-193.3 4.066 0.759 19.1 13 Nc 0.086 
γ-cyc 794jz R 150 30 64.9 47.4-88.7 197.7 135.4-374.7 2.648 0.386 13.8 13 Nc Nc 
PBO (tech.) (top. app.) + 
microencapsulated pyrethrins  
β-cyc 794jz R 298 60 137.9 95.1-184.5 375.0 266.4-720.8 2.950  0.424 52.8 28 Nc 0.236 
γ-cyc 794jz R 150 30 261.4 184.9-371.8 720.1 478.5-1666.6 2.912 0.391 26.8 13 Nc Nc 
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 Table A-IV-III Bioassay results for Myzus persicae (72 hours after dosing) using a topical application of technical alpha-cypermethrin 
     LC50 (95% CL) LC90 (95% CL)       
Treatment Clone R/S n controls (ppm) (ppm) Slope (+/-SE) 2 df RF ESR 
α-cypermethrin 
4106A S 180 30 0.495 0.320-0.729 1.473 0.952-3.540 2.71 0.34 41 16 1 - 
794jz R 240 30 3230.2 3017.3-3369.9 3769.4 3591.8-4158.1 19.11 3.27 34.3 22 6525.7 6525.7 
PBO + α-cypermethrin (tank mix) 794jz R 150 30 810.8 486.3-1331.7 8309.5 3522.9-100754.9 1.27 0.33 7.1 13 - 1637.9 
PBO (5 hour pre-treatment) + α-cypermethrin 794jz R 180 30 169.9 122.0-257.5 966.3 536.6-2816.2 1.698 0.243 17.8 16 - 343.2 
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Appendix V – Bioassay data for Chapter Five 
Data derived from PoloPlus. TM: Tank mix; PT: pre-treatment; Nc: not calculable; R: resistant; S: susceptible; n: number of insects tested; LC50 : insecticide 
concentration required for 50 % mortality in studied population; CL: confidence limits; ppm: parts per million; SE: standard error; 2: chi squared value; df: 
degrees of freedom; RF: resistance factor; ESR: effective synergism ratio. 
 
Table A-V-I Bioassays to test putative synergists against Myzus persicae (794jz clone) as a tank mix with pyrethrins (4:1) 
   LC50 (95% FL) LC90 (95% FL)       
Treatment n controls (ppm) (ppm) Slope (+/- SE) 2 df ESR  SF 
Pyrethrins only* 480 90 1630.7 (1253.9-2061.1) 6086.7 (4407.7-10092.4) 2.240  (0.229) 80.8 46 43.8 - 
PBO* 330 70 121.7 (94.3-156.7) 419.1 (300.4-693.8) 2.387  (0.220) 57.7 31 3.3 13.4 
Ethoxylated castor oil 140 20 342.6 (272.3-434.8) 802.5 (601.5-1279.7) 3.466 (0.532) 9.3 12 9.2 4.8 
Za-B2 140 20 350.5 (219.6-583.1) 1334.8 (753.4-4463.8) 2.207 (0.313) 22.9 12 9.4 4.7 
Linoleic acid 140 20 413.0 (287.3-625.3) 1350.8 (833.7-3495.4) 2.490 (0.373) 16.8 12 11.1 3.9 
Neem seed oil 80 20 463.0 (387.0-552.4) 733.4 (604.0-1073.4) 6.416 (1.353) 2.7 6 12.4 3.5 
Oleic acid 140 20 541.0 (336.1-1019.9) 1926.6 (1021.5-9464.4) 2.323 (0.360) 25.2 12 14.5 3.0 
Cl-B1 80 20 611.5 (492.1-763.5) 1257.4 (963.8-2042.4) 4.093 (0.751) 3.1 6 16.4 2.7 
Parsley seed oil (53) 60 20 802.9 (521.9-990.4) 1340.0 (1073.3-2620.4) 5.761 (1.848) 1.3 4 21.6 2.0 
Bc-B1 80 20 822.5 (615.6-1218.0) 2624.7 (1620.5-7774.1) 2.543 (0.547) 3.6 6 22.1 2.0 
Bergamot 100 20 1068.2 (784.5-1761.5) 3499.5 (2024.0-12102.9) 2.487 (0.530) 4.0 8 28.7 1.5 
* for reference: data from Chapter Three 
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Table A-V-II  Bioassays to test putative synergists against Myzus persicae (794jz clone) as a tank mix with alpha-cypermethrin (4:1) 
   LC50 (95% FL) LC90 (95% FL)       
Treatment n controls (ppm) (ppm) Slope (+/- SE) 2 df ESR SF 
Alpha-cypermethrin 
only* 
240 30 3230.2 3017.3-3369.9 3769.4 3591.8-4158.1 19.11 3.27 34.3 22 6525.2 - 
PBO* 150 30 810.8 486.3-1331.7 8309.5 3522.9-100754.9 1.27 0.33 7.1 13 1638.0 4.0 
Neem seed oil 180 30 177.6 120.1-297.9 986.2 508.3-3719.4 1.722 0.239 25.0 16 358.8 18.2 
Linoleic acid 180 30 247.7 190.8-345.1 1012.3 635.3-2261.8 2.096 0.315 11.5 16 500.4 13.0 
Parsley seed oil (53) 180 30 282.1 212.7-414.5 1223.7 729.1-3037.0 2.011 0.307 14.5 16 569.9 11.5 
Ethoxylated castor oil 180 30 282.9 198.6-475.9 1070.9 594.2-3833.6 2.217 0.332 25.9 16 571.5 11.4 
Cl-B1 120 20 386.8 268.4 – 735.4 1603.8 813.6 – 7657.3 2.075 0.444 7.4 10 781.4 8.4 
Oleic acid 90 30 400.2 296.3-726.0 878.0 556.7-5560.1 3.756 0.805 11.2 7 808.5 8.1 
* for reference: data from Chapter Three 
 
 
Table A-V-III Bioassays to test putative synergists against Myzus persicae (794jz clone) as a tank mix with PBO and pyrethrins (4:4:1) 
   LC50 (95% FL) LC90 (95% FL)       
Treatment n controls (ppm) (ppm) Slope (+/- SE) 2 df ESR SF 
Pyrethrins only* 480 90 1630.7 (1253.9-2061.1) 6086.7 (4407.7-10092.4) 2.240  0.229 80.8 46 43.8 - 
PBO* 330 70 121.7 (94.3-156.7) 419.1 (300.4-693.8) 2.387  0.220 57.7 31 3.3 3.3 
Neem seed oil 100 20 65.4 (52.0-82.0) 144.2 (109.5-232.7) 3.732 (0.648) 7.0 8 1.8 24.9 
Linoleic acid 140 20 86.0 (65.4-114.1) 173.6 (127.9-314.7) 4.200 (0.700) 15.1 12 2.3 18.9 
Ethoxylated castor oil 140 20 113.9 (80.0-147.9) 263.5 (196.7-455.0) 3.519 (0.743) 8.2 12 3.1 14.3 
* for reference: data from Chapter Three 
 
 
    Appendix V 
 
122 
Table A-V-IV Bioassays to test putative synergists against female Musca domestica (381zb strain) as a tank mix with pyrethrins (5:1) 
   LC50 (95% FL) LC90 (95% FL)       
Treatment n controls (ppm/20mg fly) (ppm/20mg fly) Slope (+/- SE) 2 df ESR SF 
Pyrethrins only* 200 40 11251.9 (9838.2-12685.5) 16342.7 (14189.4-21740.8) 7.91 (1.69) 3.4 8 14.9 - 
PBO* 242 40 589.3 (509.9-695.1) 1077.7 (846.9-2176.5) 6.30 (1.66) 15.5 10 0.78 19.1 
Neem seed oil 89 21 4635.1 (3335.6-7056.5) 14354.8 (8922.3-34597.4) 2.61 (0.46) 4.2 6 6.1 2.4 
Linoleic acid 89 28 5657.7 (3879.0-8146.0) 13832.4 (9312.5-33265.2) 3.30 (0.78) 3.1 6 7.5 2.0 
* for reference: data from Chapter Three 
 
 
Table A-V-V  Bioassays to test putative synergists against female Musca domestica (381zb strain) as a tank mix with PBO and pyrethrins (5:5:1) 
   LC50 (95% FL) LC90 (95% FL)       
Treatment n controls (ppm/20mg fly) (ppm/20mg fly) Slope (+/- SE) 2 df ESR SF 
Pyrethrins only* 200 40 11251.9 (9838.2-12685.5) 16342.7 (14189.4-21740.8) 7.91 (1.69) 3.4 8 14.9 - 
PBO* 242 40 589.3 (509.9-695.1) 1077.7 (846.9-2176.5) 6.30 (1.66) 15.5 10 0.78 19.1 
Neem seed oil 304 28 425.6 (270.9-741.1) 849.5 (544.8-3257.0) 4.27 (0.59) 97.7 22 0.56 26.4 
Linoleic acid 273 28 526.5 (441.5-630.7) 982.3 (792.0-1630.7) 4.73 (0.74) 14.6 21 0.70 21.4 
* for reference: data from Chapter Three 
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Appendix VI – Khot et al. (2008) 
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